Biological indicators for the assessment of human exposure to industrial chemicals. Antimony, soluble barium compounds, hexane and methyl ethyl ketone, thallium and tin. Industrial health and safety. EUR 14815 EN by Alessio, L. et al.
EUROPEAN COMMISSION 
Iii  Report 
w 
l)  EUR 14815 EN 
Biological indicators for 
the assessment of 
human exposure to 
industrial chemicals 
Antimony 
Soluble barium compounds 
Hexane and methyl ethyl ketone 
Thallium and tin 
Health and safety EUROPEAN COMMISSION 
/( 
)Vvd--J  . 
Health and safety 
Biological indicators for the 
-assessment of human exposure 
to industrial chemicals 
Antimony 
P.  Apostoli, S. Porru, L. Alessio 
Soluble barium compounds 
W. Zschiesche and K.  H. Schaller 
Hexane and methyl ethyl ketone 
A.  Mutti 
Thallium and tin 
G. Kazantzis 
Edited by 
L.  Alessio, A. Berlin, R. Roi, M. Th. van der Venne  ,, 
Joint Research Centre 
lspra site 
Directorate-General for Employment and Social Affairs 
Health and Safety Directorate 
Directorate-General for Science, Research and Development 
1994  EUR 14815 EN 
C~Sb  ·.  V/{p4 C. Published by the 
EUROPEAN COMMISSION 
Directorate-General XIII 
Telecommunications, Information 
Market and Exploitation of Research 
L-2920 Luxembourg 
LEGAL NOTICE 
Neither the European Commission nor any person acting on behalf of the 
Commission is responsible for the use which might be made of the following 
information. 
Cataloguing data can be found at the end of this publication. 
Luxembourg: Office for Official Publications of the European Communities, 1994 
ISBN 92-826-5331-5 
© ECSC-EC-EAEC, Brussels • Luxembourg 1994 
Printed in the Netherlands Preface to the first volume 
The evaluation of the exposure of workers to dangerous agents is one of the measures 
ensuring better health protection. This evaluation is called monitoring. 
Two approaches are available for the monitoring: 
(i)  ambient monitoring already in  use for many years and 
(ii)  biological monitoring of more recent development. 
The need  for clear definitions and for establishing the respective roles  of these two 
types of monitoring has become necessary recently. In 1980 in Luxembourg at an inter-
national seminar organized jointly by the CEC and the US  authorities  (Occupational 
Safety and Health Administration and the National Institute for Occupational Safety and 
Health) on  the assessment of toxic agents at the workplace, the following definitions 
were agreed: 
(i)  ambient monitoring  is  the measurement and  assessment of agents at the work-
place and evaluates ambient exposure and health risk compared to an appropriate 
reference; 
(ii)  biological monitoring is the measurement and assessment of workplace agents or 
their metabolites either in tissues, secreta, excreta, expired air or any combination 
of these to evaluate exposure and  health  risk compared  to  an  appropriate refer-
ence. 
In  addition,  the  term  'health  surveilance' was  also  defined  as  the  periodic  medico-
physiological examinations of exposed workers with the objective of protecting health 
and  preventing  occupation-related  disease.  The  detection  of established  disease is 
outside the scope of this definition. 
The definitions of biological monitoring and health surveillance separate components 
of a continuum which can range from the measurements of agents in the body through 
measurements of metabolites, to signs of early disease. A problem left unresolved con-
cerns the precise place within these definitions of certain  biochemical tests such as 
zinc protoporphyrin (ZPP), delta aminolaevulinic acid dehydrase (ALA-D), delta amino-
laevulinic acid (ALA) in the blood and urine, etc., which are, in fact, indicators of meta-
bolic effects which have occurred as a consequence of exposure. 
Ambient monitoring is carried out for different reasons, for example: 
(a)  determining ambient concentrations in  relation to an established legal standard or 
consensus guideline; 
(b)  determining the relationship,  if any,  between the concentrations of agents at the 
workplace and the health of the workers; 
(c)  ensuring the effectiveness of control measures; 
(d)  evaluating the need for controls in the vicinity of specific emission sources; 
(e)  indicating trends in relation to an improvement or determination at the workplace; 
(f)  providing an  historical record. 
Biological  monitoring  measures or evaluates exposure from  all  routes.  It sometimes 
allows a better evaluation of health  risk than ambient monitoring especially in  cases 
where exposure through different routes has to be  considered.  Biological monitoring 
takes into account individual variability, the impact of factors such as personal activity, 
biological characteristics and life style of the individual. 
Ill The  two  types  of  monitoring  are  complementary  in  increasing  the  protection  of 
workers' health. If both are carried out simultaneously, information should be produced 
on the relationships existing between external exposure and concentration of the sub-
stance in  biological samples, and between this concentration and early effects. 
Detailed knowledge of the metabolism of the toxic agent in the human organism and 
of the alterations that occur in  critical organ is essential in  selecting the parameter to 
be used as indicator. 
Unfortunately, however, such knowledge is usually insufficient and thus limitations exist 
in  most biological monitoring programmes. 
The conditions necessary for successful biological monitoring are: 
(i)  existence of indicators, 
(ii)  existence of analytical methods that will guarantee technical reliability in the use of 
these indicators, 
(iii) possibility of measuring the indicators on readily accessible biological specimens, 
(iv) existence and knowledge of dose-effect and dose-response relationships. 
In  carrying out a biological monitoring programme, it is indispensable to know exactly 
what the characteristics and behaviour of the indicators under study are in relation to 
length of exposure, time elapsed since beginning and end of exposure, and all physi-
ological and pathological factors other than exposure that could give a false interpreta-
tion of the results obtained. 
Conditions for biological monitoring application include adoption of analytical methods 
yielding values comparable throughout the different laboratories. 
This long-adopted approach has already permitted the CEC to standardize in 1972 a 
method for erythrocyte ALAD determination and develop programmes for interlabora-
tory comparisons for lead and cadmium determination in biological media. 
The Council of Ministers of the European Communities,  in  adopting in  1978 the First 
Action  Programme  on  Safety  and  Health  at  Work  proposed  by  the  Commission, 
stressed the need to increase protection against dangerous substances; it emphasized 
the need to promote new monitoring and measuring methods for the assessment of 
individual exposure, in  particular through the application of sensitive biological indica-
tors. 
In August 1982 the Council adopted a directive on the protection of workers exposed 
to  lead.  The monitoring of blood  lead  levels as well  as  the  determination  of ALAU, 
ALAD and ZPP are among the tools to be used for monitoring worker exposure to lead. 
A comparison of the results with action levels and limit values allows appropriate action 
to be taken. 
Considerable  data  concerning  the  biological  monitoring  of  a  number  of  industrial 
chemicals have been published in  international literature. 
Nevertheless, the difference in approches used in the research, the variety of analyti-
cal methods and the frequent discordances in  the results,  usually make it difficult to 
formulate a conclusive synthesis permitting the transfer of literature data into practice. 
The aim of this series dedicated to the human biological monitoring of industrial chemi-
cals in  occupational health is  based on  the considerable experience acquired by the 
authors in the specific topics. 
For the draft of the monographs, the following outline, suggested by R.  L.  Zielhuis and 
R.  Lauwerys, has been used: 
(i)  a review of metabolism and/or mechanism of action; 
(ii)  potentially useful biological parameters for evaluation of exposure and/or body bur-
den and/or early reversible effects: 
(iii) a critical evaluation of each parameter: 
predictive validity in regard to exposure; 
quantitative relationship between levels of external exposure and internal expo-
sure, and between exposure and effects; 
limitations of the test;  · 
(iv) a proposal for one or several tests for biological monitoring. 
Because of the considerable gaps in scientific knowledge it has not been possible to 
follow this outline strictly in every single one of the monographs. It is hoped that future 
research will fill these gaps. 
It must be recognized that the biological monitoring approach for other toxic agents 
must still be developed and that considerable research is still necessary. 
IV The  Council  in the abovementioned action  programme  and  in  the  directives recently 
adopted in this field stressed the need to provide adequate information at all levels. It 
is considered that these monographs will be of benefit to the occupational health physi-
cians, the industrial hygienists, the employers and the trade-union representatives, by 
giving the scientific rationale on which a number of biological monitoring programmes 
are based. 
The Editors 
1983 
v Preface to the second volume 
Last year we published a series of monographs in  one volume under the title 'Human 
biological monitoring of industrial chemicals series' in which benzene, cadmium chlori-
nated hydrocarbon solvents, lead,  manganese, titanium and toluene were discussed. 
When preparing these documents each author was asked to pay particular attention 
to the problem of the quantative relationships between the levels of external and inter-
nal exposure and  between exposure and effects. 
In a number of cases information on the levels of biological indicators which are indica-
tive of current exposure without short-term detectable health effects is available. 
However we were already confronted with the impossibility of determining at present if 
the levels for biological indicators without short-term detectable health effects can also 
be considered as adequate with  respect to longer-term effects. 
In  preparing the present series of monographs it became apparent that for a number 
of biological indicators corresponding to biological tests, it is not yet possible to estab-
lish if these are indicative of early reversible effects and would thus qualify for the term 
'biological  monitoring' as  defined  in  the  preface of this first volume.  For many sub-
stances, extensively used in industry, biological indicators are being developed but still 
require extensive assessment before possible routine application. 
As the object of these monographs is to provide up-to-date scientific information, not 
only for the chemical substances for which  biological indicators could  be considered 
routine,  but also for the many more substances for which  biological indicators are at 
the early stage of development, it was considered advisable to change the title to the 
series to  'Biological  indicators  for the  assessment of human  exposure to  industrial 
chemicals'. 
We' hope that this new title will avoid giving the reader the impression that for the sub-
stances presented in this volume and the subsequent ones, biological indicators can 
be already routinely applied. 
VI 
The Editors 
1984 Preface to the third volume 
Following the established frequency, we are happy to present the third volume in the 
series of monographs on 'Biological indicators for the assessment of human exposure 
to industrial chemicals', which is addressed to occupational health physicians, indus-
trial  hygienists and,  in  general, to all  who are concerned with  prevention of occupa-
tional disease in the workplace. 
The original title of the first volume of the series 'Human biological monitoring of indus-
trial chemicals series' was changed in the second volume and this change is now fur-
ther justified  by  the four  monographs  making  up  the third  volume:  alkyl  lead  com-
pounds, dimethylformamide, mercury and organophosphorus pesticides. 
As in  the previous volumes, the scope of the publication has not been  limited to the 
most widely  known  and  used  toxic  industrial  agents.  It  was  felt that consideration 
should also be given to other substances, where recent scientific advances have sug-
gested the need to verify how far assessment of exposure using biological indicators 
is reliable in real industrial situations. One of the aims of this series is,  in fact, to stimu-
late further research, especially applied research, that wou1d  have the task of validat-
ing,  on  large  groups of workers,  preliminary scientific observations that are  usually 
obtained from  studies on  relatively small .groups of subjects and  often  in  controlled 
experimental exposure situations. 
Eighteen monographs have now appeared in this series published by the Commission 
of the European Communities. The previous two volumes covered 14 monographs on 
acrylonitrile,  aluminium,  benzene,  cadmium,  chlorinated hydrocarbon solvents,  chro-
mium,  copper,  lead,  manganese, styrene, titanium, toluene, xylene and zinc. 
Highly competent scientists from the following European scientific research  institutes 
have  contributed  in  preparing  the  monographs:  Cattedra  di  Medicina  del  Lavoro 
deii'Universita di  Parma (Italy),  Clinica del  Lavoro L.  Devoto deii'Universita di  Milano 
(Italy), Coronel Laboratorium, Universiteit van Amsterdam (the Netherlands), lnstitut fur 
Arbeits- und Sozialmedizin der Universitat Erlangen-Nurnberg (the Federal Republic of 
Germany), Unite de toxicologie industrielle et medicale, Universite de Louvain, 
Bruxelles (Belgium). 
It is planned in the future to extend cooperation to other scientific institutes and thus 
involve a wider number of scientists and experts. 
The fourth volume, which is already under way, will include the following monographs: 
'Aldrin,  dieldrin  and  endrin'  by  N.  J.  van  Sittert,  Shell  internationale  Petroleum  (the 
Netherlands); 'Non-substituted aliphatic hydrocarbons' by K.  N.  Cohz, Danish National 
Institute of Occupational Health,  Hellerup (Denmark);  'Arsenic' by V.  Foa,  Clinica del 
Lavorno, University of Milan,  (Italy);  'Vanadium' by  K.  H.  Schaller,  lnstitut fur Arbeits-
und Sozialmedizin, University of Erlangen-Nurnberg (Federal Republic of Germany). 
The Editors 
1986 
VII Preface to the fourth volume 
The fourth volume of the series of monographs on 'Biological indicators for the assess-
ment of human exposure to industrial chemicals' of the Commission of the European 
Communities includes monographs on  arsenic, aldrin and dieldrin, endrin, cobalt and 
vanadium. For the first time some chemical substances widely used in agriculture are 
also examined; for these substances, in addition to the occupational exposure, particu-
lar consideration has to be given to exposure of family members and the general popu-
lation consuming agricultural products treated with pesticides. 
It is evident from these documents that the information on biological indicators result-
ing from  both occupational data relative to  users and  manufacturers, and from  non-
occupational data relative to consumers, contributes to the interpretation of the biologi-
cal  tests  used  to  evaluate the  exposure  and/or the  early  effects.  Occupational  and 
environmental exposure to  chemicals represent two situations,  with  uncertain  limits, 
that tend to get nearer and nearer, and require a common study methodology. 
A volume which will include the following monographs: 'Nickel', by P.  Grandjean (Insti-
tute of Community Health, Odense University, Denmark); 'Aromatic hydrocarbons, nitro 
and amino compounds',  by  A.  Lauwerys (Department of Occupational Medicine and 
Hygiene,  Catholic University of Louvain,  Brussels,  Belgium);  'Carbamate pesticides', 
by M.  Maroni (Institute of Occupational Health, Clinica del Lavoro L.  Devoto, University 
of Milano,  Italy) is under preparation and should be published in  1988. 
VIII 
The Editors 
1987 Preface to the fifth volume 
With the fifth volume of the series of monographs published by the Commission of the 
European Communities on  'Biological indicators for the assessment of human expo-
sure to industrial chemicals', 27 toxic substances or groups of substances widely used 
in industry and agriculture have been covered. 
This volume contains monographs on carbamate pesticides,  nickel,  aromatic amines 
and aromatic nitro-compounds, thus giving consideration to chemical compounds that 
are widely used in agriculture. Carbamate pesticides involve risks not only in the case 
of occupational exposure but also in the case of intake via the diet in the general popu-
lation.  With the inclusion of aromatic amines and  aromatic nitro-compounds, for the 
first time in  this series biological indicators for the assessment of the absorption and 
early effects  of mutagenic and  potentially carcinogenic compounds are considered, 
indicators which could then be used to identify groups at risk of exposure to genotoxic 
substances. The monograph on nickel examines the problems involved with the expo-
sure to this metal which can frequently cause immunotoxic effects both in the general 
population and in occupationally exposed subjects and considers the excess incidence 
of carcinogenic effects in subgroups of refinery workers exposed to certain nickel com-
pounds. 
In view of the many requests received, the previous four volumes have been reprinted. 
The sixth volume is under preparation and will be published in  1989. It will include the 
following  monographs:  'Carbon  monoxide' by  P.  Grandjean  (Institute  of Community 
Health, Odense University); 'Ethylbenzene and cumene' by R.  Lauwerys (Department 
of Occupational Medicine and Hygiene, Catholic University of Louvain); 'Beryllium' by 
P.  Apostoli (Institute of Occupational Health,  University of Brescia, Italy);  'Anaesthetic 
gases' by E.  Capodaglio, Institute of Occupational Health,  University of Pavia); 'Sele-
nium' by K.  H. Schaller (Institute of Occupational and Social Medicine of the University 
of Erlangen-Nurnberg, (Federal Republic of Germany). 
The Editors 
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IX Preface to the sixth volume 
The  sixth volume of this series of monographs of the Commission of the  European 
Communities on 'Biological indicators for the assessment of human exposure to indus-
trial chemicals' includes documents regarding the following substances: beryllium, car-
bon  monoxide,  ethylbenzene,  methylstyrene,  isopropylbenzene,  inhalation anaesthe-
tics and Selenium. 
Ethylbenzene,  methylstyrene  and  isopropylbenzene conclude the  discussion  on  the 
principal aromatic hydrocarbons which commenced in  1983 with benzene and toluene 
in the first volume followed by styrene and xylene in  1984. 
In  this volume,  carbon  monoxide is  included,  a pollutant produced in  workplaces by 
incomplete combustion; this gas can also be present in the atmosphere in large cities 
and thus largely involves the general population that may also be exposed because of 
tobacco combustion. 
The documents on beryllium and selenium indicate that it is necessary to gain a further 
insight into the metabolism and early effects of these metals in order to understand the 
significance of the biological indicators. 
The document on  inhalational anaesthetics faces the problems concerning the moni-
toring of workers in  operating theatres and for which reliable biological indicators are 
finally available,  in  particular the monitoring of nitrous oxide which is the most widely 
used anaesthetic gas. 
With this volume 27 monographs have already been published in this series covering 
15 metals,  17 solvents, seven other chemical substances and three groups of pesti-
cides. 
X 
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1989 Preface to the seventh volume 
With the publication of this volume, the series of monographs of the Commission of the 
European Communities on  'Biological indicators for the assessment of human expo-
sure  to  industrial  chemicals'  has  been  enriched  by  the  addition  of six  documents 
regarding antimony, barium, tin, thallium, hexane and methyl ethyl ketone. 
The number of monographs published since 1983 has thus risen to 33 with 19 metals, 
19 solvents, seven other chemical substances and three groups of pesticides having 
been considered. 
Since the first volume was issued,  great strides have been made in  the field  of pre-
vention  of occupational  diseases,  with  exposure to the  most widely  used  and  most 
harmful industrial toxic agents steadily decreasing in  the workplace. The widespread 
use of biological indicators in the field of prevention has contributed to this favourable 
course of events. 
When the publication of these documents started such rapid improvement in the work-
place situation could not be expected. 
In this light it is necessary to carefully examine the current validity of some of the indi-
cators discussed in the early monographs and introduce new indicators when such are 
available. 
The Editors 
1993 
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XIII Biological indicators for the 
assessment of human exposure 
to industrial chemicals 
Antimony 
P. Apostoli, S.  Porru,  L. Alessio Summary 
Antimony  (Sb)  is  a non-essential semi-metal.  Sb  is  mainly used  in  alloys with  other 
metals to increase their strength,  hardness and  resistance to chemical corrosion.  Sb 
is  employed  in  various  industrial  settings  and  Sb  exposure  has  been  studied  in  Sb 
smelter  and  ore-processing  plants,  in  the  glass  industry,  in  battery  plants,  bronze 
foundries and abrasives plants. 
Few data are  available on  human  toxicokinetics;  the main  route of Sb  absorption  in 
occupational environments is through the  lungs and the metal can  be  retained  in the 
lungs for long  periods  (up  to 20  years).  Urinary elimination occurs in  two  phases,  a 
rapid and  a slower one. 
Chronic occupational exposure to Sb may result in various health effects, such as irri-
tation  of the  respiratory  and  gastrointestinal  tract,  ECG  abnormalities,  skin  lesions 
('antimony spots');  a particular form  of pneumoconiosis called  antimoniosis has  also 
been described. The data on the carcinogenic properties of Sb are inconclusive. 
In  workers exposed to  antimony,  urinary Sb  (SbU)  as  well  as blood  Sb  (SbB)  levels 
may  be  higher than  those  of non-exposed  subjects,  and,  only  for  certain  Sb  com-
pounds for mean exposures ranging from  100 to 1 000 J.1g/m
3
,  a correlation has been 
demonstrated between the atmospheric Sb concentration and SbU. However, the over-
all available data do not enable us to consider SbB and SbU  as reliable indicators for 
the biological monitoring of workers, especially for low exposures,  both for individuals 
and groups of subjects.  No indicator of effect is so far available. 
3 Introduction 
Chemical and physical properties 
Antimony (chemical symbol Sb,  from the latin Stibium)  is  a non-essential semi-metal 
known since approximately 4000 BC.  It has a crystalline structure and belongs to the 
V  B subgroup of the periodic table. Arsenic belongs to the same subgroup and  has 
similar chemical and physical properties. 
Sb is a silver white, brittle, hard and easily pulverized element. It exists in the trivalent 
or pentavalent oxidation state,  in  both inorganic and organic compounds. Pentavalent 
Sb has a tendency to convert into the trivalent state in  acidic media and  acts, there-
fore, as an oxidizing agent. Sb is stable at room temperature but, when heated, it burns 
giving off dense white fumes of Sb oxide (Sb20 3)  with a garlic-like smell. 
Sb is insoluble in  water and organic solvents and soluble in aqua regia.  Small quanti-
ties of Sb in other metals increase their mechanical strength, hardness and resistance 
to corrosion. Indeed, it readily forms alloys with arsenic, tin, copper, iron, bismuth, zinc 
and lead (Gudzovskij, 1983; Weast,  1985; Winship,  1987). 
Some data concerning the physicochemical properties of Sb are listed in Table  1. 
It must, however, be mentioned that the Sb properties may vary in the different metal 
compounds. 
Production 
The amount of Sb  in  the earth's crust ranges from  0.1  to  10 mg/kg  dry weight.  The 
native Sb is rare and often contains arsenic, silver, iron and other metals as impurities. 
Sb is found in  114 minerals: the most common are stibnite (Sb2S3)  which can contain 
up to  70%  Sb,  kermesite (Sb2S20), valentinite (Sb20 3). Other natural sources of Sb 
are  complex sulphide ores of stibnite containing  mainly lead,  tin,  copper,  silver,  iron 
and mercury. Sb sulphides and oxides are the most important Sb compounds (Khata-
mov et al.,  1967; Norseth and Martinsen, 1988). 
Sources of primary Sb are chiefly China, Bolivia, the Republic of South Africa, and the 
former USSR; the total world production in  1987 was around 60 000 tonnes and 50% 
of the total world reserves is  in  China. 
The extracted ore is  sorted and  crushed, then concentrated by settling and flotation. 
Free metal is  produced by reduction of Sb sulphide with coke or by roasting the sul-
phide in the air, to obtain Sb tetraoxide which is then reduced with coke. The metal can 
then be purified by means of electrolytic processes. 
Sb  can  also  be  extracted  as  a  by-product  in  the  lead  electrolytic  refining  process. 
Lastly, recycling of non-ferrous scrap (secondary smelting) is also an important source 
of Sb (Stokinger,  1981 ; Norseth and Martinsen, 1988). 
Exposure to Sb may occur during mining, smelting or refining operations and most of 
the data on environmental Sb concentrations concern different smelting operations. 
Industrial exposure 
Sb exposure can also occur because of its numerous applications in industry. 
5 Sb  is  used in  metal alloys (with  lead, copper and tin)  in  the manufacture of printers' 
type,  pewter,  metal  bearings,  munitions,  lead  shot,  lead  electrodes,  storage  battery 
grids, plumbers' solder and cable sheathings. 
However,  it must be  considered that exposure to Sb  has not been widely studied  in 
certain industrial settings· because it occurred as an impurity: for example, in mechani-
cal bronze alloys Sb can be found at 0.2-0.3%, whereas in lead-bronze alloys it occurs 
at  at  0.1-0.7%.  Moreover,  during  the  casting  and  finishing  of some  'noble'  alloys 
employed in odontotechnical activities, with the use of the particle induced X-ray emis-
sion (PIXE) Sb has been found at atmospheric concentrations ranging from 0.5 to 4.1 
J1g/m3 ,  whereas it proved undetectable during operations with other alloys (Apostoli et 
al.,  1988). 
Sb  and  its  compounds  (oxides,  trisulphides,  pentasulphides) find  applications in  the 
manufacture of non-metal products such as pigments, paints, lacquers, enamels, plas-
tic,  rubber,  matches,  glass and  pottery abrasive phosphorus (as a beryllium replace-
ment), and vulcanizing agents. It is also incorporated in munitions, fire-proofing chemi-
cals and textiles. High purity Sb is employed in the manufacture of semiconductors, in 
the form of intermetallic compounds with alkali or alkaline earth metals, transition met-
als and elements like aluminium, gallium, and  indium. 
Sb trioxide and pentoxide are still used in the preparation of chemotherapeutic agents 
adopted in the treatment of helminthic and protozoal infections (Bradley,  1941; Stem-
mer,  1976). 
Table 2 summarizes the principal studies in which atmospheric Sb concentrations were 
measured in  different industrial settings. 
Most of the surveys have been made in ore-processing and smelting plants, whereas 
a few have been carried out in  abrasives, glass or Sb oxides manufacturing plants. 
During the  study of industrial  hygiene carried  out in  our Institute,  environmental  Sb 
concentrations ranging from  1.1  to 9.8 Jlg  Sb/m
3  in  a battery factory and from  1.0 to 
4.2 Jlg  Sb/m3  in five bronze foundries were measured (Apostoli and Alessio,  1990). 
Environmental exposure 
Sb  is  mainly introduced  into  the  environment  by  human  activities  such  as  mining, 
smelting, refining and fuel combustion or from municipal discharges. For example, con-
centration ranges of 36 to 142 mg Sb/kg were reported in dust samples in the furnace 
of solid urban waste incinerators (Ziemacki et al.,  1989). 
Moreover, Sb can be found in coal at various concentrations, as Table 3 shows. Figure 
1 reports only the calculated mobilization of trace metals whose global emission is less 
than 1 000 tonnes per year from coal-fired power plants in the European Community 
countries: Sb represents, in the secondary group, one of the most important elements 
(about 600 tonnes per year)  (Sabbioni et al.,  1984). 
Ambient air concentrations in  US towns such as Chicago were reported to range from 
1.4 to 55 ng/m
3
,  whereas lower levels ranging from  0.4 to 4 ng/m
3  were detected in 
seven different sites in the UK. At the South Pole the concentration is below 1.7 pg/m
3 
(Dams et al.,  1970; Peirson et al.,  1973; Zoller et al.,  1974). 
Main exposure to Sb in the general population is through the diet, but the data on daily 
intake are controversial. Table 4 gives the results from studies carried out from  1971 
to  1977 on  human Sb dietary intake. 
The Sb  concentration varies from  3 Jlg/kg  wet weight in  fish  to 8 Jlg/kg  in  milk and 
potato (Norseth and Martinsen,  1988). 
Drinking water usually contains less than 0.5 Jlg/1  and the maximum daily intake has 
been reported to be  15 Jlg  (Winship,  1987). 
The Sb concentration in cigarettes is 0.1  mg/kg dry weight and about 25% is from the 
paper; 20% is estimated to be inhaled. 
Another source  of environmental  exposure can  be  dental materials;  Molokhia et al. 
(1985) found concentrations between 2 and 656 Jlg/kg  (up to 1 000 times the normal 
dental tissue concentration) in  non-metallic dental materials currently used in  restora-
tion. 
Finally,  Sabbioni et al.  (1981) estimated the Sb daily exposure as Jlg/kg of 'standard 
man' proposing the following values: with air,  0.03-0.  7;  with tobacco smoke,  0.1-0.8; 
with drinking water, 0.04-0.06; and 7-60 with food. 
6 Effects on  humans 
It must be  remarked  that Sb ore  contains arsenic as an  impurity and  consequently 
there is a small  proportion of arsenic in  industrial compounds. This fact has compli-
cated the studies on the toxicity of Sb in occupational exposures, as effects observed 
could have been those of the contaminant rather than of Sb itself. 
Indeed, signs and symptoms of acute and chronic Sb poisoning are similar to those of 
arsenic poisoning. 
Sb interferes with cellular metabolism by combining with sulphydryl groups in  respira-
tory enzymes,  inhibiting their activity.  It also binds sulphydryl groups in  serums and 
affects the protein and carbohydrate metabolism and glycogen liver production (Gud-
zovskij,  1983). 
Acute  intoxication  is  unlikely to  occur in  industry,  but  can  result from  accidental  or 
intentional ingestion. The symptoms of acute poisoning include violent irritation of the 
nose, mouth, stomach and intestine with abdominal pain, vomiting, haemorrhagic diar-
rhoea,  dehydration,  muscle  pain,  irregular  respiration,  choking,  headache,  lowered 
temperature,  convulsions,  ventricular  tachycardia,  collapse  and  coma,  followed  by 
death in a few hours due to circulatory or respiratory failure and hepatic or renal com-
plications (Gudzovskij,  1983; Lauwers et al.,  1989). 
In  industrial occupational settings, most effects are related to chronic exposure to Sb 
trivalent salts. The most important effects are respiratory, cardiac, skin and suspected 
carcinogenic and reproductive effects. 
Respiratory effects 
Rhinitis  with  septal  perforation,  pharyngitis,  laryngitis,  tracheitis,  pneumonitis  and 
chronic bronchitis have been reported in workers exposed to unknown concentrations 
of Sb trioxide dust (Renes,  1953; Klucik et al.,  1962). 
Acute  exposure to  SbCI3  at the  concentration  of 73  mg/m
3  caused  irritation  of the 
upper respiratory tract  in  seven  workers  (Taylor,  1966).  Three  cases  of pulmonary 
oedema after acute exposure to unknown Sb concentrations have also been described 
(Cordasco and Stone,  1973). 
The  most important effect on  the  respiratory tract  is,  however,  a  particular form  of 
pneumoconiosis called antimoniosis. 
Parkes (1982)  states that Sb pneumoconiosis must be regarded  as a 'benign condi-
tion', with no detrimental effect upon health or life expectancy. However, the benignity 
of this condition is discussed. 
Several  authors  have  remarked  upon  pneumoconiosis-like  X-ray  pictures  obtained 
from workers with long-term occupational exposure to Sb. 
Prevalences of 1  0-50% of pneumoconiosis have also been reported by some authors 
in Sb process workers; pulmonary function tests were, however, usually moderately or 
not affected and post-mortem analysis of lungs usually revealed no fibrosis or inflam-
matory reactions. Therefore, it seems that the Sb pneumoconiosis is an  inert reaction 
to retained Sb particles (Kiucik et al.,  1962; Me Callum,  1963; Cooper et al.,  1968; Le 
Gall,  1969; Dumortier et al., 1974; Cavalier et al.,  1979; Daguenel et al.,  1979). 
In the Yugoslavian smelter studied by Potkoniak and Pavlovic (1983), 51  smelters had 
been exposed to a total dust concentration of 17-86 mg/m
3  for 9 to 31  years; the dust 
mainly consisted of Sb trioxide (40-90%)  and Sb pentoxide (2-8%),  but also of 2-5% 
free silica. The workers showed X-ray changes indicating antimoniosis, characterized 
by the presence of numerous small opacities of pin-head type densely distributed in 
the middle and lower lung fields. 
No  characteristic  pulmonary function  abnormalities were  noted;  an  obstructive or a 
mixed  restrictive-obstructive  pattern,  as  well  as  an  increased  airway  resistance and 
decreased forced expiratory flow,  were detected in some workers. 
Symptoms of chronic  bronchitis,  upper airway  irritation  and  conjunctivitis were  also 
reported. The changes developed after at least one decade of work and massive fibro-
sis or 'r' type lesions were never seen. The authors also stated that antimoniosis was 
different from  the classical  silicosis or other forms of pneumoconiosis due to  mixed 
dusts, because of the particular morphologic and radiologic picture of antimoniosis and 
the different latency in the onset of the lesions. 
7 Possible  Sb pneumoconiosis  has  been  recorded  in  industrial settings different from 
smelting as in the case of two chemical workers exposed to Sb trioxide  (Guzman et 
al.,  1986). 
Finally, it must be remarked that experimental data demonstrated that long-term (up to 
14 months) exposure to Sb trioxide concentration ranging from 1.6 to  125 mg Sb/m3 
in  different animal  species causes  lipoid  pneumonia,  interstitial pneumonitis,  fibrous 
thickening of alveolar walls, focal fibrosis,  adenomatous hyperplasia and  cholesterol 
clefts, rather than clear findings of pneumoconiosis (Grosset al.,  1955; Watt,  1983). 
Cutaneous effects 
Dermal effects, the so-called antimony 'spots',  have been  known  for many decades 
(Oliver,  1933).  Sb  spot is  a rash  consisting  of itching  papules and  pustules around 
sebaceous  and  sweat  glands,  especially  where  skin  is  exposed  to  heat or where 
sweating occurs. The rash  is  common  in  persons chronically exposed to Sb  and  its 
salts,  transient and  probably due to  a toxic rather than  allergic mechanism  (Renes, 
1953; Me Callum,  1963; Potkoniak and Pavlovic,  1983). 
Cardiovascular effects 
Cardiovascular  mortality and  morbidity and  ECG  changes  were  attributed  to  Sb  in 
workers of an abrasives plant exposed to concentrations of Sb trisulphide ranging from 
0.6 to 5.5 mg/m
3  for 8 to 24 months. Sudden deaths ceased upon abandoning the use 
of Sb,  but ECG  changes tended to persist after several years (Brieger,  1954). Klucik 
and Ulrich (1960) reported similar anomalies in workers exposed to Sb20 3  and Sb2S3 • 
Moreover, experimental studies in  dogs demonstrated that sodium Sb and potassium 
Sb  produce a non-reversible decrease in myocardial contractile force and a decrease 
in  perfusion pressure (Bromberger-Barnea and Stephens, 1965). 
Other effects 
Effects such as pain, nausea, vomiting, diarrhoea, liver enlargement, bitter taste and a 
higher  prevalence  of  peptic  ulcers  have  been  described  in  Sb  exposed  workers 
(Renes,  1953; Brieger,  1954; Gallina and Luvoni,  1958; Taylor,  1966}. 
Chronic Sb exposure has also been related to symptoms such as headache, muscle 
pain,  vertigo,  anorexia and  blood changes  (Rodier and Souchere,  1955; Gudzovskij, 
1983}. 
It is worth mentioning the haemolytic anaemia and acute renal failure described in the 
past following acute inhalation of stibine, the volatile hydride of Sb, with a clinical pic-
ture that resembles the one deriving from acute exposure to arsine (Stokinger,  1981}. 
Carcinogenic effects 
Experimental data showed a significant increase in  lung cancer in female rats follow-
ing inhalation exposure to Sb trioxide at concentrations ranging from 0 to 45 mg/m3  or 
to Sb ore concentrate at 0 to 40 mg/m
3
,  for seven hours per day, five days per week 
for up to 52 weeks (Groth et al., 1986). The only epidemiological study reports about a 
twofold excess of lung cancer in a group of 1 081  workers of an Sb and zircon smelter 
mainly exposed to Sb trioxide for an average of 22 years (range: 7-43), between 1922 
and 1971. Data on Sb exposure refer to 1963 when, after control measures were insti-
tuted, the air concentrations were approximately 50 mg Sb/m
3
; from 1971 to 1975, they 
ranged from 0.3 to 56 mg Sb/m
3
,  with an  overall average of 9.5 mg Sb/m
3
. 
No excess of death from lung cancer has been observed among those employed after 
1958 (Stokinger,  1981; Doll,  1985). 
The available human data were considered 'inadequate' by the International Agency 
for Research on  Cancer (IARC,  1989): therefore, the overall evaluation classified Sb 
trioxide as possibly carcinogenic to humans (group 2B). The American Conference of 
Government Industrial Hygienists (ACGIH,  1989) concluded that production of Sb tri-
oxide should be regarded as a suspected carcinogen (group A2). 
8 Metabolism 
Most of the toxicokinetic  information  arises  from  experimental  studies  which  have 
involved the administration of Sb organic derivatives intravenously, intraperitoneally or 
subcutaneously, because these are some of the routes used for clinical purposes. This 
fact must be taken into account when inorganic compounds used in industry are con-
sidered.  Moreover,  the  biological  behaviour is affected  by the valence state,  as  ob-
served in  a greater toxicity of trivalent forms. 
Absorption 
Sb compounds are slowly and poorly absorbed from the gastrointestinal tract in mice 
(15%  of a  single  oral  dose).  A prolonged  contact with  skin  can  determine  a  poor 
absorption. The principal route of absorption  in  workplaces is through the lungs.  Me 
Callum et al.  (1971) developed an X-ray spectrometry method to measure the inhaled 
Sb.  By calculating from  the  data they detected in  symptomless workers  with  radio-
graphic lung changes, we found a moderate correlation (r = 0.55) between measured 
lung Sb and period of employment (Figure 2). The authors also found that there was a 
correlation between length of exposure and X-ray classification. 
An  experimental model has been proposed by Leffler et al.  (1984): in hamsters, after 
intratracheal  instillation  of Sb20 3  or  Sb  industrial  dust containing  Sb  at 7.6%,  they 
described a two-phase lung clearance curve (figure 3). The authors also claimed that 
the observed differences were primarily related to the solubility rather than to the par-
ticle size and they also stated that the low solubility in  factory dust combined with a 
long biological half-life may be of importance in explaining the observed Sb lung accu-
mulation in exposed workers. 
In rats exposed to Sb2CI3  by inhalation of labelled trivalent Sb salt, Djuric et al.  (1962) 
noticed that a large proportion of the body burden was recovered in blood. A couple of 
weeks after exposure about 1  0%  of the body burden was found in  blood,  at a higher 
proportion than in any other organ. 
Distribution 
In  man,  after intravenous injection or oral  administration of drugs, the distribution is 
mainly in the liver, heart, kidneys, thyroid, adrenals and bone (Ozawa,  1956; Abdallah 
and Saif,  1962). 
According to Edel et al.  (1983)  and to Djuric et al.  (1962),  if Sb is absorbed through 
the lungs in  rats,  it accumulates principally in  red cells and to a much lesser extent in 
the liver and spleen, lungs and heart. On the other hand, localization of Sb in red blood 
cells  was  not evident either in  rabbits  or in  dogs intratracheally treated  with  SbCI3 , 
making it difficult to extrapolate the rat data to man (Norseth and Martinsen, 1988). 
Felicetti et al.  (1974a) investigated the metabolism of inhaled Sb in  Syrian hamsters. 
The animals were exposed to aerosols of labelled Sb tartrate of trivalent and pentava-
lent states, which showed the same pattern of metabolism. Whole body clearance of 
pentavalent aerosols, for example, occurred in two phases (Figure 4). Initial clearance 
was very rapid,  resulting in the elimination of 90% of the initial activity by day 7 post-
exposure.  Early  rapid  clearance  was  followed  by  a  slower phase during  which  the 
remaining Sb was eliminated with a biological half-life of about 16 days. Tissue distri-
bution  indicated that Sb accumulated mostly in  the liver (especially trivalent forms), 
skeleton  (especially pentavalent forms)  and skin.  In  blood, trivalent Sb was concen-
trated in  red blood cells at all sampling times; pentavalent concentrations were higher 
in plasma at 2-hour post-exposure but at 24-hour post-exposure these forms were also 
concentrated in  red blood cells. Other studies in dogs and rats (Felicetti et al., 1974b; 
Djuric et al.,  1962) demonstrated, however, a long-term whole body retention time of 
1  00 and 200 days respectively. 
Gerhardson  et al.  (1982)  found  that former  (20  years  after retirement)  smelters ex-
posed to Sb had on an average 12 times higher lung concentrations of Sb (315 J.lg/kg 
wet weight compared to non-occupationally exposed subjects (26 J.lg/kg).  There was 
also no tendency towards decreased concentrations over time (up to 20 years)  after 
cessation  of exposure,  thus  indicating a  long  biological  half-life.  Moreover,  the anti-
mony  concentrations  in  the  liver  and  kidney  cortex  did  not differ  from  the  values 
obtained in the reference group. 
Sb crosses the placenta in mice, after both parenteral and peroral administration (Ger-
ber et al.,  1982). 
9 Excretion 
Sb is excreted via urine or faeces. In experimental studies, it has been found that route 
and  rate of excretion are dependent on  the valency state of the compound; species 
differences were also observed. As a general rule, trivalent compounds are excreted 
via faeces, whereas pentavalent ones are excreted faster via urine (Edel et al.,  1983; 
Norseth and  Martinsen,  1988). After intravenous and  intraperitoneal injection of pen-
tavalent compounds in mice, 50 to 60% was found in urine after six hours; total excre-
tion was around 70% at 48 hours (Goodwin and Page,  1943). Twenty-four hours after 
intraperitoneal administration of trivalent and  pentavalent compounds in  hamsters or 
rats, 6 to 15% of the former and 65 to 83% of the latter were found in  urine, whereas 
the faecal excretion was 33 to 50% for trivalent Sb and 1 to 10% for pentavalent com-
pounds (Gellhorn et al.,  1946; Edel et al.,  1983). 
Djuric et al.  (1962) after a 30-minute inhalation exposure in rats, found that 10 to 30% 
of the dose was excreted in urine and faeces the first day,  decreasing by 1% within a 
few days. The  ratio  between  urinary and faecal  excretion fluctuated  around 0.9.  An 
almost similar urine/faecal partition was reported  by Felicetti et al.  (1974b)  in  beagle 
dogs after aerosol inhalation for a non-specified short time; the urine/faeces ratio was 
about 0.8 with  no significant change from day 2 to day 32. 
After intramuscular or  intravenous injection in  volunteers,  80%  pentavalent and  25% 
trivalent Sb was found in urine within 24 hours, a pattern similar to that of animal stud-
ies. Other authors (Bartter et al.,  1947) found that after intravenous administration the 
urinary excretion was four times higher than fecal.  Rees et al.  (1980)  recovered 95% 
Sb  in  urine after six hours from  an  intramuscular injection of sodium stibogluconate. 
Taylor (1966),  in  seven subjects accidentally intoxicated by SbCI3  found  urinary con-
centration in rapid decrease after exposure. There might however be a long-term com-
ponent according to the study of Mansour et al. (1967) who studied the urinary excre-
tion in  a patient treated for bilharziasis. 
Biological  indicators 
General population data 
Concentrations around 0.1  mg  Sb/kg wet weight have been detected in  the lungs of 
non-occupationally exposed subjects, whereas the liver and kidneys contain about one 
third  of the  lung  concentration  (Eiinder and  Friberg,  1986).  Lower levels have been 
measured by Gerhardson et al.  (1982), who detected 26.7 and 5 Jlg  Sb/kg wet weight 
in the lungs, liver and kidneys respectively. Similar values were obtained by Brune et 
al.  (1980). Japanese authors found 60  and 20 Jlg  Sb/kg in the lungs and liver respec-
tively,  whereas the highest concentrations were  detected  in  the adrenal  glands  (70 
Jlg/kg  wet  weight)  or  skin  (100);  no  differences  between  sex  or  age-groups  were 
noticed (Sumino et al.,  1975). 
Blood,  serum and  urinary values in  non-occupationally exposed subjects detected in 
various studies are reported in Table 5. 
An  upper limit of 1. 7 Jlg/1  for urinary Sb  (SbU)  and  of 3 J.lg/1  for blood  Sb  (SbB)  has 
been proposed for non-occupationally exposed subjects by a working group of the Ital-
ian Society of Occupational Health (Abbritti et al.,  1985). 
Occupationally exposed workers data 
The literature reports few reliable data concerning the biological monitoring of subjects 
occupationally exposed to Sb. 
Belyaeva (1967) reported values of SbB up to 200 mg/1  in workers exposed to trioxide 
and pentasulphide and the metal. SbB levels ranging from 0 to 130 J.lg/1 were reported 
in a group of firearm instructors exposed to Sb-containing dusts, whereas the levels in 
controls were found to be less than 10 Jlg/1  (Berman,  1980). 
Urinary  values  ranging  from  traces  to  exceptionally  high  values  of 600  mg/1  were 
reported by Renes (1953) in workers exposed to concentrations ranging from 0.4 to 70 
mg Sb/m
3  and with gastrointestinal symptoms. 
10 In  the  plant studied  by  Brieger  (1954),  SbU  levels of 0.8-9.6  mg/1.  corresponded to 
exposure levels of 0.6-5.5 mg Sb/m
3
. 
In  a  Milan  glassworks  (Gallina and  Luvoni,  1958),  six workers  with  gastrointestinal 
effects, probably due to Sb2CI3  poisoning, had SbU values ranging from 30 to 210 J.lg/1. 
In  three  workers  exposed  to  concentrations  of 0.5-36.7  mg  Sb/m3 ,  the  SbU  levels 
ranged  from  425 to  680  J.lg/1,  while another patient with  pneumoconiosis  had  levels 
ranging from 55 to 28 J.lg/1,  seven months and four years after retirement (Me Callum, 
1963). 
In  the  group of 272  women  in  which  reproductive  disturbances were  reported  (Be-
lyaeva, 1967), the mean SbU value was 21-29 mg/1 (range 5-182); the SbB levels were 
1  0 times higher than those of unexposed women. 
In  the plant where cancer deaths were detected  (Stokinger,  1981), and  where expo-
sure levels from 1971  to 1975 ranged from 0.3 to 56 mg Sb/m
3
, the mean SbU values 
in  1971  and 1972 were 0. 73 and 0.5 mg/1  in  1975. 
Cooper et al.  (1968) studied 28 subjects occupationally exposed to Sb and found uri-
nary spot values ranging from 7 to 1 020 J.lg/1;  SbU was determined during the period 
1962-68, in  which Sb exposure levels ranged from 0.08 to  138 mg/m
3
. 
Le Gall (1969) did not detect Sb in the urine of workers exposed to 3.4-14.7 mg Sb/m
3
. 
Smith  and  Griffiths  (1982)  found  considerably  higher  SbU  values  (1 0-200  J.lg/1)  in 
exposed workers compared with non-exposed subjects(< 1-5 J.lg/1). 
Earlier studies showed that in occupationally exposed subjects, high urinary excretion 
is  present for some years after cessation of exposure  (Kiucik and  Kemka,  1960;  Me 
Callum,  1963). 
Table 6 shows the SbB and SbU values obtained by Ludersdorf et al.  (1987)  in  work-
ers of a glass-producing industry employed in various activities for which the environ-
mental concentrations varied from < 50 to 840 J.lg  Sb/m
3
. 
Lastly,  in a recent study on Sb metabolism, Bailly et al.  (1991) evaluated Sb exposure 
in  male workers from a non-ferrous smelter producing Sb pentoxide and sodium anti-
moniate; the mean airborne Sb  concentration ranged from  86 ± 78 J.lg/m
3  in the wet 
process  to  927  ± 985  J.1g/m3  in  the  dry  process.  The  authors  found  a  correlation 
between the airborne Sb  concentration  (log  value)  and  SbU  (log  value)  in  post-shift 
urine samples (r  = 0.83): the correlation was  better (r  = 0.86)  if the increase in  SbU 
concentration during the shift was considered.  On  the  basis of the regression  equa-
tion,  the  authors suggest  a tentative  biological  limit value  of 35  J.lg  Sb/g  creatinine 
between the start and the end of the shift. 
According to Norseth and Martinsen (1988), blood and urinary Sb concentrations have 
no  value  for  risk  estimation  of  pulmonary  effects.  Workers  with  radiological  lung 
changes were not found to have particularly high SbU values, as compared with work-
ers without such changes. 
It must, however, be noted that Me Callum et al.  (1971)  in symptomless workers with 
radiographic changes,  detected a correlation  between  length of exposure and  X-ray 
classification. 
Apart from the abovementioned study by  Bailley et al.  which refers to mean occupa-
tional exposures ranging from  1  00 to 1 000 J.lg  Sb/m
3
,  a correlation between air _con-
centrations and SbB or SbU values has not been reported so far. SbU measured at the 
end of a shift has been considered as an indicator of recent exposure, due to the rapid 
excretion after absorption. Moreover, in  biological monitoring, the elimination that can 
occur years after cessation of Sb exposure should be taken into account. 
On the other hand, SbB can be found at higher levels in exposed subjects compared 
with  non-exposed subjects,  but the  biological significance of SbB  has  not yet been 
defined. 
It must however be remarked that when interpreting such different results of the above 
reported surveys, the different analytical procedures should also be considered. 
To date no indicator of effect is available. 
11 Conclusions 
The studies on effects of Sb in humans seem to show a moderate toxicity of the metal, 
although Sb exposure has not been studied extensively and most of the data refer to 
earlier researches. 
It must also be  remarked that,  on  the one hand, the classical occupational exposure 
to Sb such as in smelting and ore processing occurs, rather infrequently and with lower 
exposures while, on the other hand, exposure to Sb may sometimes be unrecognized 
or undesired so that it can be easily overlooked. 
Moreover, the Sb metabolism has not been thoroughly investigated, either experimen-
tally or in humans and, in particular, the behaviour of Sb in urine and blood is not com-
pletely known. 
However, for SbU,  two phases of excretion have been identified:  a rapid  one  (within 
hours of exposure), and a slower one, but it is not known whether this latter phase is 
related to the body burden of the metal. 
Significant differences have been detected between SbU and  SbB levels in  exposed 
workers with respect to non-exposed control subjects. 
However, most of the studies which report such differences are the older ones and the 
analytical techniques adopted must be considered when evaluating the results. 
While the literature refers to a study dealing with the useful adoption of SbU in  moni-
toring workers exposed to concentrations higher than 100 J.lg/m3 ,  it does not appear to 
be practicable today to use SbU and SbB as indications in the routine biological moni-
toring of workers exposed to lower Sb concentrations. 
Research  needs 
Further research is required dealing with the following topics: 
The development of reliable analytical methods for the determination of SbU and SbB. 
The study of occupational environments in  which  exposure to Sb is considered as a 
'minor' or part of a multiple exposure. 
The study of SbU and SbB to clarify their significance as biological indicators of expo-
sure and/or internal dose. 
The study of the relationship between external exposure (both current and cumulative) 
and  levels of biological indicators in  exposed workers. 
The study of the relationship between SbU and SbB in exposed workers. 
The individuation of biological indicators of effect and  of the possible dose/response 
and dose/effect relationships. 
The study of the state of health of exposed workers and of subgroups of subjects with 
increasing levels of the biological indicators. 
Analytical  methods and  problems of analysis 
There are many analytical methods available, but some of them (for example, colorime-
try and polarography) are today of little interest for biological matrixes (Smith and Grif-
fiths, 1982). A great variability exists in the literature data, not only because of the ana-
lytical difficulties, but also because of the lack of quality assurance programmes. 
The most important problems are the contaminations, the losses of Sb due to adsorp-
tion or precipitation or volatilization during sample treatment and the difficulties related 
to the acid  digestion,  which  is  necessary for biological  samples both  to  destroy the 
organic matrix and to assure the conversion of all the Sb forms to the pentavalent oxi-
dation state (Gallorini et al.,  1978; Iyengar et al.,  1978). 
Nowadays,  the  most  utilized  methods  are  those  in  atomic absorption  spectrometry 
(AAS) and, among them, those with hydride generation (HGAAS) and those with elec-
12 trothermal atomization (ETAAS). The HGAAS enables a detection limit to be reached 
in the order of 0.1  J..lg/1,  but there are problems related to the Sb oxidation state and to 
the matrix interferences. On the contrary, the accuracy of the ETAAS is conditioned by 
the matrix interferences and from  the high volatility of Sb;  in  spite of the use  of the 
L'Vov platform and matrix modifier such as palladium or magnesium nitrate, the detec-
tion limits of HGAAS cannot be  reached  (Thompson and Thomerson,  1974; Bencze, 
1981; Bettinelli et al.,  1988). It must also be underlined that the deuterium background 
correction is not an accurate technique (Fernandez and Giddings, 1981). The methods 
in ETAAS with metal extraction are largely used: they enable a detection limit of 0.2-1 
*g/1 to be reached. 
Very sensitive methods with neutron activation analysis (NAA) have been adopted, but 
they are difficult to use and of limited availability (Bettinelli et al.,  1988). 
Lastly,  the  inductively coupled  plasma mass  spectrometry  (ICPMS)  has  been  intro-
duced,  which  enables  a  detection  limit of 0.02 J..lg/1  to  be  reached  (Thompson  and 
Houk,  1986). 
Table 1 - Physicochemical properties of antimony 
Atomic number 
Atomic weight 
Melting point (
0C} 
Boiling point (
0C} 
Density (g/cm
3
) 
Electro  negativity 
Oxidation states 
Table 2- Main studies on occupational exposure to Sb 
Author  Year  Type of work 
Renes  1953  Sb smelter 
Brieger  1954  Abrasives 
plant 
Karajovic et al.  1960  Sb smelter 
Klucik and Ulrich  1960  Sb smelter 
Me Callum  1963  Sb20 3 
production 
Cooper et al.  1968  Sb smelter ore 
processing 
Le Gall  1969  Sb smelter ore 
processing 
Cavelier et al.  1979  Manufacture 
of Sn  and Sb 
oxides 
Cortona et al.  1979  Secondary 
foundry 
Donaldson and Cassady  1979  Sb trioxide 
production 
Stokinger  1981  Sb smelter 
Potkoniak and Pavlovic  1983  Sb smelter ore 
processing 
Ludersdorf et al.  1987  Glass industry 
Apostoli  1990  Bronze found-
and Alessio  ries 
Battery plant 
Table 3 - Sb content in coal of different countries 
Country  Concentration (ppm) 
No. of coal  mean 
samples 
examined 
United Kingdom  15  3.3 
West Germany  6  3.5 
France  2  5.2 
Belgium  13  2 
USA  166  1.1 
(Sabbioni et al., 1983) 
51 
121.75 
630.7 
1750 
6.68 
2.05 
-3, 0,  + 3,  + 5 
Environmental con-
centration (range,  in 
mg Sb/m
3
) 
0.4--70.7 
0.6-5.5 
16-248 
1.3-237 
0.5-36.7 
0.08-138 
0.3-14.7 
0.3-Q.6 
0.001-0.15 
0.2--8.7 
0.3-56 
17--86 
0.005-0.84 
0.001-0.004 
0.001-0.01 
range 
1-10 
1.8-5 
-
-
0.1--8.9 
13 Table 4 - Human dietary Intake of antimony in various countries 
Country  Daily Intake  Reference 
{J..lg/day) 
Sweden  2.2-15.6  Wester (1974) 
United Kingdom  34± 27  Hamilton and Minski 
(1973) 
Germany  23  Schleutz (1977) 
USA  247-1 275  Murthy et al.  (1971) 
Table  5  - Blood,  serum  and  urinary  Sb  concentrations  of  non-occupationally  exposed 
subjects 
Author  Year  No of  Specimen 
subjects 
Hirayama  1959  104  Blood 
Mansour et al.  1967  3  Blood 
Urine 
Kasparek et al.  1972  149  Serum 
Hamilton et al.  1973  75  Blood 
Wester  1973  16  Urine 
8  Serum 
Bencze  1981  34  Blood 
Smith and Grif- 1982  18  Urine 
fiths 
Fodor and  1983  2  Urine 
Barnes 
Blekastad et al.  1984  281  Serum 
Ludersdorf et al.  1987  51  Blood 
8  Urine 
Minoia et al.  1990  360  Urine 
27  Blood 
22  Serum 
1  Legend: 
Col. =  colorimetry 
SSMS = spark source mass spectrometry 
HGAAS =  hydride generation atomic absorption spectrometry 
ETAAS = electrothermal atomic absorption spectrometry 
HGAFS =  hydride generation atomic fluorescence spectrometry 
NAA =  neutron activation analysis 
HY-AAS =  hydride atomic absorption spectrometry 
Method
1  Valves {J..lg/1) 
Col.  0.0-135 
NAA  1.5-5.5 
2.9-9.1 
NAA  2.5 ± 1.37 
SSMS  2 ± 0.6 
- 0.5-2.6 
{J..lg/24h) 
NAA  0.75 ± 0.5 
HGAAS  0.5-6.2 
ETAAS  < 1-5 
HGAFS  2.Q-2.6 
NAA  < 0.3 ± 0.2 
HY-AAS  0.3-1.7 
0.2-0.7 
AAS  0.19-1.1 
NAA  0.03-3.5 
NAA  0.01-1.7 
Table 6 - Urinary and blood antimony in workers of a glass-producing industry* 
Specific activity  No,  of  SbU  SbB 
subjects 
Min.  X  Max.  Min.  X  Max. 
Me  Iter  32  0.2  0.9  2.9  0.4  0.8  1.8 
Batch mixer  45  1.5  5.0  15.7  0.5  1.1  2.4 
Craftsman  8  0.4  0.9  3.7  0.5  0.7  1.0 
Glass washer  24  0.6  1.2  . 6.3  0.4  1.1  3.1 
Total  109  0.2  1.9  15.7  0.4  1.0  3.1 
* Modified from Ludersdorf et al.,  1987 
Sb air concentrations: 
melting area  < so-s Jlg/m
3 
batch bunker  4Q-840 Jlg/m
3 
Min: lowest value; X:  median; Max: highest value. 
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Figure 2 - Correlation between  length of exposure and Sb  lung concentration in  Sb 
smelters (modified from data by Me Callum et al.,  1971) 
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Figure 3 - Lung retention (mean  ± standard error of the mean of Sb in hamsters after 
the  intratracheal instillation of antimony trioxide and  antimony dust (modi-
fied from  Leffler et al.,  1984) 
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sented (modified from Felicetti et al.,  1974a) 
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21 Biological indicators for the 
assessment of human exposure 
to industrial chemicals 
Soluble barium compounds 
W.  Zschiesche and K.  H.  Schaller Summary 
Barium (Ba)  is a light soft metal. In the earth's crust it is mainly found as a sulphate or 
carbonate.  It is  almost always divalent.  Ba obviously reduces the passive potassium 
outward current at cell  membranes. Also an  indirect action  by  release  of calcium  in 
cells seems to result. Absorption occurs mainly as a chloride, fluoride or carbonate via 
inhalation or oral ingestion. The main storage is found in the skeleton, high concentra-
tions are also found  in  eye tissue. The biological half-life is assessed between 2 and 
20 hours.  Ba is mainly excreted with about 90%  in faeces and with only 1 to 1  0% via 
urine. Some accumulation after occupational exposure seems to be possible. The criti-
cal toxic dose is  about 200 mg  barium  chloride orally administered.  In the  literature, 
only a few studies on the external exposure in  industries have been published. Some 
exposure is known  in  steatite production,  in the cosmetic and  pharmaceutical indus-
tries,  and  recently  also  in  some  welding  processes.  When  welding  with  high  Sa-
containing consumables, high external concentrations of soluble Ba up to 200 mg/m3 
can occur (TLV = 0.5 mg/m
3
). 
For the determination of Ba in body fluids, electrothermal atomic adsorption spectrom-
etry  or  inductively  coupled  plasma  emission  spectroscopy  after  dilution  of urine  or 
deproteinization of plasma respectively by nutric acid is applied. 
The non-occupational exposure from food and water may lead to a greater variation of 
the Ba concentrations in  urine between 0.1  and 75 Jlg/1  and  in  plasma from 0.1  to 40 
Jlg/1.  For the monitoring of occupational exposure the quantification of Ba in plasma or 
urine is recommended. 
Only very few studies are available on internal occupational exposure. In welders with 
high external exposure the Ba concentrations could  be found  in  urine up to 460 Jlg/1 
and  up to 75 Jlg/1  in  plasma.  In the low occupational exposure range there is a wide 
overlap with the non-occupational load in biological body fluids. Therefore the biologi-
cal monitoring in occupational medicine can be recommended on a mainly group basis. 
Except for hypokaliaemia, no specific early indicators of effect are known. Symptoms 
of acute  poisoning  can  be  any  kind  of heart arrhythmia,  ischemic heart symptoms, 
hypertension,  paralysis  of striated  and  smooth  muscles,  hypersalivation,  abdominal 
cramps and diarrhoea. No proven long-term effects are known. 
25 Barium 
Chemical and physical properties 
Barium, chemical symbol Ba,  is a soft metallic, silver-coloured element. 
Table 1 Physicochemical properties of Barium 
Atomic number 
Atomic weight 
Melting point 
Boiling point 
Specific gravity 
Valency status 
Solubility of barium compounds 
56 
137.33 
710°C 
1 537°C 
3.76 g/m
3 
Strictly divalent (II) 
The biological effects of Barium strongly depend on its solubility and bioavailability. The 
solubility of the most important compounds is as follows: 
Ba sulphate 
Ba carbonate 
Ba nitrate 
Ba fluoride 
Ba chloride 
Ba hydroxide 
Ba chromate 
Natural resources 
Practically insoluble in water, most acids and alkalines; 
Slightly soluble in concentrated sulphuric acid 
Practically insoluble in water; very soluble in nitric acid and 
hydrochloric acid (stomach!), where it forms soluble Ba 
chloride and nitrate respectively. 
Very soluble in water: 
Very soluble in water: 
Very soluble in water: 
Very soluble in water and acids: 
Only slightly soluble in water. 
About 0.04 to 0.05% of the upper layer of the solid earth's crust consists of barium. It 
is highly reactive, so it is not found in an elementary status in the earth's crust. Here it 
mainly occurs as sulphate (baryte = heavy spar) and carbonate (witherit). 
Metallic barium is also highly reactive in the air with oxygen, nitrogen and humidity as 
well as with water, with which it forms alkaline Ba(OH)  2. The world mine production of 
Ba sulphate  (baryte)  was about 4.5 million tonnes in  1974; the figures  indicated for 
1985 and  1986 vary  between  4.8  million  and  5. 7 million  tonnes  (Falbe  and  Regitz 
1989; Machata 1988; Reeves 1986; WHO 1990). 
Industrial use 
The most widely used Ba compounds are Ba sulphate and Ba carbonate. 
Ba sulphate is mainly applied in  oil-mining industries to form  drill mud.  It is also used 
as a radiation absorber in cement, e.g. in nuclear power plants, as a pigment in colours 
and lacquers and as a filler material in various chemical recipes (e.g.  in  lithopone). 
Ba carbonate is also applied as a pigment and a filler material, as well as a biocide; in 
27 steel industries it is used as a surface hardener. It also occurs in paper, rubber, ceram-
ics, printing colours, pyrotechnique industries, agricultural additives and as an impurity 
in  soapstone.  Ba carbonate is  also added in the flux and the coating respectively of 
some cored wires and rod electrodes in welding technologies. 
Ba sulphide is formed from the sulphate by heating with coal.  It is mainly applied as a 
biocide  and  a depilator.  Carbonate  as well  as  various  soluble compounds such  as 
hydroxide, acetate, chlorate, chloride and nitrate may occur as a biocide and in paper, 
rubber, ceramic, prints,  and dyestuff industries. 
Chloride and fluoride are also used  in  metallurgy for hardening steels. 
Fluoride is also  added  in  some flux cored  wires and  coated stick electrodes for arc 
welding. 
Ba chromate is  used as a pigment in  colours, ceramics and glasses. 
Organic compounds such as stearate are less important. They may be used as stabi-
lizers in plastic industries and as a lubricant in metal industries (Falbe and Regitz 1989; 
Stockinger  1981;  Spoor  1964;  Moreton  1981;  Reeves  1986;  Machata  1988;  WHO 
1990). 
Effects in vitro and in animal trials 
Experiments in cell physiology show that Ba can directly inhibit the passive transmem-
braneous potassium conductivity, mainly for the outward current. It also seems to inter-
act with calcium whether as a substitute with some intrinsic activity or as a messenger 
to release Ca from the endoplasmatic reticulum of the cells. After extracellular applica-
tion Ba ions lead to spontaneous depolarization of cells with phasic contractions of stri-
ated and smooth muscles with subsequent flaccid paralysis. 
At the heart Ba  ions lead to a spontaneous depolarization of the cells.  In the central 
nervous system Ba can release various transmitters. 
In  animal  trials  after  injection  of  Ba  ions  into  the  brain  ventricles  tonic  and  clonic 
cramps  could  be  observed.  After  injection  into  respectively the  peritoneum  and  the 
blood vessels of mammalians the acute symptoms were as follows: Contraction of the 
arterioles with a rapid increase of the systolic blood pressure only,  but not of the dias-
tolic  blood  pressure;  bradycardia,  increase of ventricular activation time,  increase of 
QRS-time,  confluence  of T and  U waves  in  ECG,  disorders  of repolarization,  atria-
nodular and ventricular premature systoles up to ventricular fibrillation.  In the course 
of an intoxication, contractions of the muscles with subsequent flaccid paralysis of stri-
ated  muscles  including  the  diaphragm,  hypersalivation,  fluid  diarrhoea  and  severe 
hypokaliaemia, even without diarrhoea or before diarrhoea has been observed. 
Longterm exposure with  parenteral injection of soluble Ba compounds and  inhalation 
of Ba carbonate  (13  mg/m
3  over 1 month)  additionally revealed the following  symp-
toms: anaemia, leucocytosis, loss of weight, decrease of serum proteins and blood glu-
cose, osteoporosis, lung sclerosis, dystrophy and hyperplasia of liver, spleen and kid-
neys. 
(Argibay et al.  1983; Armstrong and Taylor 1980; Armstrong et al.  1982; Augustine and 
Eckert 1984; Clement 1981; Cohen et al.  1983; Constanti et al.  1981; Cukierman and 
de  Carvalho  1982;  Douglas and  Rubin  1964;  Eaton  and  Brodwick  1980;  Ehara and 
I  nazawa 1980; Erdelyi 1979; Frank and Rohani  1982; Gallant 1983; Gerasimova and 
Roszinskin 1980; Hermann and Gorman 1979; Hiraoda et al. 1980; Malave et al.  1983; 
Meier and Katzung 1978; Milanov and Stoyanov 1982; Mugelli et al.  1983; Mukai and 
Takagi  1983;  Mukai  et al.  1982;  Munch  et al.  1980;  Nachshen  and  Blaustein  1982; 
Nagel 1979; Nakazato and Onoda 1980; Naylor and Grindwald 1982; Oliveira-Filho et 
al.  1978; O'Neill 1983; Osterrieder et al.  1982; Popava 1978;  Potreau and  Raymond 
1980; Roza and Berman 1971; Saeki et al. 1981; Shanbaky et al. 1978 and 1982; Tara-
senko  and  Pronin  1974;  Tarasenko  et al.  1977;  Woll  1982;  Yanagihara and  lrisawa 
1980; Yashuda et al.  1983; Zengel et al.  1980; Zengel and Magleby 1981). 
Effects on  humans 
Barium is not known as an essential trace element for man. 
Inhalation of Ba sulphate dust can lead to a benign pneumoconiosis with small nodular 
opacities in  the lungs with general distribution (baritosis).  It is  often found  in  workers 
mining,  grinding or bagging baryte,  but also in  lithopone manufacture and soapstone 
production. 
Pure  Ba sulphate is  not known to lead to any lung  impairment.  It is highly unsoluble 
and therefore not toxic, so it is applied in  medicine as a contrast medium. 
Barium  containing  minerals  may  be  contaminated  with  quartz,  which  may lead  to a 
mixed pneumoconiosis with subsequent lung function  disorders (Seaton  et al.  1986; 
ILO 1983). 
28 Soluble Ba compounds such as chloride, fluoride, nitrate are irritant to the mucosa and 
the skin. The inhalation as well as the ingestion of water-soluble Ba compounds may 
lead  to  severe toxic  effects.  Also  the  oral  ingestion  of Ba  carbonate  may be  toxic, 
because it is solved in  hydrochloric acid of the stomach, where it forms highly soluble 
Ba chloride. 
The miniumum single toxic dose has been evaluated from case reports as about 0.2-
0.8 g Ba chloride. The letal dose is estimated between 0.8 and 20 g Ba chloride. Intoxi-
cations with  soluble Ba compounds occurred due to misclassification of flour,  bakery 
ingredients, due to the external application of depilatories and biocides as well as with 
suicidal intention. 
The prognosis of the intoxication seems to be  positively influenced  by vomiting  and 
diarrhoea, which may reduce the bioavailable Ba dose. 
All  symptoms of an  intoxication come up  acutely with a latency between 30  minutes 
and some hours. 
The following disorders have been observed in  man: 
Initially:  Gastroenteritis  including  vomiting  and  diarrhoea  and  blood  in  the  faeces; 
tenesmus and cramps of the bowls. Paraesthesia of the face, the neck and the upper 
arm;  headache,  dizziness,  hyperhydrosis,  tremor  of the  extremities,  hypersalivation 
(sometimes dryness of the mouth); inhibition on the reaction of the pupils on  light and 
of the convergence of the eyes with diplopia. Acceleration of the heart rate up to  140 
beats per minute (later on normalization or even subnormal rates); hypertension up to 
180/110 mm  Hg  (later on  normalization  or even  hypotension);  reduction  of the  body 
temperature.  Severe  hypokaliaemia with  concentrations  down  to  1.6  mmol  per  liter 
serum. Sometimes short fasciculations or spasms of the striated muscles including sin-
gultus. 
In the further course: paraesthesia of all extremities; diminution of the muscle reflexes; 
flaccid paresis of the sceletal muscles, mainly developing upwards. Dysarthria, dysph-
agia. Cardia! arrhythmias of any kind;  disorders of the electric activation and repolar-
ization of the heart (digitalis-like action of Ba).  Excessive leucocytosis:  up to  70  000 
leucocytes per microlitre blood in WBC. Sometimes disorders of the pyramidal tract. 
The final stage: Overall paralysis of striated muscles including the diaphragm; ventricu-
lar fibrillations of the heart; cyanosis. Occasional renal disorders with kidney failure are 
described  (may be  brought about by therapeutical attempts with intravenous applica-
tion of sulphates with succeeding deposition of Ba sulphate in the kidneys).  No affec-
tion of the consciousness.  Death due to paralysis of the ventilatory muscles or due to 
heart failure (Adzhiev 1968;  Becker 1951;  Berning  1975; Camerer 1943; Dean  1950; 
Diengott et al.  1964; Domenjoz 1945; Fazekas 1955; Gould et al.  1973; Habicht et al. 
1970;  International  Labour Office  1983; Jeske and  Musialowicz 1978;  Lacroix  1943; 
Lecomte  1959;  Lewi  and  Bar-Khayim  1964;  Lydtin  et  al.  1965;  v.  Marchtaler  1950; 
Maretic et  al.  1957;  Morton  1945;  Preisz  1956;  Rausch  1951 ; Smith  and  Gosselin 
1976; Talwar and  Sharma 1979; Wetherill et al.  1981). 
A subchronic intoxication of a part of the population in Si Chuan (China) was found with 
vomiting, diarrhoea and a reduction of muscle reflexes and flaccid paresis; the cause 
of this intoxication was a contamination of table salt with soluble Ba salts  (ILO  1983; 
WHO 1990). 
No sure long-term effects of Ba are known. Acute intoxications- if not fatal- recover 
to the restitutio ad integrum. Some investigations of cardiovascular risks in correlation 
with the Ba content of drinking water show conflicting results; no sure impact of Ba on 
blood pressure, rate of vascular and heart diseases and after long-term exposure can 
be assessed (Brenniman et al.  1979 and 1981; Kojola et al.  1979; WHO 1990). 
Metabolism 
Absorption 
The absorption of soluble Ba from the airways and the lungs as well as from the gas-
trointestinal tract, where it is mainly absorbed in the small intestine (Dean  1950), can 
be estimated from animal trials between 30%  and 70%  of the applied dose (Cuddihy 
and Ozog 1973; Cuddihy and Griffith 1972; Cuddihy et al.  1974; Sutton and  Shepard 
1973; Reeves 1986). No data in  man have been established. 
29 In  man  some reports of cardia! disorders like arrhythmias and the impairment of re-
polarization have been observed after the Ba sulphate enema. This effect is predomi-
nantly described in  some studies in  patients who had been suffering from  cardiovas-
cular  risks,  but  not  in  all  studies.  The  cardia!  effects  are  generally  explained  as 
vegetative reactions due to the manipulations in the stomach and the gut. It is not clear 
whether Ba may be involved in these effects after absorption to some degree (La Van 
et al.  1962; Eastwood 1972; Berman et al1965; Gibbs et al1972; Roeske et al.  1975). 
Distribution 
The half-time of soluble Ba has been studied in  man in some trials after intravenous 
and intramuscular injection of soluble radioactive Ba isotopes. The results are in accord-
ance with those of studies in  mammalians. The half-life has been assessed between 
2.5 and  6 hours  within the first 5 hours and  from  28  to  35  hours with  a delay of 50 
hours after the application,  both  in  blood and  in  urine (Bauer et al.  1959;  Harrison et 
al.  1966 and  1967;  Me  Cauley and  Washington  1983; Cuddihy et al.  1974;  Cuddihy 
and Griffith 1972; Erre et al.  1980). 
So  a two- or even  multi-compartment storage system  of Ba in  the organism  can  be 
assumed (Marcus and Becker 1980;  Reeves 1986). 
After intravenous injection the tissue content reaches its maximum within the first two 
hours with a subsequent decline afterwards (Harrison et al.  1967). 
In  man about 22-24 mg  Ba is  being stored in the organism, about 20 mg  of which is 
found in the skeleton, which means about 90% of the Ba pool of the body. The Bacon-
centration in bone is about 2 mg Ba/kg bone (wet weight). Even higher concentrations 
can  be found in  lung,  heart, muscle and pigmented parts of the eye tissue. Age does 
not seem to affect the overall  Ba storage in  the organism  markedly.  Regional  differ-
ences of storage and distribution in various countries have been described (Schroeder 
et al.  1972; Harrison et al.  1967; Kojola et al.  1979; Reeves 1986). 
Excretion 
In man about 90% or even more of the excreted Ba is found in the faeces. Only about 
10% or less is being eliminated in urine. Furthermore, the secretion with sweat of about 
6% of the excreted Ba is important. The ratio faeces vs urine excretion is estimated as 
9:1  on average, some authors give values up to 200:1  (Harrison et al.  1966 and 1967; 
Kojola et al.  1979; Syed et al.  1981; Schroeder et al.  1972; Sutton and Shepard 1973; 
Tipton  et  al.  1969).  The  ratio  is  the  same  after  gastrointestinal  as  well  as  after 
parenteral application. 
The average excretion of Ba in the faeces varies between 0.3 and 1.2 mg per day and 
the  renal  elimination  between  0,2  and  30  J.lg/day,  which  equals  the  average  daily 
uptake in ordinary diet (Schroeder et al.  1972; Sutton and Shepard 1973; Tipton et al. 
1969;  Syed  et al.  1981;  Havlik  et  al.  1980;  Reeves  1986;  WHO  1990).  The  renal 
plasma clearance  has  been  calculated very differently by  two authors as  about 330 
ml/day and 10 1/day respectively (Harrison et al.  1966; Schroeder et al.  1972 with ref-
erence to the data given by Tipton et al. 1966 and 1969). The cumulative overall excre-
tion of Ba after the uptake is about 70-75% within the first three days and about 85% 
within the first 10 days (Harrison et al.  1966 and  1967; Reeves 1986). 
Biological  indicators 
Barium concentrations in serum/plasma and urine of 
non-occupationally exposed persons 
Data from  the  older literature  have to be  evaluated  with  precaution.  In  the  last few 
years  analytical  methodologies  have  become  more  sensitive  and  specific than  the 
older ones. Table 2 shows the barium levels in serum/plasma as well as in  blood and 
in  urine found by various investigators in  non-exposed subjects. 
The barium levels in plasma samples show a high interindividual variation (Zschiesche 
et al.  1989 and 1992). Most or all of the barium in blood is found in the plasma fraction 
(Nagel  1979; Schroeder et al.  1972;  Reeves  1986). The concentrations ranged from 
<1.0 to 38.8 J.lg/1,  most of the values being below 8 J.lg/1. 
30 The renal  barium excretion may also be characterized by high interindividual as well 
as  by  intra-individual variations.  Over a five  days period the  levels ranged  between 
<1.0 and 72.3 Jlg/1 and between <1.0 and 78.2 Jlg/g creatinine. Most of the values were 
below 20 Jlg/1  or g creatinine respectively.  {Zschiesche et al.  1987,  1989 and  1992). 
The intra-individual behaviour of the Ba concentrations in biological materials was very 
different even  without  any occupational  exposure.  Constantly  high  as  well  as  con-
stantly  low  values  could  be  observed,  but  also  a  changeable  internal  exposure. 
Examples are given in Table 3. 
In  a recent study of unexposed Italian subjects a mean barium concentration in  urine 
of 2.7 ± 1.5 Jlg/1  (N  = 35),  in  blood of 1.2 ± 0.6 Jlg/1  {N  = 25)  could be determined.  In 
this study tremendous efforts were made in eliminating errors in the preanalytical and 
analytical phase {Minoia et al.  1990). 
Occupational exposure to soluble barium 
In the literature very few studies of Ba exposed workers with regard to biological moni-
toring have been  published. A TLV of 0.5 mg/m
3  has been derived from workers of a 
plant in  the  USA with exposure to Ba nitrate {ACGIH  1980 and  1991 ).  This TLV has 
not been established quite profoundly so far {Stockinger 1981). 
Essing et al.  {1976) investigated 12 workers in the soapstone industries, who had had 
a long-term exposure to Ba carbonate with concentrations between 0.17 and  2.3 mg 
Ba/m3 air. They did not find any radiological disorders of the lungs and the pelvis. Two 
of them had systolic and diastolic hypertension. 
Two workers had a partial block of the right cardial brunch. Seven workers experienced 
symptoms of chronic bronchitis, three of whom had signs of a obstructive lung disease 
as well; all of them were smokers.  Five workers showed low-grade small nodular and 
reticular opacities respectively in chest-X-ray (p,s or t 0/1  to 1/0 according to ILO clas-
sification  1980).  No  sufficient  signs  of  a  Ba  intoxication  could  be  found.  An  acute 
paralysis has been described by Shankle and Keane 1988 in a worker who had inhaled 
Ba  carbonate  in  the  chrome  plating  industry.  Within  1  h,  he  experienced  abdominal 
cramps, nausea, and vomiting, and later there was excess salivation, paralysis of the 
extremities,  and  renal  dysfunction. A serum  potassium  level of 0.3  mmol/1  and  a Ba 
level  of 250  mEq/1  were reported.  After treatment with  potassium  infusion,  complete 
recovery occurred within 5 days. The potassium and Ba levels reported by the authors 
would  reflect a tremendous internal exposure as well as  extreme hypokalemia.  Both 
findings hardly seem compatible with life, so the validity of these data seems uncertain 
(Zschiesche et al.  1987). 
Dare et al.  (1984)  as well as  Oldenburg et al.  (1988)  and  Moreton et al.  (1981)  had 
proved that 30% to 90% of Ba in the fumes of some particular, coated stick electrodes 
and flux-cored wires are soluble in water or 0.1  M hydrochloric acid respectively within 
some  minutes.  This  meets  the  requirements  of the  definition  'soluble'  barium  com-
pounds. 
Dare et al.  (1984)  as well  as  Schramel et al.  (1985)  repcrt on  four and five welders 
respectively who had  been exposed to Sa-containing welding fumes. Dare et al.  indi-
cate Ba concentrations in urine between 31  and 234 Jlg/1 after shift in an experimental 
trial with reference values between 1.8 and 4. 7 Jlg/1.  Schramel et al. found Ba concen-
trations of 26-198 Jlg/1  urine in welders and of 4.5 Jlg/1 as reference value.  No data on 
ambient monitoring or medical investigations are being reported. 
A major study with the quantification of the internal as well  as the external exposure 
and the evaluation of any possible adverse effects of soluble Ba ions is an experimen-
tal investigation of 18 welders by Zschiesche and co-workers (1987,  1988,  1989 and 
1992). 
In this experimental study eight welders used coated stick electrodes on a nickel basis, 
4 mm diameter,  length 350 mm  each  (German  DIN  standard 85739:  E Ni  Fe  BG  1), 
the fumes of which contained 37.3% barium on the average. Welding was applied over 
one working week (five days)  in  medium-sized shops without local exhaust systems. 
On average, each welder consumed between 96 and 1  06 stick electrodes per day with 
an arc time of about 80% over four hours. This equals a realistic 40% arc time per eight 
hour shift. Ten welders used self-shielded flux cored wires with a diameter of 2.0 mm 
(USAWS standard 5.79-80: E 71  T 8 Ni 1).  In the mean, between 5.8 and 7.1  kg wire 
were  consumed  per welder per  day.  The  average  barium  content  in  the fume  was 
12.4%. Five welders had been working without local exhaust systems,  the other five 
applied a gun-integrated exhaust device offered by the wire producer. The other parts 
of the study design met the conditions in stick electrode welding. 
The external exposure is shown in  detail in Tables 4-6. In stick electrode welding the 
31 median barium concentration in the breathing zone was 4.4 mg/m3 air (range 0.1-22.7 
mg/m3).  Welding  with  flux  cored  wires  without  local  exhaust  device  resulted  in  a 
median external exposure in the breathing zone behind the protection shield and mask 
of 2.0 mg/m3 (range 0.3-35.9 mg/m3), when welding with the integrated exhaust sys-
tem of a median barium concentration of 0.3 mg/m3 (range 0.1  - 1.5 mg/m3). All fig-
ures given are mean time weighted average values. 
None  of the  stick  electrode  workers  had  applied  barium-containing  consumables 
before.  Out  of  the  flux  cored  wire  welders  three  had  been  welding  with  barium-
containing consumables in the week before the study started, another two some weeks 
before. The pre-exposure  Ba  levels in  urine and  plasma did not show any influence 
due to this previous exposure. 
Each  day  pre- and  postshift  urine  spot  samples  and  plasma  from  venous  blood 
samples were taken. An increase of the internal dose in plasma as well as in urine was 
observed over the one-week study.  It was found in the shape of sawteeth with relative 
maxima after shift and  relative  minima in  the  preshift specimens.  In  stick electrode 
welders the maximium median concentrations in urine were found on Wednesday after 
shift, to have a median value of 101.5 Jlg/1 (89.1 Jlg/g creatinine) and a maximum single 
concentration of 407 Jlg/1  (370.6 Jlg/g creatinine). Flux cored wire welders, who did not 
apply the exhaust device,  experienced the  highest median  barium concentrations in 
urine,  on  Friday after shift,  with a median of 113.1  Jlg/1  (77.3 Jlg/g  creatinine).  In this 
case the maximum individual concentration was 313.8 Jlg/1  (287.9 Jlg/g creatinine). 
In  accordance with the effective reduction of the external exposure by the integrated 
local ventilation system, the flux cored wire welders using this opportunity had the low-
est renal barium elimination. In these the highest values were also found in the Friday 
postshift urine  specimens  with  a maximum  median  concentration  of  44.3 Jlg/1  (49.2 
Jlg/g  creatinine).  The  maximum  individual  concentration  was  63.2  Jlg/1  (179.5 Jlg/g 
creatinine). 
The behaviour of the renal barium excretion is shown in  Figure 1. 
In plasma the interindividual as well as the intra-individual variation of the barium con-
centrations was lower than in the urine specimens. 
Also in  this biological fluid there was a sawteeth-like increase to be  observed.  In  all 
three groups of the welders the highest barium concentrations were found on  Friday 
after shift. At this time in stick electrode welders the median plasma concentration was 
24.7 Jlg/1  and the highest single value was 63.4 Jlg/1. 
In flux cored wire welders without the application of local exhaust the highest median 
concentration  was  16.6 Jlg/1,  the  maximum  individual  concentration  being  74.0 Jlg/1. 
Again, flux cored wire welders, who used the local ventilation system experienced the 
lowest internal  Ba  load  in  plasma with  a maximum  median  concentration  of 4.4 Jlg/1 
and the highest single value of 7.9 Jlg/1.  The results are shown in  Figure 2. 
On  average there was good correlation between external and  internal exposure. The 
coefficient of correlation was  best for the concentrations  in  plasma after shift of the 
same day with  r = 0.63  (Figure 3). The correlation with the barium concentrations in 
the postshift urine specimens was less striking with r = 0.44 for the liter-reference and 
r = 0.47  for the  creatinine-reference  (Figure  4).  Nevertheless,  all  these  correlations 
were statistically significant (p = 0.05). Even weaker was the correlation of the external 
barium exposure with  the preshift urine concentrations of the next day with  r = 0.40 
(liter-reference) and 0.36 (creatinine-reference). Also this correlation was significant (p 
= 0.05). 
The correlation of the  barium concentrations within  both the biological  matrices was 
also good.  It shows a coefficient of correlation of r = 0.60 (liter-reference for the urine 
levels)  and  0.62  (creatinine-reference of the urine levels)  in  the post-shift specimens 
of the corresponding days. The correlation of the concentrations in  plasma after shift 
and in  urine of the next morning was r = 0.74 (liter) and 0.55 (creatinine) respectively. 
The results are shown in  Figure 5. 
As can be seen from the course of the barium concentrations in the biological materi-
als, the values on median base do not normalize completely by Monday morning after 
a free weekend (day 12 of the study). This fact is mainly evident for the plasma values. 
The differences before  and  after welding  with  barium-containing  consumables were 
partly  significant  (p  =  0.05).  On  the  other  hand,  the  preshift  Ba  concentrations  in 
plasma and  urine  on  Monday after the  weekend  were  within  the  range  of the  pre-
exposure values.  So,  a slight accumulation, which is probably not toxically important, 
may be seen after high long-term exposure to soluble barium compounds. 
The biological half life of barium both in  plasma and in  urine was calculated between 
1  0 and 18 hours in all cases of this study. This is in good agreement with the previous 
experimental results. 
32 Biological indicators of health effects 
In  the literature there are only very few studies on  health  effects in  workers occupa-
tionally exposed to soluble barium compounds. 
The  informal notice that no sure health effects were seen  in  workers, who  had  been 
exposed to Ba nitrate led to the evaluation of the TLV in the USA (ACGIH  1980). Ess-
ing et al. found some excess of chronic and  even obstructive bronchitis in soapstone 
workers who had been smokers. Both the studies did not involve suitable sensitive and 
specific  methods  to  detect early  effects  of soluble  barium.  The  already  mentioned 
study by Zschiesche and coworkers (1989 and 1992) included the following investiga-
tions:  Anamnesis,  neurological  investigation,  determination  of  heart  beat  rate  and 
blood pressure, ECG with limb and precordial tracings each day before and after shift; 
permanent two channel recording of ECG  over 12 days; quantification of electrolytes 
in serum (Na,  K, total and ionized Ca, Mg), acid-base-status each day before and after 
shift;  total  protein  in  serum,  protein  electrophoresis  in  serum  and  sensitive  tubular 
nephrogenic enzymes (N-acetyi-13-D-glucosaminidase, alanineaminopeptidase) before 
and during the trial. 
Out of these parameters only  potassium  showed  a reduction  of the  plasma level  in 
some welders down to  2.9 mmol/1.  Nevertheless, the intra-individual potassium levels 
of these  welders varied  markedly and  became  partly  normal  again,  even  if the  Ba 
exposure continued. Furthermore, no dose-effect pattern could be recognized from the 
values. 
All other parameters including detection of premature heart action, disturbance of heart 
repolarization,  sensoric and  motoric disorders  including  dynamometry did  not show 
any newly upcoming impairments, no differences before and after shift and no trends 
during  the  trial  compared  to the  basic  data collected  during  two  days  before  when 
welding with non-barium containing consumables. 
Conclusions 
Summarizing all data published on  biological monitoring, it is obvious that only limited 
knowledge  on  the  basic  barium  level  in  blood  and  urine  respectively of the  general 
population is present.  Except for two studies,  in  particular no reliable serum or blood 
concentrations have been published. 
The data on biological monitoring of the environmental exposure show great variations 
interindividually as well  as  intra-individually; to some degree also greater differences 
between various studies are evident for the urine concentrations.  Mainly the study by 
Zschiesche and co-workers (1989 and  1992) shows a wider range of the Ba concen-
trations in  biological material. 
Two other studies by Schramel et al.  (1985) and by Minoia et al.  (1990) show smaller 
variations.  It is quite evident that the daily uptake of barium  as well  as the excretion 
may be  strongly influenced by dietary factors,  which  may particularly affect the con-
centrations in  urine spot samples (Sutton and Shepard 1973; Schramel et al.  1985.). 
Taking together the results of all studies available, there seems to be an upper normal 
limit (upper 95% range, one-tailed) of about 10 to 15 Jlg  Ball or Jlg/g creatinine in urine 
spot samples  in  the majority of investigations  in  Europe.  The  upper normal  limits in 
serum and blood seem to be somewhat lower (around 5 to 8 Jlg/1). 
There is only one extensive study on  biological monitoring of workers who have been 
occupationally exposed to soluble barium compounds. 
In this investigation the overlap of 'normal' values with the results of biological moni-
toring even after heavy external exposure seems to be wide. Therefore, at the present 
state of knowledge BM of barium seems preferably applicable on group basis and for 
the demonstration of any change of exposure in the course of time. Single spot values 
may  probably  not  be  able  to  demonstrate  or  disprove  an  occupational  exposure, 
except where relatively high Ba concentrations are found. 
Research needs 
Further  studies  on  the  environmental  internal  exposure  in  various  geographical  re-
gions; 
the  evaluation  of a correlation  between  normal  barium  concentrations  in  urine  and 
serum/blood and of the external load by drinking water and food; 
33 further studies on the internal exposure of workers who are occupationally exposed to 
various soluble Ba compounds, such as nitrate, chloride, fluoride or carbonate, whether 
after long-term exposure or with intermittent exposure; 
evaluation of a possible change of biological half-life of barium in different 
body fluids with  regard to duration of exposure; 
further studies on  acute or chronic adverse effects of soluble barium compounds on 
occupationally exposed persons; 
the evaluation of a minimum toxic dose or concentration after long-term exposure for 
man. 
Analytical methods 
Determinations  of barium  with  conventional  analytical  reagents  is  unsatisfactory for 
microquantities.  Inductive  coupled  plasma  (ICP)-atomic  emission  spectrometry  and 
electrothermal atomic absorption spectrometry (ETAAS)  are  suitable for the determi-
nation of barium in biological body fluids (serum/plasma, urine), both in the physiologi-
cal and occupationally relevant ranges without time-consuming sample processing. 
Because of the absence of line overlaps at the wavelengths for barium and  because 
of the high spectral resolving power of the commercially available ICP spectrometers, 
the  specificity of the  ICP method  may be  considered  certain.  ICP-emission spectro-
metry has a whole range of advantages for barium determination in  comparison with 
atomic  absorption  spectrometry with  electrothermal  atomization,  which  is  otherwise 
frequently used  for metal determinations in  biological material. Thus,  ETAAS  is rela-
tively error-prone because barium absorbs at long wavelengths which lie in the range 
of the emission energies of the graphite furnace. Carbide formation must be expected 
with barium as well.  In  addition, the ICP method uses aequous standards for calibra-
tion and a standard addition procedure can be avoided (Angerer and Schaller 1988). 
For the ETAAS determination of barium the spectrophotometer has to fulfil several opti-
cal specifications, especially to measure reliably in the long wavelength ranges (553.6 
nm).  After dilution  of the  samples the  barium  concentrations  can  be  determined  by 
standard addition technique and  background correction. The  ICP shows a detection 
limit of around 0.2 J.i/l,  the ETAAS of 2 J.ig/1. 
A high risk of contamination must be expected in assays of low barium levels. To  pre-
vent exogenous contamination all bottles and tubes used for specimen collection and 
sample treatment must be specially cleaned with  1  0%  nitric acid and ultrapure water. 
Table 2:  Plasma or serum, blood and urine barium concentrations of occupationally non-
exposed persons found in the recent literature. 
Reference  Speci- No.  of  No. of  Mean  Range  Method 
mens  Speci- Subjects  (standard 
mens  deviation) 
or Median 
Zschiesche  Serum  83  18  2.0 J.IQ/1  <1-38.8  ET-AAS 
et al.  1987  J.IQ/1 
and  1989 
Minoia et al.  Blood  25  25  1.2 ± 0.6  0.47-2.9  ET-AAS 
1990  J.IQ/1  J.IQ/1  and/ or ICP 
(not speci-
fied) 
Zschiesche  Urine  106  18  9.3 J.IQ/1  <1-72.3  ET-AAS 
et al.  1987  J.IQ/1 
and  1989 
Zschiesche  Urine  106  18  7.0 J.IQ/g  <1-78.2  ET-ASS 
et al.  1987  creatinine  J.lg/g crea-
and  1989  tinine 
Schramel et  Urine  25  25  4.5 ± 4.2  0.2-12.7  ICP 
al.  1985  J.IQ/1  J.IQ/1 
Schramel et  Urine  25  25  6±6  0.2-21  ICP 
al.  1985  J.IQ/day  J.IQ/day 
Dare et al.  Urine  3  3  --- 1.8-4.7  ET-AAS 
1984  J.IQ/1 
Minoiai et  Urine  35  35  2.7±1.5  0.25-10.1  ET-AAS 
al.  1990  J.IQ/1  J.IQ/1  and/or ICP 
(not speci-
fied) 
34 Table 3: Course of the barium concentrations in urine and plasma in some welders in the 
pre-exposure phase of the study (Zschiesche et al. 1989). 
Welder 
no. 
1.1 
3.2 
1.4 
Examples are given for generally low, generally high and for variable barium con-
centrations. All values are given as pg/1. 
Material  Day 
1  2  3  4 
Pre- Post- Pre- Post- Pre- Post- Pre- Post-
shift  shift  shift  shift  shift  shift  shift  shift 
Urine  1.5  2.4  2.3  2.7  - - -
Plasma  0.5  0.3  0.2  0.8  - - - -
Urine  18.4  19.4  7.0  46.8  22.9  47.0  36.1  38.6 
Plasma  6.6  7.0  6.4  38.8  -
Urine  7.4  4.3  44.3  14.3  - - -
Plasma  8.0  1.0  1.5  3.7  - -
-=  no specimens taken (weekend) 
Table 4: External exposure (personal air sampling) of welders when using coated stick elec-
trodes without fume extraction. 
Welder 
1.1 
1.2 
1.3 
1.4 
1.5 
1.6 
1.7 
1.8 
Given  are  time  weighted  averages  (TWA)  of total  fume  concentrations  in  the 
breathing  zone,  of barium  concentrations  and  the  barium  content  in  the  total 
fume(%). 
Day  Fume total  Ba-air (mg/  Ba-air (% total 
(mg/m
3
)  TWA  m
3
} TWA  fume) TWA 
5  27.5  7.7  28.1 
6  11.6  2.3  20.9 
7  18.9  5.2  27.4 
8  12.6  3.0  24.2 
9  21.5  6.1  28.5 
5  13.8  2.8  20.2 
6  15.8  3.3  19.2 
7  72.6  19.2  26.4 
8  29.2  6.1  21.0 
9  16.7  4.4  26.1 
5  5.3  4.5  84.7 
6  9.1  4.4  48.6 
7  0.8  0.1  16.7 
8  8.3  3.5  42.4 
9  8.7  2.1  24.6 
5  11.5  5.4  46.4 
6  14.1  6.1  43.6 
7  37.0  15.1  40.9 
8  58.7  13.9  23.7 
9  81.7  18.4  22.5 
5  n.w.  0.6  -
6  1.5  0.2  10.0 
7  31.6  12.2  38.7 
8  48.0  10.9  22.7 
9  4.5  17.0  22.8 
5  8.7  4.4  50.3 
6  16.2  1.7  10.2 
7  57.8  15.3  26.5 
8  151.4  14.9  9.8 
9  88.7  15.8  17.8 
5  67.3  22.7  33.7 
6  61.0  20.6  33.8 
7  n.w.  3.1  -
8  n.w.  1.2  -
9  8.3  2.5  30.4 
5  n.w.  0.1  -
6  6.0  0.2  4.0 
7  n.w.  0.9  -
8  8.7  1.8  20.6 
9  15.6  4.1  26.2 
35 Table 5: External exposure of welders (personal air sampling) when using flux cored wires 
without fume extraction. Given are time weighted averages (TWA)  of total fume 
concentrations in  the brea·i l"ing zone, of barium concentrations and  the barium 
content in the total fume(%). 
Welder  Day  Fume total  Ba-air (mg/  Ba-air (% total 
(mg/m
3
)  TWA  m
3)TWA  fume) TWA 
2.1  5  3.1  0.3  10.7 
6  0.6  0.2  24.8 
7  1.1  0.2  19.7 
8  2.9  0.5  16.5 
9  3.6  0.5  13.7 
2.2  5  2.6  0.2  8.6 
6  1.9  0.2  8.8 
7  1.4  0.2  12.2 
8  2.7  0.3  9.9 
9  4.4  0.6  12.8 
2.3  5  2.4  0.2  7.1 
6  0.8  0.1  18.1 
7  2.6  0.4  15.2 
8  1.3  0.1  11.0 
9  4.8  0.5  10.6 
2.4  5  1.9  0.2  9.5 
6  3.0  0.4  12.4 
7  1.3  0.2  14.8 
8  5.3  1.0  19.3 
9  3.1  0.4  14.3 
2.5  5  1.9  0.1  6.2 
6  4.2  0.3  7.3 
7  1.5  0.2  12.1 
8  2.7  1.5  56.5 
9  4.3  0.6  13.2 
3.1  5  7.8  1.4  17.4 
6  7.8  1.7  22.1 
7  8.1  1.1  13.8 
8  12.2  2.3  18.5 
9  23.5  3.8  16.1 
3.2  5  35.4  5.0  13.8 
6  21.8  3.2  12.5 
7  18.4  1.9  10.4 
8  5.5  0.3  6.2 
9  13.7  2.0  14.5 
3.3  5  14.1  2.0  13.4 
6  9.4  2.4  25.2 
7  4.3  1.6  35.9 
8  6.4  0.7  11.5 
9  15.8  2.3  14.8 
3.4  5  10.5  1.2  9.2 
6  24.7  3.5  14.1 
7  6.2  1.1  17.7 
8  5.7  0.5  9.0 
9  16.0  2.3  14.4 
3.5  5  31.2  4.9  15.9 
6  42.1  6.0  14.3 
7  12.3  1.7  15.6 
8  4.2  0.4  10.5 
9  16.6  2.4  14.6 
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Fig.  5 Correlation between the internal barium exposure in  plasma postshift samples 
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46 Biological indicators for the 
assessment of human exposure 
to industrial chemicals 
Hexane and methyl ethyl ketone 
A.  Mutti 1-Hexane 
Summary 
Hexane is a major component of the rubber solvent fraction distilled from  petroleum. 
Occupational exposure occurs in a number of activities but especially in the production 
and use of glues, paints, varnishes and printing inks. Shoemakers, however, make up 
the main occupational target group. 
Several  outbreaks  of hexane-induced  peripheral  neuropathies  have  been  reported; 
neurophysiological changes have also been found in subjects exposed to relatively low 
airborne concentrations. 
Inhalation is the main absorption route; the lung uptake is about 20%  of inhaled hex-
ane.  Percutaneous absorption may also occur,  but it is thought to be very low. About 
1  0%  of the  total  uptake  is  excreted  unchanged through  exhaled  air,  trace  amounts 
being detectable in  urine. 
Biotransformation involves the mono-oxygenase system, giving rise to 2-hexanol, 2,5-
hexanediol, 5-hydroxy-2-hexanone, and 2,5-hexanedione (HD).  Such metabolites are 
conjugated in  part with glucuronic acid,  and then excreted in  urine. 
Hexane  concentrations  in  blood,  alveolar  air  and  urine  are  correlated  with  current 
exposure. Time-weighted average exposure is better mirrored by the urinary excretion 
of metabolites,  among which  HD  seems to  be  the best indicator for monitoring  pur-
poses.  In  fact,  urinary HD  is  both  correlated  with  exposure and  is thought to  play a 
pathogenetic role in  hexane-induced neuropathy. 
Owing to its relatively long  half-life,  HD tends to accumulate over the working week. 
Such a behaviour is  toxicologically important and  should  be considered when imple-
menting biological monitoring programmes. 
Urinary levels of 3 mg/g creatinine and 5 mg/1  (hydrolysed samples) would correspond 
to 8h-TWA concentrations of 50 ppm of hexane in the air. 
Very recently, it has also been suggested that hydrolysis might lead to the formation of 
interfering  substances thus  artefactually  increasing  2,5-HD  levels  in  urine  samples 
from  subjects  exposed  to  low  hexane  concentrations.  About  200  J.lg/1  of  2,5-HD  in 
samples undergoing simple extraction would correspond to hexane airborne concen-
trations of 50 ppm. 
49 Hexane 
Older name:  n-hexane 
Synonym: hexyl-hydride 
Chemical and physical properties 
Colourless, flammable 
liquid 
Boiling point 
Melting point 
Vapour pressure  (15.8 °C) 
(20  °C) 
Vapour density 
Flash point 
Solubility 
CAS-Number 
Formula 
Molecular weight 
1 ppm = 3.52 mg/m
3 
1 mg/m
3  = 0.284 ppm 
Production 
: 68.7 oc 
: 95.6 oc 
: 1  00 mmHg (13.3 KPa) 
: 124 mmHg  (16.5 KPa) 
: 3.0 (air = 1 at the boiling point of 
hexane) 
: -30 oc 
: insoluble in  water (0.014 g/1 00 ml 
at 20  °C); soluble in ether and chloro-
form,  50 g in  1  00 ml ethanol 
: 110-54-3 
: CsH14 
CH3-CH 2-CH  2-CH2-CH 2-CH3 
: 86.20 
Hexane is produced by distillation of petroleum. Commercial hexane also contains four 
isoparaffinic  isomers  (2-methylpentane,  3-methylpentane,  2,2-dimethylbutane,  2,3-
dimethylbutane)  as  well  as  methylcylopentane,  cyclohexane,  and  minor amounts of 
other hydrocarbons in the C5-C7  range. Certain solvent mixtures also include aromatic 
or chlorinated hydrocarbons and  ketones. 
Industrial exposure 
Hexane is widely used in food-oil extraction and as a solvent of glues, paints, varnishes 
and printing inks. Pure hexane is used as a laboratory reagent, mainly for high perfor-
mance liquid chromatography. 
An  estimated  2 500 000  workers  are  potentially  exposed  to  hexane  in  the  United 
States, where 500 million pounds were used annually in  1985 (Dunnick et al.,  1989). 
Although  its use  has been  reduced  in  recent years,  hexane  is  still  ubiquitous in  the 
shoe and leather industry. Table 1 summarizes the typical levels of exposure recorded 
during  field  surveys  or  metabolic  studies  on  occupationally exposed  workers.  Over 
recent years, there has been a tendency towards a reduction of exposure to hexane 
in  industry, achieved either by exhausting vapours generated during adhesive drying 
or by substituting it with less harmful solvents, or both. 
51 Table 1  : Exposure to hexane in the shoe industry 
No. of samples  Median  Range  References 
(mg/m
3
)  (mg/m
3
) 
41  160  32-500  Perbellini et al., 1981 
58  350  50-780  Mutti et al., 1981 
30  59.6  15-195  lmbriani et al., 1984 
10  243  8-1143  Mutti et al.,  1984 
20  59.0  7-232  De Rosa et al., 1981 
128
1  35  7-102  Ahonen and Schimberg, 1988 
1  Four  workplaces 
The NIOSH has recommended that the permissible exposure limit (PEL)  be  reduced 
from 500 to 100 ppm (350 mg/m
3
), with a ceiling level of 510 ppm  (1  800 mg/m
3
)  aver-
aged  over  a  15-minute  period  (Mackinson  et  al.,  1981).  The  current  ACGIH-
recommended threshold limit value (8h-TWA)  is 50 ppm (180 mg/m
3
). 
Effects on humans 
Like many other organic solvents, which by definition are inert chemicals, hexane has 
long been considered to be a relatively safe substance and for that reason it has been 
introduced in the shoe industry as a substitute for the much more toxic benzene.  For 
the same reason, nearly 400 cases of 'shoemakers' polyneurophathy' occurring in Italy 
over the 15 years up to 1976 (published cases reviewed by Abbritti et al.,  1976) were 
attributed to other agents, mainly tri-ortho-cresyl-phosphate (TOCP), the possible role 
of hexane exposure being systematically overlooked. 
Neurotoxic effects 
In  1967,  the  earliest cases  linking  hexane exposure to  peripheral  neuropathy were 
reported in Japan (Yamada,  1967). Later, an additional 93 cases involving sandal  mak-
ers exposed to 500-2 500  ppm  of hexane for several months were reported  (Yama-
mura, 1969). 
Little attention was paid to these reports, until a similar neuropathy involved 86 work-
ers exposed to methyl-n-butyl ketone (MnBk) and methyl-ethyl ketone (MEK)  in a plas-
tic coating and  printing plant (Billmaier et al.,  1974). MnBk has been  identified as an 
aetiological agent, but it is likely that MEK also played a potentiating role (Salda et al., 
1976). It became thus apparent that hexacarbons could induce peripheral neuropathy, 
possibly through the formation of a common reactive metabolite.  Since then,  hexane 
has been  recognized as the probable cause of peripheral neuropathy in  hundreds of 
cases involving shoemakers, mainly home workers, in various countries. 
Abuse of commercial glues and hexane-containing solvents has also been associated 
with peripheral neuropathy (for review, see O'Donoghue, 1985). In either cases, axonal 
degeneration has been recognized as the underlying pathological change, character-
ized by a central-peripheral distal distribution. The typical lesion is the 'onion bulb' or 
focal  axonal swelling  'giant' axons being formed  by  paranodal accumulation of neu-
rofilaments and mitochondri. Myelin damage has usually been regarded as secondary 
effect of axonal swelling (Spencer and Schaumburg, 1977). 
The clinical course is insidious and develops over several weeks to months, leading to 
bilateral, symmetrical, sensorimotor peripheral  neuropathy.  Sensory changes show a 
glove and  stocking  distribution  and  involve  loss  of touch,  vibration  and  temperature 
sensation.  In  more severe cases,  motor disturbances are  apparent,  involving  either 
hands or feet, or both. Muscle weakness makes it difficult to grasp objects, e.g. glasses 
or cups,  and to go  upstairs.  Subjective symptoms include headache, tiredness,  nau-
sea, anorexia. Following removal from exposure, the progression of clinical signs may 
continue for several weeks. The prognosis is usually good, but mild to moderate cases 
require several months for recovery (Cianchetti et al.,  1976). 
Exposure-response relationship 
Whereas exposure levels under conditions of abuse are very high - the air concentra-
tion exceeding thousands ppm  - and are  repetitive in  order to achieve and  maintain 
an  euphoric state, much lower levels usually occur in  industry (Table  1).  Because of 
their retrospective nature, almost no case reports include exposure conditions in their 
description. Furthermore, most reported cases occurred before the possible aetiologi-
52 cal  role of volatile substances was suspected. As  a result,  it is very difficult to link a 
definite exposure  pattern  and/or level to the  outcome.  However,  though  limited,  evi-
dence about the occurrence of an exposure-response relationship and the existence 
of a threshold does exist. 
Exposure in  industries where cases of polyneuropathy have been reported were usu-
ally in the range of 500 to 1 500 ppm and lasted several months. Co-exposure to other 
compounds  with  unpredictable  interactions  with  hexane  metabolism  also  occurred. 
However, a couple of reports refer to levels ranging from 60 to 240 ppm and 30-1  150 
ppm  (1 05-4 060 mg/m
3
)  (Table  2).  This table is  of course aimed at showing the diffi-
culties in  establishing a threshold rather than at estimating the incidence of hexane-
induced polyneuropathy, which  is certainly much greater than that arising from cases 
published  in  international journals.  For example,  respectively 678 and  119 additional 
cases of subclinical and clinical neuropathy due to hexane were diagnosed in six Ital-
ian occupational health institutes during the period 1976-80 (Chiesura, 1981). Over the 
same period, exhaustion systems were lacking in  some 40%  of Italian plants,  where 
exposure levels exceeding the ACGIH-recommended TLV (180 mg/m3)  were found in 
a similar proportion, i.e. 37.7% (De Rosa et al.,  1981). 
In  a  cross-sectional  study  on  currently  exposed  workers,  a significant  reduction  in 
median nerve motor conduction velocity was detectable in  workers exposed to levels 
giving rise to a cumulative exposure (hygienic effect x years) exceeding 20 when the 
TLV was set at 360 mg/m3  (Mutti et al.,  1981).  In  a subsequent survey,  neurological 
complaints and changes in motor nerve conduction velocity (MCV) were found in work-
ers exposed to median values of 362 mg/m
3
. Abnormal findings were also significantly 
over-represented in a subgroup of workers with median exposure levels of 173 mg/m3 
(Mutti et al.,  1982a, 1982b). In a small group of heavily exposed subjects (median lev-
els 448 mg/m
3
)  with  peaks  up  to  5 000-7 000 mg/m
3  (when  exhausters had  broken 
down), abnormal somatosensory evoked potentials and/or nerve conduction velocities 
were found in 6 out of 15 workers (Mutti et al., 1982c). The latter study was carried out 
three  months  after  substantial  improvements  in  the  working  environment  lowered 
exposure to trace amounts. Thus, hexane-induced electrophysiological changes should 
be  regarded  as chronic or slowly reversible effects. According to the above findings, 
the current ACGIH-recommended TLV (180 mg/m
3
)  should be regarded as a relatively 
safe exposure level. However, Sanagi et al.  (1980) were able to show mild subclinical 
changes in muscle strength and nerve conduction velocity in a small group of workers 
exposed to  186 mg/m
3  on average, although they concluded that hexane vapour lev-
els of less than  1  00 ppm for eight hours per day were not likely to produce a clinical 
neuropathy. 
Table 2:  Exposure in industries where cases of hexacarbon-induced polyneuropathy had 
been reported 
No of  Solvent  Exposure  level, ppm  Clinical  Reference 
cases  mixture  duration  findings 
6  Hexane 64%  3-10 months  2 500  Sensorimotor  Wada et al., 
Methyl- polyneur- 1965 
pentanes and  apathy 
cyclopentane 
93  Hexane 70%  6 months  500-2 500  Sensory in  Sobue et al., 
Toluene  100%  1968 
Motor in 43% 
Optic in 3% 
MCV 
reduced in 
50% 
3  Hexane 16%  6-10 months  650-1  300  Sensorimotor  Herskowitz et 
Acetone,  Fibrillations  al.,  1971 
methyl- at the EMG 
pentanes, 
methyl cycle-
pentane 
86  MnBk10%  Several  331-516  Sensorimotor  Bill  maier et al., 
MEK  months  MCV slowing  1974 
9-36 months  Progression 
after removal 
from 
exposure 
53 No of  Solvent  Exposure  level, ppm  Clinical  Reference 
cases  mixture  duration  findings 
4  Hexane  5-7 months  60-240  Sensorimotor  Takeuchi et al., 
12.5%  Fibrilations at  1974 
Many others  EMG 
8  Hexane  ?  30-1  150  Sensorimotor  Paulson et al., 
1976 
In  a single published study,  both biological monitoring and  electroneurographic mea-
surements were simultaneously performed, giving rise to some information about the 
dose-response relationship (Governa et al.,  1987). A more detailed discussion of this 
study is given in the section dealing with the definition of biological limit values. It ought 
to  be noted that electrophysiological measurements, especially nerve conduction ve-
locities,  may underestimate the  occurrence  of neuropathy when  axonopathy  is  the 
underlying mechanism. 
Mechanism of action 
Excellent  reviews  covering  experimental  studies  are  available  (O'Donoghue,  1985; 
Spencer et al.,  1980). Thus, only a brief discussion will be reported here.  Inhibition of 
glycolysis by 2,5-hexanedione (2,5-HD), the metabolite common to hexane and MnBk 
thought to be responsible for their neurotoxicity, may impair axonal transport functions 
(Spencer et al.,  1980). Several enzymes involved in glycolytic and phosphorilative pro-
cesses have been found to be inhibited by 2,5-HD (glyceraldehyde-3-phosphate dehy-
drogenase, fructose-6-phosphate kinase, and enolase).  Inactivation of thiamine pyro-
phosphate  was  also  suggested  as  the  underlying  mechanism  of the  'dying-back' 
process (Shoental and Cavanagh,  1977). 
Paranodal accumulation of neurofilaments has been attributed to 2,5-HD-induced for-
mation of pyrroles and  subsequent cross-links of cytoskeletal  components  (Saida et 
al.,  1976).  However, a negative relationship has been found  between the potency of 
neurotoxic hexacarbons (in terms of latency) and the number of axonal swellings, thus 
suggesting that the latter phenomenon is a secondary effect and not a requirement for 
axonal neuropathy (Krasavage et al.,  1978). 
Recently, Abou-Donia et al.  (1988)  confirmed the involvement of cytoskeletal proteins 
in the molecular pathogenesis of hexacarbon neuropathy, the inhibition of phosphory-
lation of neurofilament protein being an associated change. Whatever the mechanism 
underlying the dying-back process, the formation of a r -diketone is an essential step. 
In fact,  whilst A, B and l'l diketones were ineffective, other r -diketones could  experi-
mentally induce peripheral neuropathy in  animals (Spencer and Schaumburg,  1977). 
More importantly, a relationship has been found between the relative neurotoxicity of 
hexane metabolites and blood levels of 2,5-HD achieved in rats treated by gavage (see 
Fig.  1, from Krasavage et al.,  1980). 
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Fig. 1  . Relationship between the peak serum levels of 2,5-hexanedione and the severity of neuro-
toxic changes following the administration of hexane metabolites.  {Adapted from  Krasav-
age et al.,  1980.) 
Metabolism 
Absorption 
Uptake of hexane occurs primarily through inhalation of vapours. Although percutane-
ous absorption has been suggested as the major route of entry in man (Nomiyama and 
Nomiyama 1974),  experiments in  guinea pigs contradicted such an  assumption  (Ja-
cobson et al., 1982). On the other hand, cases of polyneuropathy have frequently been 
reported  in  subjects not having direct contact with glues or solvents, which indicated 
the aetiological role of volatile substances dispersed in the working environment under 
poor hygienic conditions (Abbritti et al., 1976). Despite the toxicological importance of 
the respiratory route,  pulmonary retention of inhaled hexane is  relatively low,  figures 
from  16.4 to 25.2%  (median  20%)  having been  consistently found  by using different 
methods (Veulemans et al.,  1982; Brugnone et al.,  1983;  Mutti et al.,  1984). A value 
as low as 5.6% was found by Nomiyama and Nomiyama (1974). 
Distribution 
Data of distribution are mainly derived from in  vitro  experiments aimed at evaluating 
the  solubility  and  the  tissue/blood  partition  coefficient.  Hexane  is  poorly  soluble  in 
blood,  whereas it is highly soluble in  fat,  the fat/blood partition coefficient being  130 
(Table 3). 
55 Table 3: Solubility of hexane in blood and human tissues (From Perbellini et al., 1986) 
Tissues  Air/tissue  Tissue/  Relative  Relative  Half-life 
partition  blood  mass of  blood  (minutes) 
coefficient  partition  the organ  supply, per 
coefficient  cent of 
body 
weight 
Blood  0.8  6.4 
Brain  5.0  6.2  2.3  0.14  7.3 
Liver  5.2  6.5  2  0.24  3.7 
Kidney  3.0  3.7  0.5  0.22  0.6 
Muscle  5.0  6.2  43  0.15  90 
Heart  2.8  3.5  0.4  0.04  3 
Lung  1.0  1.2  1.6  - -
Fat  104  130  20  0.05  3440 
The distribution of solvents also relies on  physiological parameters and  is  a dynamic 
phenomenon where a key role is played by perfusion. Whereas after single exposures 
the adipose tissue is expected to contain  a relatively small fraction of absorbed hex-
ane,  repeated  exposures lead to accumulation of the solvent in  fat,  owing to its long 
half-life  in  this  compartment  (Perbellini  et  al.,  1986).  On  the  contrary,  vessel-rich 
organs  (including  the  brain)  receive  relatively  large  amounts  of hexane,  which  are, 
however,  rapidly  cleared  from  the  tissue  even  without  considering  the  proportion 
undergoing metabolic transformation. 
Biotransformation 
Hexane is metabolized by microsomal enzymes giving rise to several oxidation prod-
ucts. Probably due to steric hindrance at other sites of the molecule, 2-hexanol is the 
predominant  oxidation  product  and  is  further  oxidized  to  MnBk  or  2,5-hexanediol, 
which  are  then  transformed  into  2-hydroxy-5-hexanone  and  subsequently  into  2,5-
hexanedione  (Fig.  2).  Other  compounds  have  been  found  in  urine  from  hexane-
exposed subjects, e.g. y-valerolactone and 2,5-dimethylfuran, but these sustances are 
thought to be formed  during the gas chromatographic analysis from  a precursor (Di 
Vincenzo et al.,  1976). 
Metabolic interferences 
Metabolic  interactions between  hexane  and  other solvents  occurring  in  commercial 
mixtures have been reported (Aitenkirch et al.,  1977). There is also evidence suggest-
ing that methylethylketone  (MEK)  co-exposure potentiates hexane and  MnBk neuro-
toxicity in various systems and models. Whereas attempts at inducing peripheral neu-
ropathy  in  animals  treated  with  MEK  alone  have  been  unsuccessful  (Saida  et  al., 
1976), hexane-induced neuropathy appeared sooner and in more animals when expo-
sure to 9 000 ppm  of hexane  (eight hours per day,  seven  days per week for periods 
up to 19 weeks) was combined with 1 000 ppm of MEK (Aitenkirch et al., 1978)./n vitro 
models also demonstrated that combined MEK:hexane exposure of murine spinal cord 
explants shortened onset of neuropathological changes and  lowered the threshold of 
dose-response relationship for hexane (Veronesi et al.,  1984). 
The mechanism by which MEK potentiates MnBk/hexane neurotoxicity is still unclear. 
MEK could  act as a microsomal enzyme inducer (Couri  et al.,  1977).  Such  a hypo-
thesis is,  however,  inconsistent with separate experiments showing that the recovery 
of hexane metabolites is actually reduced to  one quarter rather than being increased 
after MEK co-exposure (Iwata et al., 1983b) and that 2,5-HD levels in the sciatic nerves 
of rats  acutely exposed  to  hexane:MEK mixtures  are  actually  lower than  in  nerves 
taken from animals exposed to equimolar concentrations of hexane alone (White and 
Bus,  1980). A tempting hypothesis has been put forward by Ralston et al.  (1985) and 
has also been suggested by Ladefoged and Perbellini (1986) to explain similar effects 
due to acetone co-exposure. 
According  to  these  authors  the  lower  recovery  of  2,5-HD  during  co-exposure  to 
acetone would be associated with a concomitant slowing in body clearance. However, 
it is more likely that toxicodynamic rather than toxicokinetic factors account for MEK 
potentiation of hexane neurotoxicity.  It has been suggested that MEK competes with 
2,5-HD for the same binding sites (Ralston et al.,  1985). The question then arises as 
to whether MEK binding to  noncritical sites may actually increase 2,5-HD binding to 
56 critical sites unavailable to MEK.  Other interactions have been investigated. Toluene 
and  xylenes showed  antagonistic effects  (Takeuchi  et al.,  1983;  Nylen  et al.,  1989) 
which  would  be  easily  explained  by  metabolic  interferences  greatly  reducing  the 
biotransformation of administered hexane (Perbellini et al.,  1982b). 
hexane 
~'  ~  0  0  ~ 
~--~-~-~ 
2-hexanol 
t 
0 
~ 
2,5-hexanedlol  5-hydroxy-2-hexanone  4,5-dihydroxy-2-hexanone 
0  I  0  I 
~~ 
methyl-n-butyl ketone  5-hydroxy-2-hexanone  2,5-hexanedione 
(2-hexanone) 
Fig. 2.  Main hexane metabolites in mammals. 
Excretion 
About 15% of absorbed hexane is excreted unchanged through exhaled air during the 
post-exposure period (Fig. 3). Hexane concentration in the alveolar air during the post-
exposure period follows a biphasic course with half-life of 11  and 99 minutes, respect-
ively.  These two phases might account for the clearance of hexane from the vessel-
rich organs and from the muscle group, respectively. A third compartment gives a very 
small and undetectable contribution, owing to the slow release of the solvent from the 
adipose tissue where  it tends to accumulate over the working  week,  the calculated 
half-life  being  approximately 60  hours  (Table  3).  Trace  amounts of the  solvent  are 
recovered in the urine (lmbriani et al.,  1984). Most hexane taken up is oxidized to alco-
hols and ketones. 
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Fig. 3. Time course of total respiratory intake and absorption of hexane during eight hours of expo-
sure  (left)  and  of alveolar excretion during the  post-exposure  period  (right)  in  a worker 
exposed to 243 mg/m
3  of hexane in the air (mean daily exposure). (Adapted from Mutti et 
al.,  1984.) 
Phase 2 of biotransformation involves the conjugation of these metabolites with glucu-
ronic acid and possibly with other unidentified substances, since acid hydrolysis yields 
additional recovery of metabolites when it is performed after enzymatic hydrolysis with 
8-glucuronidase/sulphatase (Fedtke and Bolt,  1986). 
57 Since altogether the urinary excretion of the main metabolites (Fig.  2)  accounts for a 
small fraction of absorbed hexane, one should conclude that most of the latter is either 
fragmented into smaller volatile substances or tightly bound to its target or carrier mac-
romolecules in the body. 
Biological  indicators 
The biological tests proposed for evaluating hexane exposure are the following: 
•  2,5-hexanedione in  urine; 
•  2-hexanol in  urine; 
•  hexane in expired air; 
•  hexane in  blood; 
•  hexane in  urine. 
The reader should refer to the report on  benzene in this series for a critical appraisal 
of methods  of expressing  results  of analyses performed  in  urine  (Lauwerys,  1979). 
One exception to such standardization procedures is represented by hexane in  urine, 
which  is thought to  dynamically change in  bladder depending on  blood  levels. As  a 
result,  it should not be  either adjusted to constant specific gravity or expressed as a 
function of creatinine. 
2,5-Hexanedione in  urine 
The gas chromatographic analysis of urine subjected to acid hydrolysis both preceded 
and  not by enzymatic hydrolysis with  B-glucuronidase/sulphatase has been  used  by 
several authors (Perbellini et al.,  1981;  Iwata et al.,  1983a; Mutti et al.,  1984; Fedtke 
and Bolt,  1986; Ahonen and  Schimberg,  1988). 
A comparison between various gas chromatographic conditions and  preparation pro-
cedures is also available (Perbellini et al.,  1990; Kawai et al., 1990). Recently, reverse 
phase high performance liquid chromatography has also been proposed as a reliable 
method to measure 2,5-HD in urine (Marchiseppe et al., 1989). Although cumbersome, 
both these techniques may now be  used for the routine  monitoring of hexane expo-
sure. 
Reference values 
Trace  amounts of 2,5-HD are  detectable in  the  urine of persons  not occupationally 
exposed to hexane. They have been revealed by gas chromatography-mass spectrom-
etry  following  extensive  acid  hydrolysis  and  subsequent  extraction.  The  source  of 
2,5-HD is  unclear.  It might be  originated either by an  endogenous production of hex-
ane,  e.g.  by  lipid  peroxidation,  or  by  atmospheric  contamination  (Fedtke  and  Bolt, 
1986). 
According  to  the  recent report  of Kawai  et al.  (1990),  however,  2-acetylfuran  would 
confound 2,5-HD analysis in hydrolysed urine samples. Using a DB-1  column (60 m in 
length, 0.25 mm inner diametre, 0.25 Jlm  in film thickness), these authors were able to 
separate 2,5-HD from a much greater amount (about four times) of acetylfuran, which 
showed the same retention time in a DB-WAX column (30m in  length, 0.25 mm  inner 
diametre, 0.25 11m  film thickness). Thus,  although detectable, the levels of 2,5-HD in 
urine samples from subjects not occupationally exposed to hexane are actually very 
low and measurable only after extensive hydrolysis. In view of its confounding effects 
at very low exposure levels, such a practice should be avoided or carefully monitored. 
It is now well established that 2,5-HD is the neurotoxic metabolite of hexane. Further-
more,  the peak serum  level  reached  after administration  of precursors  is  correlated 
with the severity of neurotoxic changes, i.e. with the critical effect (Fig.  1). Thus, serum 
levels of 2,5-HD indicate not only exposure,  but also internal dose,  i.e.  the effective 
dose at the critical organ. The measurement of 2,5-HD in serum is too elaborate and 
time-consuming for routine applications. The same concepts may,  however,  be easily 
extrapolated to urinary 2,5-HD. In fact, the peak level in serum has been found to occur 
in  various mammalian species a few hours after exposure,  with a time-lag similar to 
that necessary for the appearance of peak values in  urine (Perbellini et al.,  1982a). 
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A single,  though  very interesting,  report  is  available  concerning  the  dose-response 
relationship between 2,5-HD in  urine and the prevalence of electroneuro-myographic 
(ENMG)  abnormalities  (Governa et al.,  1987).  In  this study,  a statistically significant 
nonparametric correlation was found between end-of-shift 2,5-HD in  urine and ENMG 
scoring (Kendall's T 0.4179, p < 0.01). The predictive validity of 2,5-HD-U with regard 
to the concomitant presence for ENMG abnormalities also suggested that this marker 
may be a useful substitute for ENMG for early detection of neurotoxic lesions at pre-
clinical states (Table 5). 
Although the threshold of 7.5  mg/1  for 2,5-HD shows a high predictive validity (1.68), 
significant ENMG  changes  were  found  in  three  subjects  (out of 40  examined)  with 
2,5-HD values of 3.0, 3.3, and 4.5 mg/1,  respectively. Thus, the authors concluded that 
their  data  'are  not  adequate  to  set  any  permissible  urine  concentration  of hexane 
metabolites.' Similar findings have recently been  reported  by Bartolucci et al.  (1990), 
who found that 2,5-HD levels of 5 mg/1 or greater are associated with electrophysiologi-
cal  changes. These authors pointed  out the high specificity and  negative diagnostic 
value of urinary 2,5-HD with regard to ENeG abnormalities. 
Table 5:  Urinary concentration of 2,5-HD in post-shift urine spot samples as a predictor of 
ENMG  abnormalities.  The  threshold  for  2,5-HD  was  arbitrarily  set  at  7.5  mg/1 
(adapted from Governa et al., 1987) 
Post-shift urinary concentration of 
2,5-HD 
< 7.5 mg/1 
> 7.5 mg/1 
Total 
Sensitivity: 0.79 
Specificity: 0.90 
Validity:  1.69 
Electroneuromyographic scoring  Total 
<3 
21 
5 
26 
>4 
3  24 
11  16 
14  40 
Positive predictive value: 0.69 
Negative predictive value: 0.84 
Diagnostic value:  1.53 
Good relationships  between  hexane concentrations in  the working  environment (8h-
TWA)  and the urinary excretion of 2,5-HD have been found by independent investig-
ators (Perbellini et al.,  1981; Iwata et al.,  1983a; Mutti et al., 1984; Ahonen and Schim-
berg,  1988), though  somewhat lower correlation  coefficients  have been  reported  by 
Kawai  et  al.  (1990),  who  recommend  hydrolysis  be  avoided  to  prevent  artefacts. 
According to these authors, the best predictor of hexane exposure would  be  2,5-HD 
obtained by simple extraction from urine: some 0.2 mg/1 would correspond to exposure 
levels near the TLV.  One should recognize, however, that such a method can only be 
applied if a mass-selective detector coupled with a gas chromatograph equipped with 
a capillary column is available. 
The differences in the slopes of the regression lines reported by different authors may 
be accounted for by several reasons. The first one is the variable composition of com-
mercial mixtures that may contain, or not, solvents interfering with hexane metabolism. 
In fact, the slope of the above relationship may be modified by co-exposure to MEK or 
to toluene. The second reason may be the different day of the week during which urine 
collection took place,  since the ratio  2,5-HD  in  urine/hexane in  air tends to increase 
over the working week. Thus,  1  00 mg/m
3  (8h-TWA) would correspond to about 1 mg/1 
of urinary 2,5-HD at the end of the first shift on Monday and to about 3 mg/1  on Friday, 
intermediate values having been observed at the end of the other working days (Per-
bellini et al.,  1985). 
The study by Ahonen and Schimberg (1988), though involving only four subjects, offers 
some  interesting  data pointing  to the first  explanation.  In  fact,  these subjects were 
exposed to mixtures containing different proportions of hexane and excreted different 
fractions of 2,5-HD with regard to absorbed hexane. The authors concluded that there 
was a non-linear accumulation at higher doses. However, the highest exposure levels 
were associated with the lowest exposure to interfering substances. A similar conclu-
sion may be drawn from the comparative analysis of all published data (Table 6). 
Finalty, different preparation procedures might affect the proportion of 2,5-HD hydroly-
sed from  urine. According to Kawai  et al.  (1990), the 2,5-HD would account for less 
than one quarter that estimated by common analytical procedures applied to hydroly-
sed urine samples from subjects non-exposed to hexane. If so,  the most critical point 
for the slope of the relationship between air hexane concentrations and  urine 2,5-HD 
levels would be the exposure interval examined by the various authors.  In  fact,  con-
59 founding levels of 2,5-HD are likely to reduce the slope obtained when  evaluating a 
limited  range  including  only  low  exposure  levels.  Under  these  conditions  a  much 
greater proportion  of 2,5-HD would  be  attributable to  background  excretion  as  com-
pared to that affecting samples obtained from  heavily exposed workers. 
Table 6:  2,5-HD in urine/hexane in air ratio and possible metabolic interference from other 
components of the solvent mixture 
Author  2,5-HD levels corresponding to  Other components of the mixture 
180 mg/m
3  hexane in air  (interference suspected) 
mmol/1  mmol/mol 
creatine
1 
Perbellini et al.,  48  3.22  Hexane isomers. Six other 
1981  solvents not including toluene 
and MEK found at low concen-
trations (no) 
Iwata et al., 1983a  16  12  Toluene and MEK, accounting 
Mutti et al.,  1984  402  3 
for 67% of the mixture (yes) 
Hexane isomers, heptane and 
cyclohexane (no) 
Ahonen and Schim- 14  1  Toluene and acetone 
berg, 1988 
1  1 mmol/mol creatinine= 1 mg/g. 2 extrapolated value. 
According to Perbellini et al.  (1981) an 8h-TWA exposure to 180 mg/m
3  would corres-
pond to an average concentration of 5.3  mg/1 of 2,5-HD in  urine. This value is in reas-
onable agreement with that of 3.0 mg/g of creatinine proposed by Mutti et al.  (1984}. 
Somewhat lower values have been  proposed by Iwata et al.  (1983a) and  by Ahonen 
and  Schimberg  (1988). According to these authors, the urinary concentration corres-
ponding  to  the  same  exposure  levels  would  be  16  (s.g.  1  016)  and  14  (s.g.  1  024) 
mmol/1,  respectively (about 1.8 and  1.6 mg/1,  respectively), probably because of simul-
taneous exposure to  toluene  and/or ketones,  which  were  not found  in  the  mixtures 
examined by Perbellini et al.  (1981)  and  Mutti et al.  (1984). 
Ahonen and Schimberg also examined several sampling times and alternative ways to 
calculate  exposure-related  values  for  2,5-HD,  namely the  daily  increase,  the  peak 
value, the 24 total excretion, the peak increase over baseline, etc. Of all additional pro-
cedures,  the  evaluation  of  the  'next  morning'  spot  sample  seems  to  be  practical 
enough  and  useful  when  exposure  is  limited to  a few  hours over the  working  shift. 
Owing to the time-lag of the peak values, the end-of-shift sample might actually under-
or overestimate the 8h-TWA exposure levels. 
Various  mathematical  models  have  been  applied  to  calculate  biological  exposure 
indexes equivalent to airborne exposure limits (Leung and Paustenbach, 1988). Physi-
ologically based  models suggest that the time-lag for  peak values and  the  relatively 
long half-life of 2,5-HD (14.2 h) result in a progressive rise of urinary levels correspond-
ing to the same hexane exposure over the working week,  with a threefold increase in 
Friday post-shift values as compared to the corresponding time on  Monday (Perbellini 
et al.,  1986 and  1990). Fig. 4 shows the progressive rise of 2,5-HD baseline (i.e.  prior 
to exposure) levels during the working week. One major objection to such an approach 
is that, whereas exposure limits represent conditions to which nearly all  workers may 
be exposed without adverse effects, pharmacokinetically extrapolated values are usu-
ally based on the parameters of the 'average man', i.e. of the 50th percentile of a nor-
mal  population.  One  should  recognize,  however,  that  such  an  error is  probably not 
greater than those associated with  the  definition of exposure limits, the  most widely 
used of which,  i.e. the ACGIH-recommended TLVS have recently been the subject of 
some controversy (Roach and  Rappaport,  1990; Castleman and Ziem,  1988). 
Urinary levels of 3 mg/g of creatinine and 5 mg/1 in samples collected at the end of the 
working  week seem to  be  appropriate standards for practical  purposes.  On  the  one 
hand,  such values would correspond to about 180 mg/m3  of hexane in  air (8h-TWA). 
On the other hand, they are well below the threshold of the dose-response relationship 
shown by Governa et al.  (1987). However, one must be aware that such values might 
underestimate actual exposure levels to  mixtures containing  MEK,  toluene and  acet-
one.  Interactive  effects  of  MEK  may  be  dangerous,  since  toxic  effects  might  be 
expected  in  a  significant  proportion  of  workers  showing  urinary  2,5-HD  below  the 
above levels. 
60 one.  Interactive  effects  of  MEK  may  be  dangerous,  since  toxic  effects  might  be 
expected  in  a significant  proportion  of  workers  showing  urinary  2,5-HD  below  the 
above levels.  · 
~ 
.§. 
~ 
':1:1  ·•·.  ""··  g  6  ·'-·  . .  . . 
c:  ..  . 
a.  .....  g  . .  . 
8  . 
~  as  c:  4  ·c: 
::::s 
0 
:I: 
&b 
N' 
2 
2  3  4  5  7 
day 
Fig. 4.  Urinary excretion rate of 2,5-hexanedione suggested by a mathematical model with a simu-
lated  exposure to hexane to  360 mg/m
3  for eight  hours for five days a  week.  The total 
amount of 2,5-hexanedione daily excreted is also shown.  (Adapted from  Perbellini et al., 
1986).  More  recently,  the  same  authors  reported  somewhat  higher  values  for  2,5-
hexanedione,  urinary concentrations  ranging  from  3.3  to  4.3  mg/1  (prior to subsequent 
exposure) and from  3.4 to 4.1  mg/1  (end  of shift)  being associated with exposure to 180 
mg/m
3  of hexane (Perbellini et al., 1990.) 
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Fig.  5.  Relation between environmental and venous blood  concentrations of hexane.  Data ob-
tained at the end of a four + four hours' workshift. (Adapted from Perbellini et al.,  1986.) 
61 Hexane in blood 
Hexane blood concentrations are closely correlated with the airborne levels measured 
in the air simultaneously collected by grasp sampling, the slope of the regression line 
being about 0.5 (Fig. 5). 
Somewhat higher values have been obtained by Veulemans et al. (1982) who exposed 
volunteers  to  360  mg/m
3  of hexane.  In  this  experiment,  the  steady-state  level  was 
quickly achieved and values of 200 mg/1 were recorded at rest, the corresponding fig-
ures for workloads of 20,  40,  and  60  W being 230,  260 and 290 mg/1,  respectively. 
Owing to the short half-life of the solvent in  blood,  its  evaluation seems not to  offer 
substantially better information as compared to simple and non-invasive environmental 
monitoring. 
Hexane in alveolar air 
Alveolar air is in dynamic equilibrium with arterial blood. It is thus useful to estimate the 
amount of solvent taken up and it offers a non-invasive means to evaluate the respir-
atory excretion during the post-exposure period. 
During exposure, there is reasonable agreement between the alveolar retention coeffi-
cients  reported  by various  authors,  the retention  data ranging  from  0.164 to  0.252, 
median 0.20 (Brugnone et al.,  1978; Mutti et al.,  1984; Veulemans et al.,  1982). Thus, 
alveolar  levels  are  about 80%  (75-84%)  of the  inhaled  concentration.  Owing to  the 
short half-life and hence the rapid equilibrium with inhaled air,  hexane concentration in 
this compartment cannot be used to assess 8h-TWA levels,  but perhaps just to moni-
tor short-term or peak exposures. Nor is it likely to be detectable in pre-shift samples 
(Fig.  6). 
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Fig. 6. Time course of alveolar concentrations of hexane during post-exposure period in the same 
subject as in Fig.  3.  Measured values were plotted versus time both on linear (continuous 
line) and on lin-log scale (dashed line). Experimental curve was obtained by extrapolation 
to  zero time.  Fast phase  (first hour) was  calculated by subtracting slower component at 
each sampling period.  (Adapted from Mutti et al., 1984.) 
Hexane in urine 
The  concentration  of hexane  in  urine  has  been  measured  by  gas  chromatography/ 
mass selective detector (phragmentography)  by  lmbriani et al.  (1984).  According to 
these authors, urinary hexane levels are highly correlated with 8h-TWA levels of 180 
mg/m
3
.  Urinary hexane is thought to reflect blood  levels.  The permselectivity of the 
bladder probably accounts for the fact that the corresponding figures for blood hexane 
are 15 times greater. 
62 Research needs 
The following are recommendations for further research: 
•  standardization of analytical techniques for 2,5-hexanedione in urine; 
•  development of practical methods to measure 2,5-hexanedione in serum; 
•  further investigations on dose-effect/response using the urinary excretion of 2,5-HD 
as  an  indicator of the  internal  dose  by comparing  its  levels with  neurophysiological 
parameters; 
•  studies  on  factors  influencing  hexane biotransformation,  particularly the  metabolic 
interactions with other solvents contained in commercial mixtures; 
•  better  characterization  of the  pharmacokinetics  of hexane  and  its  metabolites,  in 
order  to  clarify  both  the  meaning  of  biological  tests  and  the  risk  associated  with 
repeated exposures at the workplace. 
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Fig.  7.  Effect of pH  on release of 2,5-hexanedione during acid hydrolysis. Increasing amounts of 
3.6 N HCI were added to 1 ml of urine from one subject to obtain the indicated pH value. 
Water was added to reach the final volume of 1  .6 ml for each sample, followed by heating 
at 1  oooc for 30 min.  (Adapted from Fedtke and Bolt,  1986.) 
Practical Recommendations 
The measurement of 2,5-HD in urine samples collected at the end of a working week 
seems to provide the best information about both exposure and neurotoxicological risk. 
Urinary levels of 3 mg/g creatinine and 5 mg/1  (hydrolysed samples) would correspond 
to Bh-TWA concentrations of 50 ppm of hexane in the air. The preparation of samples 
is  a critical step.  According to  Fedtke and  Bolt (1986),  the amount of 2,5-HD in  the 
urine extracts depends on the pH-value adjusted prior to acid hydrolysis (Fig. 7).  How-
ever, very recently, it has been suggested that hydrolysis might introduce artefacts, i.e. 
the  formation  of  interfering  substances  overlapping  2,5-HD  during  gas  chromato-
graphic analysis, thus increasing the background level of urine samples from subjects 
exposed  to  low  hexane  concentrations  (Kawai  et  al.,  1990).  Two  alternative  ap-
proaches  may  overcome this  problem.  In  our  laboratory,  urine  samples  undergoing 
acid hydrolysis are adjusted to pH  2.0, i.e. to a value at which artefacts are minimized 
(Fig.  7).  Alternatively,  simple  extraction  without  previous  hydrolysis  may  be  used 
(Kawai  et al.,  1990), though it  is  likely that the  latter solution amplifies the analytical 
error associated with the extrapolation  of exposure  levels from  biological monitoring 
data, owing to the much lower slope of the regression line between hexane in the air 
and 2,5-HD in urine. About 200 pg/1 of 2,5-HD in samples undergoing simple extraction 
without previous  hydrolysis would  correspond to  hexane airborne concentrations  50 
ppm (Bh-TWA). No data are available to suggest no-observed-effect levels on the basis 
of the relationship between the internal dose estimated in  this way and  early neuro-
toxic effects as revealed by electrophysio1ogical changes. 
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Summary 
Methyl ethyl ketone (MEK)  is a major component of mixtures currently used in several 
industrial  applications,  mainly as  solvent of glues,  rubbers,  lacquers, varnishes,  and 
plastics. 
Adverse  effects on  the  central  and  peripheral  nervous  system  have  been  reported, 
most often following exposure to MEK-containing solvent mixtures.  MEK is known to 
potentiate the toxicity of several other solvents. Although the neurotoxicity of MEK is 
still  controversial,  there  is  evidence  of  its  synergistic  interaction  with  hexacarbons, 
hexane- and  methyl-n-butyl  ketone-induced  neuropathy  being  potentiated  by  MEK 
co-exposure. 
Some  50%  of inhaled  MEK is  taken  up.  Only a minor fraction  of absorbed  MEK is 
excreted  unchanged  via exhaled  air  (3-1 0%)  or  urine  (0.1 %).  Biotransformation  in-
volves hydroxylation to 3-hydroxy-2-butanone (acetyl methyl carbinol) and subsequent 
reduction to 2,3-butanediol, which are excreted in urine together with the parent com-
pound.  However,  the  urinary excretion of such  substances within the 24  h following 
exposure apparently accounts for a small fraction  (less than  10%) of absorbed MEK. 
Nevertheless, available data suggest that their concentrations  in  the end-of-shift uri-
nary spot samples are closely correlated with the 8-h time-weighted average MEK con-
centration  in  the  air and  may thus  be  conveniently  used  as  biological  indicators of 
exposure.  Current exposure  may also  be  monitored  by  measuring  MEK in  blood  or 
alveolar air. 
The urinary excretion of MEK is  probably the most practical approach for monitoring 
purposes, urinary levels of about 2 mg/1 corresponding to an average airborne concen-
tration of 200 ppm. 
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Synonyms: 2-butanone, MEK 
Chemical and physical properties 
Colourless, volatile liquid with acetone-like odour 
Boiling point 
Melting point 
Vapour pressure 
Vapour density (air =  1) 
Flash point 
Solubility 
CAS-number 
Formula 
Molecular weight 
1 ppm = 2.94 mg/m3 
1 mg/m
3  = 0.34 ppm 
Exposure 
:79.6°C 
:- 86°C 
:20 mmHg (at 20°C) 
:2.41 
:21 °F 
:soluble in  water 
:78-93-3 
:CH3-CO-CH2  -CH3 
:72 
MEK is a colourless,  volatile liquid with an  acetone-like odour.  It  is  readily soluble in 
water and in  nonpolar fluids, the ratio between its water/air and oil/air partition coeffi-
cients being close to 1.0 (Sato and Nakajima, 1979). As a result, it increases the mis-
cibility of polar and nonpolar substances. This property, together with its high volatility 
and low toxicity, accounts for its use as a major component of solvent mixtures, espe-
cially with acetone, ethyl acetate,  and hydrocarbons in the C5-C7 range,  mainly hex-
ane and toluene. Such mixtures are used as solvents for glues, rubbers, lacquers, var-
nishes, and plastics. Industrial uses include the manufacture of shoes, colour printing, 
plastic coating,  paint removing.  It is also used to de-wax lubrificating oils,  but MEK is 
seldom used alone. In  1979, the production volume was estimated to be 343 000 tons 
in the USA (Chemical Manufacturers Association, 1982, quoted by O'Donoghue et al., 
1988). 
Adverse effects 
Since MEK exposure seldom occurs alone,  it is  difficult to ascribe to  MEK exposure 
those effects that have usually been observed in  workers exposed to MEK-containing 
solvent mixtures. There are,  however, a few exceptions.  In  subjects exposed to  1  00-
200 ppm of MEK for a few minutes, irritation of eyes, nose, and throat was observed 
(Nelson et al.,  1943). A longitudinal study among steel workers exposed to MEK con-
centrations exceeding 150 ppm (150-450), associated with much lower concentrations 
of other solvents not affecting the exposure conditions, showed a progressive improve-
ment in simple reaction times after some changes in the working environment resulting 
in  better  hygienic conditions and  exposure levels  lowered to 31-1 05  ppm  (Anshelm 
Olson et al., 1981). Furthermore, whereas at the first examination reaction times were 
correlated with exposure intensity, no such relationship was observed at the follow-up, 
thus proving that the effects were both exposure-related and partially reversible. Such 
68 findings are in agreement with experimental studies showing no behavioural effects of 
exposure to MEK at 200 ppm for four hours (Dick et al.,  1984 and 1989). 
Evaluating the role of MEK co-exposure in subjects exposed to MEK-containing hexa-
carbon  mixtures known for the neurotoxic properties of some components, e.g.  hex-
·ane  and  methyl-n-butyl  ketone,  is  a  much  more  difficult task.  Although  neurotoxic 
effects have been ascribed to MEK exposure (Dyro, 1978), experimental studies aimed 
at inducing peripheral neuropathy in animals treated with MEK alone have been unsuc-
cessful  (Saida  et  al.,  1976; Altenkirch  et  al.,  1978).  However,  several  independent 
investigators have consistently found that MEK co-exposure potentiates the neurotoxic 
effects of methyl-n-butyl ketone and hexane (Abdei-Rahman et al.,  1976; Couri et al., 
1977; Altenkirch et al.,  1978;  Ralston  et al.,  1985). There is  also evidence that MEK 
co-exposure  increases  the  hepato- and  nephrotoxicity  of  haloalkanes  (Brown  and 
Hewitt,  1984; Brondeau et al.,  1989; Hewitt et al.,  1986) and that it reduces the elim-
ination  rate  of  ethanol,  thus  enhancing  ethanol-induced  behavioural  effects  (Cun-
nigham et al.,  1989). 
Ames  assays  gave  negative  results  and  did  not  demonstrate  significant mutagenic 
activity (O'Donoghue et al.,  1988).  However,  MEK was found to induce aneuploid  in 
Saccaromices cerevisiae strain D61.M at relatively high concentrations (Zimmermann 
et al.,  1985). 
Metabolism 
Absorption 
Although it may be absorbed through the skin (Wurster and Munier, 1965), MEK is pri-
marily taken  up via the  respiratory  route.  In  a field  study,  Perbellini  and  co-workers 
(1984)  monitored the environmental concentration of MEK during 4-h  exposure peri-
ods, during which alveolar air was also sampled (time of sampling unspecified). Since 
MEK concentration in the alveolar air was about 30% of its breathing zone level, the 
pulmonary retention was estimated at around 70%. 
During experimental exposure of volunteers, Liira et al.  (1988a) estimated the relative 
pulmonary uptake to be  about 41%  (exposure to MEK alone)  and 45%  (co-exposure 
to xylene).  In a different experiment, the same authors introduced three exercise peri-
ods  (1 0 min/1 00 W)  in the protocol. The pulmonary retention turned out to be some-
what higher (53%) than previously reported even under sedentary conditions (Liira et 
al.,  1988b). Although the relative  uptake was similar under sedentary conditions with 
exercise periods, the estimated total pulmonary uptake increased by one third, owing 
to the increase in  the pulmonary ventilation during the exercise (from  11  to 35 1/min). 
Such  inconsistencies  may  be  explained  by  the  different methods  used  to  estimate 
absorption. In fact,  whereas Perbellini et al.  (1984) calculated the uptake on the basis 
of alveolar air samples (end of tidal volume),  Liira and co-workers estimated absorp-
tion from the difference between  inhaled and  exhaled concentrations. As recognized 
by the authors, the latter may artefactually vary according to the breathing technique, 
since hyperventilation  may readily increase the deadspace air and thus the exhaled 
concentration. 
Distribution 
As expected on the basis of its similar solubility in oil and in water, MEK showed estim-
ated tissue/blood partition coefficients close to 1 for all tested tissues. Table 1, adapted 
from  Perbellini  and  co-workers  (1984),  lists the tissue/air and  the calculated  tissue/ 
blood partition coefficients.  It can  be  inferred that MEK supply to the different tissues 
during exposure depends on their blood flow.  Despite its volatility, MEK is expected to 
be retained owing to its high solubility in  blood. 
Biotransformation 
With regard to the metabolism of MEK, oxidation and reduction products, i.e. 3-hydroxy-
2-butanone,  2-butanol  and  2,3-butanediol,  were  identified  in  serum  of guinea  pigs 
treated with MEK (DiVincenzo et al.,  1976). After an oral dose of 1690 mg/kg in  rats, 
such  a  metabolic  pathway  led  to  transformation  into  2,3-butanediol,  accounting  for 
69 some  30%  of administered  MEK (Dietz  and  Traiger,  1979).  In  this experiment,  the 
maximum MEK and 2,3-butanediol blood concentrations occurred respectively after 4 
and 18 hours, thus suggesting that MEK biotransformation is much slower than that of 
other solvents. Its solubility in blood probably accounts for the relatively slow biotrans-
formation and disappearance rate. 
Table  1.  Methyl  ethyl  ketone  solubility in  human tissues (adapted  from  Perbellini et al. 
(1984) 
Tissues  Tissue/air  Tissue/blood 
Blood  183 ± 12  1 
Kidney  197 ± 17  1.05 
Liver  180 ± 15  0.98 
Brain  168 ± 26  0.92 
Fat  161  ± 14  0.88 
Muscle  212 ± 30  1.16 
Heart  254 ± 25  1.39 
Lung  147 ± 10  0.80 
Excretion 
Conflicting  results  have  been  obtained  in  humans.  Volunteers  ingesting  375  mg  of 
MEK  in  gelatin  capsules  excreted  about  30%  of the  ingested  dose  by  exhalation 
(Munies and Wurster,  1965). In  subjects exposed to 65-333 ppm for two hours,  MEK 
concentration in the expired air was about 10% of the inhaled concentration. According 
to Liira et al.  (1988b), only 2 to 3% of the inhaled dose was exhaled unchanged after 
the exposure. The urinary excretion of MEK and  its known metabolites also accounts 
for a minor fraction of absorbed dose. Only 0.1% of absorbed MEK would be excreted 
unchanged  in  urine  (Miyasaka et al.,  1982). The  amount of MEK and  its metabolite 
acetylmethylcarbinol  eliminated  by  the  kidneys  correspond  together to  0.1%  of the 
alveolar MEK uptake (Perbellini et al.,  1984). Finally,  only about 3%  of the absorbed 
MEK would  be excreted as  2,3-butanediol  (Liira et al.,  1988b). Since the recovery of 
absorbed MEK is very low,  one must conclude that its excretion should occur chiefly 
through  uncharacterized  metabolites,  possibly  acetate  or  acetoacetate  (Liira  et al., 
1988b). 
Metabolic interactions 
Earlier studies failed  to  show any metabolic  interactions,  so that the  synergism  be-
tween  MEK and  hexacarbons was  attributed to a possible competition between MEK 
or its metabolites and gamma-diketones for binding to non-critical targets (Ralston et 
al.,  1985).  Perbellini and  co-workers  (1985)  were able to show that the slope of the 
linear  regression  between  hexane  exposure  and  the  urinary  excretion  of  2,5-
hexanedione, its putative neurotoxic metabolite, was enhanced in shoemakers simul-
taneously exposed  to  MEK as  compared  to  subjects exposed to  hexane-containing 
MEK-free mixtures.  Such a notion received experimental support by Robertson et al. 
(1989) who, at variance with earlier findings of the same group (White and Bus, 1980), 
were able to demonstrate that in  rats exposed to  hexane,  MEK co-exposure resulted 
in  higher levels of 2,5-hexanedione both in  plasma and  in  peripheral nerves. In  vitro 
experiments by  Veronesi  and  colleagues  (1984)  also  showed that the threshold for 
hexane  neurotoxicity was  shifted  towards  lower  levels  by  MEK co-exposure  with  a 
monotonous trend depending on  MEK concentrations in the medium. 
Experimental coexposure to m-xylene and  MEK in  man  resulted  in  inhibited  xylene 
metabolism, whereas it did not cause any change in the concentration of MEK in blood 
or the excretion of 2,3-butanediol in urine (Liira et al., 1988a). The experiment on MEKI 
ethanol interactions during acute exposure in  man  by Liira et al.  (1990b)  deserves a 
more detailed description. Ethanol administration either before or after MEK exposure 
inhibited the  primary oxidative metabolism of MEK,  thus causing  an  increase  in  the 
blood concentrations of MEK (Fig. 1) and 2-butanol (Fig. 2) as compared to those meas-
ured during and after exposure to MEK alone. These changes appeared shortly after 
ethanol administration, which took place either before or after exposure.  Serum con-
centrations of 2,3-butanediol were decreased initially, but there was an increase eight 
hours after exposure. 
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Fig.  1. MEK in blood (mean and SO)  during 
and  after  exposure  to  200  ppm  of 
MEK for four hours (open circles) and 
same exposure with (a) preceding (b) 
following  ethanol  ingestion  (closed 
circles).  (Adapted  from  Liira  et  al., 
1990b) 
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Fig. 2. 2-Butanol in blood (mean and SO) dur-
ing  and  after exposure to  200  ppn  of 
MEK for' four hours (open circles) and 
same exposure with  (a)  preceding  (b) 
following  ethanol  ingestion  (closed 
circles).  (Adapted  from  Liira  et  al., 
1990b) 
In  the  same  experiment,  the  amount of MEK excreted  unchanged  in  the  urine  and 
exhaled air turned out to be increased by alcohol administration (Fig. 3), independently 
of whether ethanol was administered prior to (a)  or after (b) exposure. The recovery of 
2,3-butanediol from  urine was  much  greater when  ethanol  was  administered  before 
exposure than following exposure to MEK alone or ethanol administration after MEK 
exposure (Fig. 4). 
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Fig.  3.  Concentration of MEK in  urine (mean  and  SO)  during and after exposure to 200 ppm  of 
MEK for four hours (open circles) and same exposure with (a) preceding ethanol ingestion 
(0.8  g/kg)  (closed  circles)  and  (b)  ethanol  ingested at end  of exposure  (closed  circles). 
(From  Liira et al., 1990b.) 
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Fig. 4.  Excretion of 2,3-butanediol in urine after exposure to 200 ppm of MEK (MEK, open circles) 
for  four  hours  and  same  exposure  with  preceding  ethanol  ingestion  (E+MEK,  closed 
circles) and with ethanol ingested at end of exposure (MEK+E, closed circles). Data points 
were  obtained  from  pooled  urine samples from  five subjects.  (Adapted from  Liira et al., 
1990b.) 
In any case, the time course of the urinary excretion of MEK and its metabolites seems 
to  follow that of serum  levels,  thus suggesting  that metabolic  interferences  actually 
take place during Phase 1 of biotransformation. It ought to be noted that an important 
role is played by the schedule of administration, the effects of previous ethanol intake 
being much greater than those caused by ethanol ingestion at the end of the exposure 
period. 
Finally,  in volunteers experimentally exposed to acetone:MEK mixtures to assess pos-
sible neurobehavioural effects,  co-exposure reduced  respectively  MEK and  acetone 
serum levels by 50% and by one third as compared to the concentrations reached fol-
lowing exposure to each solvent alone (Dick et al.,  1989). 
Table 2.  Summary of metabolic interactions between MEK and other solvents reported in 
the literature. 
Species  Coexposure to  Effect of MEK  Effect on  MEK  References 
metabolism 
Rat  Hexane  + toxicity  Not studied  Takeuchi et al., 
1983 
Rat  Hexane  - metabolism  Not studied  Iwata et al., 1983 
Rat  Ethanol  -excretion  Not studied  Cunningham et 
al.,  1989 
Rat  Hexane  + metabolism  Not studied  Robertson et al., 
1989 
Man  Hexane  + metabolism  Not studied  Perbellini et al., 
1985 
Man  m-Xylene  - metabolism  No effects  Liira et al., 1988a 
Man  Acetone  - serum acetone  -serum MEK  Dick et al.,  1989 
Man  Ethanol  Not studied  - metabolism  Liira et al.,  1990b 
+ =  increased or synergystic effect- =  reduced or inhibitory effect 
In  summary,  various  metabolic  interactions  between  MEK  and  other  solvents  have 
been  described  (Table  2).  Most of such  interactions may  be  accounted for by cyto-
chrome isoenzyme induction, which may be of the additive, synergistic, or competitive 
type,  as demonstrated by  Raunio et al.  (1990).  However,  metabolic interactions con-
tinue to  be  unpredictable on  the basis of the chemical structure of the  parent com-
pounds. As a result, caution has to be exercised in extrapolating any conclusions from 
similar situations and in  making assumptions not supported by empirical evidence. 
Biological indicators 
The biological tests that have been proposed to monitor exposure to MEK include: 
MEK in  urine; 
3-hydroxy-2-butanone (acetyl methyl carbinol)  in  urine; 
2,3-butanediol in  urine; 
MEK in  blood; 
MEK in alveolar air. 
72 The reader should refer to the report on  benzene in this series for a critical appraisal 
of methods of expressing  results  of analyses  performed  in  urine  (lauwerys,  1979). 
One  exception  to the  use  of standardization  procedures  is  MEK in  urine,  which  is 
thought to dynamically change by simple diffusive mechanisms regulated by the rela-
tive solubility in various compartments and hence by the partition coefficient rather than 
by  renal  handling,  thus  essentially  depending  on  the  arterial  blood  levels  reached 
before sampling.  From a practical point of view,  only MEK in  urine seems to be suit-
able for routine monitoring of exposure. 
MEK in urine 
Simple and reliable head space techniques may be used for the gas chromatographic 
analysis of MEK in bodily fluids, namely in blood and urine. Although only a minor frac-
tion  (less than  1%)  of absorbed MEK is excreted unchanged in the urine, the urinary 
excretion  of MEK has  been  proposed  as  a biological  index to  monitor occupational 
exposure to this solvent, owing to the good relationship between airborne and urinary 
concentrations of the solvents (Brugnone et al.,  1983). Furthermore, such an approach 
shows  inherent  practical  advantages  from  the  analytical  point  of view.  In  fact,  the 
'head-space' method is rather simple and quick, expecially if compared to much more 
time-consuming extraction and derivatization techniques necessary to measure MEK 
metabolites in biological fluids. However, such an indicator has been recommended for 
use on  a group basis,  because of the great interindividual variability and  limited ex-
perience (Myiasaka et al., 1982). In their paper, Ghittori et al. (1987) proposed the con-
cept of BEEL. 
Table 3. Linear regressions between airborne and urinary concentrations of MEK following 
occupational or experimental exposure. 
Authors  No of subjects  r  Urinary MEK corresponding to 
exposure to 200 ppm 
Miyasaka et al.,  62  0.74  5.3 mg/1  uncorrected 
1982 
0.75  3.3 mg/1,  s.g. 1 016 
0.60  3.4 mg/g creatinine 
Perbellini et al.,  27  0.69  2.1  mg/1  uncorrected 
1984 
Ghittori et al.,  1987  65  0.91  2.2 mg/1 uncorrected 2 mg/1 
(BEEL
1
) 
1  BEEL: biological equivalent exposure limit (95%  lower confidence limit of the regression equa-
tion). 
The  biological equivalent exposure limit)  serves to compare each single urinary con-
centration value with the chosen threshold, in order to make a decision of compliance 
or non-compliance. Thus, the lower 95th percentile of each determination (starting from 
the coefficient of variation of the method and assuming a normal distribution) was re-
commended  in  a decision  of non-compliance for values exceeding  the  BEEL;  con-
versely, it was advised to employ the upper 95th percentile in a decision of compliance 
biological exposure for urinary concentrations below the BEEL. 
Similarly, Myiasaka et al.  (1982) reported the 95% confidence intervals for the statisti-
cal  parameters of the regression between environmental and  biological data.  In  both 
cases,  it was recognized that like TLVs,  biological  limit values should  protect 'nearly 
all'  exposed  workers  over  a working  lifetime.  Both  the  above  proposals  were thus 
aimed at translating into statistical terms the concept of 'nearly all' workers. 
Although obtained by  using the same technique,  quite inconsistent limits have been 
proposed by these authors (Table 3). Such inconsistencies remain when the lower 95% 
confidence limit is  calculated from the regression  parameters proposed by Japanese 
authors (4.0 mg/1). Although the values found by Perbellini et al.  (1984} are supported 
by similar findings obtained by  independent investigators (Ghittori et al.,  1987).,  some 
feelings  of uncertainty  remain  with  regard  to the  possibility of extrapolating  urinary 
MEK concentrations corresponding to 8h-TWA exposures to 200 ppm of MEK (current 
ACGIH-recommended TLV}. 
It should also be  recognized that such an approach to the definition of biological limit 
values assumes that the corresponding TLV has actually been validated. Unfortunately, 
the  standard  recommended  by ACGIH  for  MEK is  among  those that have recently 
73 been subject to some controversy. In fact, the standard chosen was found to be incon-
sistent with the documentation quoted to support its validation (Roach and Rappaport, 
1990). 
It is therefore prudent to recommend the lowest value proposed thus far,  i.e.  2 mg/1. 
One should also be aware that, even below this limit, complaints about nose and throat 
irritation may be reported by workers exposed to 1  00 ppm or more. However, accord-
ing to individual values reported in the literature thus far, such a condition is unlikely to 
occur in  current industrial settings. 
MEK metabolites in urine 
In man, the urinary excretion of MEK accounts for less than 0.1% of the absorbed dose 
(Myiasaka et al.,  1982).  Another  minor fraction  of the  solvent taken  up  undergoes 
metabolic transformation and may be recovered in the urine in the form of 3-hydroxy-
2-butanone or acetyl-methyl-carbinol (less than 0.1 %) or 2,3-butanediol (about 2-3%). 
In both cases, analytical techniques are time-consuming. Previous enzymatic and acid 
hydrolysis is required to measure 3-hydroxy-2-butanone (Perbellini et al., 1984), whilst 
extraction  and  derivatization  is  necessary to  determine  2,3-butanediol  (Liira  et  al., 
1988a). As a result,  although correlated with  exposure,  these indicators seem to be 
impractical for routine biological monitoring of occupational exposure to MEK. 
MEK in  blood 
Owing to the solubility of the solvent, MEK blood concentrations are widely scattered 
depending not only on exposure levels, but also on  physical exercise and duration of 
exposure, the saturation of this compartment being not easily achieved as is  usually 
the case for less polar solvents. Nevertheless, experimental data show close relation-
ships between blood MEK and  both airborne and alveolar levels measured on simul-
tanously collected samples (Perbellini et al.,  1984;  Liira et al.,  1988a). Although the 
venous blood concentration during and after the exposure period turned out to parallel 
that found in expired or alveolar air,  its evaluation seems not to offer substantially bet-
ter information as compared to simple and non-invasive air sampling procedures. 
MEK in alveolar air 
Alveolar air is in dynamic equilibrium with arterial blood. It is thus useful to estimate the 
amount  of solvent taken  up  during  exposure.  Furthermore,  it  offers  a  non-invasive 
means to evaluate the respiratory excretion during the post-exposure period. 
During  exposure,  the  estimated  pulmonary  absorption  reported  by  various  authors 
ranges from 41  (Liira et al., 1988b) to 70% (Perbellini et al., 1984), the variability being 
accounted for by sampling techniques, which have been designed to evaluate exhaled 
or alveolar air,  respectively, and by exposure levels, much higher in experimental than 
in field studies. 
From  a practical point of view,  owing to the short half-life  (respectively of 30 and  81 
minutes for the two phases characterizing the time course during the post-exposure 
period)  and  hence  the  rapid  equilibrium  with  inhaled  air,  MEK concentration  in  this 
compartment cannot be  used to assess 8h-TWA exposure levels,  but just to quantify 
absorption and perhaps to monitor short-term or peak exposures. Nor is it expected to 
be measurable in pre-shift samples, in order to provide reliable estimates of exposure 
during the preceding workshift. 
Conclusions 
MEK is a major component of many commercially available solvent mixtures. Despite 
its  low toxicity,  MEK is  toxicologically important because of its  interference with  the 
metabolisms and toxicity of other components of such mixtures. 
Although only a minor fraction (less than 1  %) of absorbed MEK is excreted unchanged 
in the urine, the urinary excretion of MEK has been proposed as a biological index to 
monitor occupational exposure to this solvent, owing to the good relationship between 
airborne and urinary concentrations of the solvents. End-of-shift levels of about 2 mg/1 
would correspond to an average airborne concentration of 200 ppm. 
74 Needs for further research 
The following are recommendations for future research: 
•  to  better define the  toxicological  properties  of MEK,  with  special  emphasis  on  its 
interactions with the metabolism and toxicity of other organic solvents; 
•  to better characterize MEK metabolism and kinetics; 
•  to  better define the  relationships  between  external  dose  and  biological  indices  of 
exposure/internal dose; 
•  to validate analytical methods simple and reliable enough to be applied for the rou-
tine biological monitoring of exposure to MEK. 
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77 Biological indicators for the 
assessment of human exposure 
to industrial chemicals 
Thallium and tin 
G.  Kazantzis I-Thallium 
Summary 
Thallium  is  a  highly reactive  metal forming  monovalent thallous and trivalent thallic 
salts.  It is widely distributed in the earth's crust in low concentration and is present in 
emissions from coal-burning power plants and from copper,  lead and zinc smelters. It 
has been extensively used as a rodenticide and more recently in the production of photo-
voltaic cells, in electronic circuitry, as a catalyst in organic synthesis and in  myocardial 
imaging. 
Thallium  is  highly toxic,  giving rise,  in  acute poisoning,  to a characteristic pattern of 
gastroenteritis followed by sensory and motor neuropathy with involvement of the cra-
nial nerves, and central nervous effects. Where survival extends beyond a week or so 
the neurological features progress and are followed by a marked alopecia.  Following 
long-term,  low-level occupational exposure,  subje.ctive symptoms including asthenia, 
anorexia, irritability and  pains in the limbs may be followed by peripheral neuropathy 
and by loss of hair. 
Water-soluble inorganic salts ofthallium are rapidly absorbed following ingestion, inhala-
tion or skin  contact,  and  absorption  may be  complete following  ingestion.  Following 
rapid  absorption, thallium is widely distributed in  the body,  the highest concentration 
being found in  the kidneys.  In  blood thallium is found  predominantly in  the red  cells, 
but concentrations are low,  indicating a rapid equilibration with tissues. Thallium ions 
are transported across cell membranes in  a similar manner to potassium. Thallium is 
excreted in both urine and faeces and in  small part via hair and into milk. Excretion in 
both urine and faeces may persist for many weeks despite low blood levels in poisoned 
patients. With time the concentration of thallium increases in  hair, which may contain 
the major part of the body burden, thus providing an important additional route for slow 
excretion. 
In normal unexposed subjects the highest tissue concentrations of thallium have been 
found in hair, followed by nails and the wall of the colon. The most recent studies have 
shown both urine and blood levels of thallium in  unexposed subjects to range below 
1pg/litre. 
Thallium  concentration  in  urine  is  the  most  reliable  indicator  of thallium  exposure. 
When estimated with appropriate safeguards, it is of value in  biological monitoring of 
population samples following both occupational and environmental low-level exposure. 
Thallium concentration in  hair may provide a useful indicator of cumulative absorption 
of thallium provided external contamination can be excluded. 
A urinary thallium concentration of 300 pg/litre has been suggested as the threshold 
for thallium  poisoning  until  an  agreed figure is established.  However,  following  low-
level exposure, subjective symptoms have been reported which require further evalu-
ation with  regard to their relevance as early indicators of effect. At present there are 
no reliable data on  dose-response relationships for thallium  indicative of an  earliest 
adverse health effect. 
81 Introduction 
Chemical and physical properties 
Thallium (chemical symbol Tl)  shares group lila of the Periodic Table with indium, gal-
lium,  aluminium  and  boron.  It  is  a  blue-white  metal  of tetragonal  crystalline  form; 
atomic number 81; atomic weight 204.4; melting point 303.5 oc; boiling point 1457 oc, 
and with oxidation states of +  1 and +3.  It is a highly reactive metal, readily soluble in 
acids, which forms a series of monovalent thallous and trivalent thallic salts, the latter 
being less stable. The principal salts of industrial significance are thallous oxide (TI20), 
thallous hydroxide (TIOH)  and thallous sulphate (TI2S04). Thallous oxide can  be pre-
pared by heating thallium in air to about 350 oc, the hydroxide produced by dissolving 
the oxide  in  water,  and  the sulphate by dissolving thallium  in  hot,  concentrated  sul-
phuric acid. 
Production and industrial uses 
Thallium  is widely distributed  in  the earth's crust with an  overall concentration of the 
order of 1 mg/kg. It is found in the USA and Brazil in the minerals lorandite and crook-
site. In seawater it has an average concentration of the order of 0.01 pg/litre. For indus-
trial  purposes thallium is  more often  recovered from the roasting  of pyrite ores from 
lead  and  zinc  smelters,  the  flue  dust  being  treated  to  render  the  thallium  content 
soluble. It has also been obtained from residues in the production of sulphuric acid by 
the lead-chamber process. Total  world production is unlikely to have exceeded a few 
thousand tons per annum. 
Thallous sulphate has been extensively used as a rodenticide. In many countries it has 
been replaced by other less toxic compounds, but with the development of resistance, 
the use of thallium is increasing again. Thallium is used increasingly in the electronics 
industry and is used also in photoelectric cells, in infrared spectrometers, in other opti-
cal systems and for colouring glass.  In the chemical industry it is of use as a catalyst 
in  organic synthesis, for the oxidation of hydrocarbons and olefins, for polymerization 
and  for  epoxidation  (Wade  and  Banister,  1973).  More  recently,  thallium  as  thallous 
chloride, Tl
201
,  has been increasingly used in  myocardial perfusion imaging. 
Environmental and occupational exposure 
The dietary intake of thallium  has  been  estimated to be  of the order of 2pg/day,  but 
data are sparse (Carson  and  Smith,  1977).  Polluted atmospheres may contribute as 
much,  or  more,  thallium  to  daily  intake,  as  a  normal  diet.  The  principal  exposure 
sources in the general population are air emissions from coal-burning power plants and 
copper,  zinc and  lead  smelters.  Iron  and  steel  production,  and  also  emissions from 
cement factories represent a significant source of environmental contamination. Emis-
sions  from  cement  factories  were  found  to  originate  from  thallium-bearing  roasted 
pyrite, added to ground limestone for the production of special types of cement (Ewers, 
1988). The contamination of vegetables and fruit grown  in  private gardens with thal-
lium containing dust fallout from a cement plant has been shown to give rise to mark-
edly increased urine and  hair thallium levels in the local population (Brockhaus et al., 
1981). The use of thallium-containing rodenticides has  led to the accidental contam-
ination of food giving rise to many cases of poisoning in  humans, in  particular in chil-
dren,  in  domestic and wild  animals and  in  birds. Thallium has been used  in the past 
as a depilatory agent in  the treatment of ringworm of the scalp, again causing  many 
cases of poisoning some with a lethal termination (Munch,  1934). 
In the working environment inhalation of thallium and absorption giving rise to milder 
forms of poisoning has followed the handling of flue dusts, the extraction of the metal 
and the handling and manufacture of thallium-containing rodenticides. Absorption has 
also followed ingestion from contaminated hands and food and as a result of skin con-
tact. 
Effects on  humans 
Acute poisoning has been reported most frequently following accidental, homicidal or 
suicidal ingestion of a thallium salt,  and rarely observed following occupational expo-
sure. Thallium compounds are extremely toxic, the critical organ being, in general, the 
central nervous system, although the system primarily affected is in part dependent on 
83 the length of survival following absorption. The triad of gastroenteritis, polyneuropathy 
and alopecia has been generalty regarded as the classic syndrome of acute thallium 
poisoning (Gastel et al., 1978). The minimum lethal dose of thallium has been reported 
to be of the order of 12-20 mg/kg in adults and 2-1 0 mg/kg in children. While a single 
dose of ingested thallium may be rapidly fatal, thallium is a cumulative poison following 
low-level, longer term exposure. 
Acute thallium poisoning most commonly presents with gastroenteritis. Nausea, vom-
iting, diarrhoea and abdominal pain develop within hours of absorption, with in some 
cases pains in the limbs, cardiovascular and respiratory involvement. In other cases of 
acute poisoning paraesthesia has  been  the  presenting symptom.  (Wainwright et al., 
1988). After a few days, involvement of the nervous system becomes apparent, with 
paraesthesia,  exquisitely  painful  and  tender  extremities,  muscle  weakness,  mental 
confusion or delirium, convulsions with circulatory and respiratory involvement followed 
by death. Where the period of survival extends beyond one week or so a varied neuro-
logical  picture  may develop involving the central,  peripheral  and  autonomic nervous 
systems with  persistent headache, both sensory and motor neuropathy, cranial nerve 
involvement with  retrobulbar neuritis, ataxia and tremor. Tachycardia, cardiac arrhyth-
mias and  hypertension may also develop. 
In survivors the neurological features progress with a steady proximal spread to involve 
cranial nerves, eye muscle innervation and respiratory muscles, which may mimic the 
pattern of Landry's ascending paralysis, or of Guillain-Barre polyneuritis. After an inter-
val  of one to three weeks marked alopecia develops,  in  which the head hair can  be 
readily pulled away.  Further details on the clinical features and treatment of acute thal-
lium poisoning and on the pathological features of the disorder are given by Kazantzis 
(1986).  Less  common features have included a syndrome mimicking systemic lupus 
erythematosus (Aiarcon-Segovia et al.,  1989) and dermatological involvement with an 
acneiform eruption and eczematous lesions (Heyl and  Barlow,  1989). As a sequel to 
thallium  poisoning,  severe  deterioration  of  intellectual  function  has  been  reported 
(Thompson et al.,  1988). 
The diagnosis is  usually established during  life  by the detection of thallium  in  urine. 
Nerve conduction studies have shown evidence of a distal sensorimotor neuropathy, 
affecting primarily the conduction velocity of the faster fibres,  in  one reported case of 
acute poisoning with a urinary thallium concentration of 3.5 mg/litre. (Yokoyama et al., 
1990). The peripheral  nerve lesion  is  primarily a distal  axonopathy,  and  it has  been 
stressed that in the less severe cases this may be missed if the plantar nerves of the 
foot are not examined (Dumitru and Kalantri, 1990). Hair from poisoned patients shows 
a characteristic black zone filling the root and hair shaft near the root, the intensity cor-
responding to the degree of severity of the intoxication (Metter and Vock,  1984). 
Occupational exposure to thallium has occurred mainly in the course of extraction of 
the metal and  in  the manufacture of thallium salts and thallium containing  products. 
Occupational  thallium  poisoning  has  been  uncommon,  and  no  deaths  have  been 
reported.  Poisoning has followed long-term, low-level exposure from the inhalation of 
thallium containing dust or fume, via ingestion from contaminated hands or food or as 
a result of percutaneous absorption.  The  clinical  course  has  been  characterized  by 
subjective symptoms with fatigue, anorexia, pains in the legs and feet and paraesthe-
sia.  In  12 non-fatal cases of industrial thallium poisoning the principal symptoms were 
reported  to  be  fatigue,  limb  pains  and  loss  of hair  (Munch,  1934).  Objective  signs 
where present,  have consisted mainly of evidence of polyneuropathy, weakness and 
slowing of pupillary reflexes and  changes  in  tendon reflexes.  Polyneuropathy has in 
some cases been followed by loss of hair after an interval. In four cases where absorp-
tion  was thought to follow skin contact in  rodenticide manufacture, minor degrees of 
polyneuropathy and of alopecia were noted, with a maximal urinary thallium excretion 
of 380 Jig/litre (Giomme and  Sjostrom, 1955). The diagnosis of occupational thallium 
poisoning is usually made from the occupational history, from the subjective symptoms 
detailed above, together with any objective evidence of neurological involvement, from 
loss of hair and from the thallium concentration in  urine. 
The underlying  biochemical mechanisms of toxicity have been considered by Fowler 
(1988). Swollen mitochondria and alterations in the endoplasmic reticulum in a number 
of tissues have been observed following acute in vivo exposure to thallium. Mitochon-
drial swelling and stimulation of succinate oxidation with uncoupling of oxidative phos-
phorylation is indicative of the inhibitory action of thallium on cellular energy production 
(Melnick  et  al.,  1976).  Delta-amino  laevulinic  acid  dehydratase and  ferrochelatase, 
enzymes of the mitochondrial haemo-biosynthetic pathway are also affected by thal-
lium. A close correlation has been  shown with disruption of the hepatic endoplasmic 
reticulum and these haemo-dependent enzyme activities (Woods and  Fowler,  1986). 
84 Thallium  has  been  shown to  substitute for  potassium  in  the  activation  of adenosine 
triphosphatase of liver plasma membranes. In the presence of sodium, such activation 
is obtained with thallium concentrations only  1  Oo/o  of those of potassium,  while in  all 
other  respects  the  sodium  potassium  activated  and  the  sodium  thallium  activated 
adenosine triphosphatases were identical (Favari and Mourelle,  1985). 
Metabolism 
Absorption 
Water-soluble compounds of thallium are rapidly absorbed following ingestion, inhala-
tion or skin contact. Studies in the rat have shown almost complete absorption follow-
ing  ingestion.  In  a study  in  the  rat  in  which 
204TI  as  a thallous  nitrate  solution  was 
administered by six different routes, the body burden, as a proportion of the adminis-
tered  dose was found  to  be  similar whatever the  route  of administration  (Lie  et al., 
1960). It was deduced from this study that complete absorption had occurred from the 
gastrointestinal tract following ingestion and from the respiratory tract following intratra-
cheal instillation. 
Distribution 
Following rapid absorption, thallium is widely distributed in the body;  in animal studies 
the  highest concentration  is  found  in  the  kidney,  followed  by  salivary gland,  testis, 
muscle, bone,  lymph nodes, gastrointestinal tract,  heart, spleen and  liver, all of which 
had relatively small differences in concentration between them (Lie et al.,  1960). Thal-
lium concentration in blood remained low indicating rapid equilibration with tissues.  In 
the  blood,  thallium  was  located  predominantly  in  the  red  blood  cells.  Observations 
have been  limited in  humans.  In  a fatal case reported by Cavanagh et al.  (1974} the 
concentration of thallium in the kidney was found to be 20 mg/kg, heart 13 mg/kg, brain 
10 mg/kg, with concentrations between 5-6 mg/kg in skin, liver,  bone and muscle. 
Experimental evidence suggests that thallium  ions are transported across cell  mem-
branes by the same mechanism as for potassium. The rapid cellular uptake of thallium 
in a manner analogous to potassium correlates well with regional perfusion of the myo-
cardium  and  thus delineates areas of ischaemia or  infarction  when  administered  as 
Tl
201  in  myocardial imaging.  However,  once inside the cell,  thallium is  released  less 
readily  than  potassium.  Studies  on  the  interaction  between  thallium  and  potassium 
have been reviewed by  Kazantzis (  1986). 
Excretion 
Thallium  is  excreted  in  both  animals and  man  via the intestine and the  kidneys,  the 
total  faecal  excretion  exceeding  urinary.  In  studies  on  the  rat,  thallium  has  been 
observed  in  urine  and  faeces within  one  hour of oral  administration  of thallous sul-
phate. About two thirds of the body burden of thallium is eliminated in faeces and about 
one third in urine. However, in severe poisoning constipation commonly occurs, which 
may reduce faecal elimination to zero, and with renal involvement urinary excretion is 
also reduced. In human poisoning thallium excretion has been observed in both faeces 
and urine persisting for many weeks despite low plasma levels. In unexposed persons, 
the highest tissue concentration of thallium has been found  in  hair.  In the long term, 
hair and,  to  a lesser extent,  nail  provides an  important additional  route for the slow 
excretion of thallium from the body. Thallium is also excreted in milk by nursing moth-
ers. 
Data are inadequate for the estimation of the biological half-life of thallium in humans, 
but observations in  a single case of severe thallium poisoning,  based  on  the  urinary 
excretion of thallium over a three-month interval, were consistent with a half-life of 30 
days  (Gastel  et  al.,  1978).  In  animal  studies  the  toxicokinetics  of thallium  can  be 
described in terms of a three-compartmental model consisting of: 
(i)  a  fast  exchange  compartment  comprising  blood  and  well  perfused  peripheral 
organs; 
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Figure 1  : Frequency distribution of thallium concentrations in 24-hour urine samples of a popula-
tion  (N = 1265) living near a cement plant emitting thallium containing dust (Brockhaus 
et al.  1981) 
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Figure 2:  Frequency distribution of thallium concentrations in  hair samples of a population  (N  = 
1163) living near a cement plant emitting thallium containing dust (Brockhaus et al. 1981) 
86 (ii)  a slow exchange compartment comprising brain as the target organ for neurotox-
icity; 
(iii)  a compartment comprising intestine in which there is an extensive entero-enteral 
cycle. 
This three-compartment model has been shown to be applicable to humans (de Groot 
and van Heijst, 1988). The elimination half-life after a toxic dose of 10 mg thallium/kg 
body weight has been estimated to be about 4 days in the rat and 6.5 days in the dog. 
A total body clearance of about 75 ml/min has been calculated for humans. Because 
of impaired excretion in  both faeces and urine,  in  severe thallium poisoning half-lives 
of 9.5  days and  15 days  have been  reported for  patients with  impaired  elimination 
(Koshy and Lovejoy, 1981) corresponding with a total body clearance of 20-35 ml/min. 
Biological  indicators 
Indicators of internal dose 
Only  limited  studies  have  been  performed  on  thallium  concentrations  in  blood  and 
urine in unexposed persons. In one study, the concentration of thallium in whole blood 
was  estimated  by atomic absorption spectrophotometry in  320 inner city children  in 
New Jersey between the ages of 1 and 5 years. Values ranged between non-detectable 
(less than 5 tJg/litre)  and 80 tJg/litre,  with a mean concentration of 3.0 tJg/litre. About 
80% of the children showed no detectable thallium in blood, 17.5% had between 5 and 
20 tJg/litre, while five children had levels between 40 and 80 t.tg/litre, although all were 
without any evidence of thallium toxicity (Singh et al.,  1975). The authors stressed that 
thallium content of blood is not a reliable indicator of body burden of thallium or thal-
lium intake. 
Thallium concentration  in  early morning urine samples in  nine non-exposed subjects 
ranged from  0.13 to  1.69 tJg/litre  (Weinig  and Zink,  1967). Smith and Carson (1977) 
gave a range of 0.6 tJg/litre to 2.0 tJg/litre with a mean urinary thallium concentration of 
1.3 tJg/litre. 
Twenty-four hour urine samples and  hair samples from  over 1 000 subjects living in 
the vicinity of thallium emitting cement plants together with samples from a reference 
population were estimated for thallium concentration by electrothermal atomic absorp-
tion spectrometry equipped with a heated graphite furnace atomizer (Brockhaus et al., 
1981). The mean thallium urinary level in the reference group from the rural area was 
0.4 tJg/litre ± 0.2 tJg/litre, range < 0.1-1 .2 tJg/litre, and from the urban area 0.3 tJg/litre 
± 0.2 tJg/litre, range < 0.1-0.9 tJg/litre.  By contrast, in the population living in the vicin-
ity of the cement  plant,  mean  urinary thallium  concentration  was  5.2 tJg/litre  ±  8.3 
t.tg/litre with a range from < 0.1-76.5 tJg/litre (Geometric mean 2.6 t.tg/litre.)  Hair thal-
lium levels were estimated only in the exposed populations with a mean value of 20.3 
ng/g ±42.7 ng/g (Geometric mean 9.5 ng/g.) The frequency distribution for urine and 
hair thallium concentrations is shown in  Figs 1 and 2. A questionnaire was also com-
pleted by each subject which included questions on health effects that could be related 
to increased thallium intake. No control subjects were taken and no objective tests per-
formed. From the replies to the questionnaire a clear dose-response relationship was 
found  between  thallium  in  urine  and  the  prevalence  of sleep  disorders,  tiredness, 
weakness, nervousness, headache, paraesthesia and muscle and joint pain. A similar 
exposure-response relationship was found  when  hair thallium was taken as the indi-
cator of exposure. However, a negative correlation was found between urine and hair 
thallium  levels and  hair loss.  The thallium content of the pyrite additive used in  the 
cement plants was about 400 ppm, giving rise to a total thallium emission of about 5 
kg/24 hours. 
From September 1979 the use of thallium additives containing more than 2 ppm was 
prohibited  and the local  population  was  advised to avoid the consumption  of home 
grown foodstuffs.  Follow-up studies were performed on the local population together 
with  a health questionnaire as  given above,  special attention  being  paid to children 
attending a kindergarten in the vicinity of the cement plant (Dolgner et al.,  1983). As 
compared  with  their reference  population  with  a  mean  urinary thallium  level  of 0.3 
pg/litre ±0.14 tJg/litre, thallium excretion fell over a three-month period from a mean of 
5.2 ±8.3 tJg/litre to a mean of 3.0 ±5.6 tJg/litre,  with a range from 0.2 to 37.7 t.tg/litre. 
Almost 20% of the population studied still had a urinary thallium concentration above 
87 5 ~g/litre. No clear evidence of adverse health effects was reported in this study. The 
authors concluded that there was  no  likely causal relationship between thallium and 
the occurrence of congenital malformations in the children identified. 
Spot samples of urine were collected for thallium estimation together with a medical 
history  and  physical  examination  from  128  male  workers  from  the  cement  plants 
referred to above (Schaller et al.,  1980). In contrast to the population sample who had 
ingested thallium containing locally grown foodstuffs, the thallium levels in the urine of 
the workers were only slightly or moderately elevated, with a range of less than 0.3-
6.3 ~g/g creatinine, where an upper normal limit of thallium excretion in urine was com-
puted at 1.1  ~g/g creatinine.  The investigators reported  no evidence of symptoms or 
signs characteristic of thallium poisoning, but gave no details of the examinations per-
formed. 
In  a further study on  the cement plant workers, 36,  selected at random,  had thallium 
levels estimated in blood, urine and hair together with a neurological examination and 
electrophysiological investigation including motor and sensory nerve conduction veloci-
ties, evoked potentials and electroencephalography (Ludolph et al., 1986). One half of 
the examined workers suffered from concurrent disorders, including diabetes mellitus. 
While multiple symptoms and signs of neurological disorder were detected, no corre-
lation was found between the electrophysiological findings and thallium levels in blood, 
urine or hair. Urinary thallium levels were increased above 5 ~g/litre in five of the exam-
ined workers, blood thallium levels above 2 ~g/litre were found in  16 workers and hair 
thallium levels above 20 ~g/kg in four workers. The investigators concluded that more 
thorough  epidemiological techniques would  be  required  to  reveal  a possible  causal 
relationship between chronic low-dose thallium exposure and neurological deficits. 
Urinary thallium was estimated  in  a group of non-exposed individuals and  in  workers 
from  two  cement  factories  and  two  cast  iron  factories  using  a  sensitive  ETA-AAS 
method with  a L'Vov  platform and deuterium  background  correction.  (Apostoli  et al., 
1988) While thallium was not detectable in  the materials examined or in  air samples 
from the factories, significantly higher thallium levels were found in the workers com-
pared with the reference sample. 
Table  1  :  Urinary thallium  concentrations  in  workers with  suspected  thallium  exposure 
(From Apostoli et al., 1988). 
Groups  Number  Mean  Tl  Urine Jlg/litre 
exposure 
length  Mean and  Range 
(years)  SD 
Not exposed  72  0.22±0.14  O.OEH>.61 
Cement factories  30  0.38±0.30
2  0.08-1.22 
Cement workers I  20  14.3±9.3  0.40±0.34  0.08-1.22 
Cement workers II  10  11.7±7.4  0.33±0.16  0.09-0.60 
Cast iron foundries  21  0.33±0.27
1  0.06-1.04 
Cast iron foundry W1  12  15.4±8.2  0.29±0.21  0.06--0.70 
Cast iron foundry W2  9  16.8±7.8  0.38±0.29  0.1o-1.04 
1  p < 0.001.  2  p < 0.05. 
A study has  recently been  completed  on  unexposed  healthy subjects  living  in  three 
provinces of North  Italy with  the aim  of determining trace element concentrations in 
urine, whole blood, serum (or plasma) and of determining reliable reference values for 
a series of elements, including thallium (Minoia et al.,  1990). The collection, handling 
and storage of samples was carried out under rigorous standardized protocols. Ana-
lytical procedures included electro-thermal atomic absorption spectroscopy (ETA-AAS), 
inductively coupled plasma atomic emission spectrometry (ICP-AES) and neutron acti-
vation analysis (NAA). The subjects selected for this study were from both urban and 
rural areas and were screened by means of a questionnaire, clinical examination and 
a haematological and biochemical series of tests to exclude subjects outside the nor-
mal range. Those with a history of occupational exposure to metal compounds, heavy 
smokers, those under physiological stress and those with certain defined disease cat-
egories were excluded. The values obtained for thallium are shown in Table 2. 
88 Table 2: Thallium concentration in 24-hour urine samples, blood and serum of healthy Ital-
ians (From Minoia et al., 1990). 
Thallium concentration Jlg/litre 
Sample  Number of  Mean  Expl
1  Reference  Range of  Upper limit 
subjects  ±a mt
1  range  values  uncer- metabolic 
(XL- XM)  (range)  tainty  anomalies 
Urine  496  0.42±0.09  (0.06-- 0.07-0.7  > 0.7-0.82  > 0.82 
0.82) 
Blood  418  0.39±0.05  (0.1-1.1)  0.15-0 .63  > 0.63--1.1  > 1.1 
Serum  360  0.18±0.009  (< 0.05- 0.02-0.34  > 0.34 0  >0.4 
0.4)  0.4 
1Mean value± o mt where om is o/nv•,  o is the standard deviation, n is the number of observa-
tions, and tis the Fischer coefficient for n-1  (p = 0.05). 
Hair thallium levels were estimated by inductively coupled argon plasma (ICAP) emis-
sion spectroscopy in  199 children and 322 adults from a non-exposed population in a 
study which sought an age-dependent excretion in hair of a series of metals (Paschal 
et al., 1989). In adults a geometric mean of 0.056 Jlg/g hair compared with a geometric 
mean of 0.066 Jig  thallium/g hair in children, showing no significant difference. 
In a group of 39 workers engaged on the manufacture of alloy anode plates for use in 
magnesium seawater batteries where one of the magnesium alloys included 5% thal-
lium, 29 workers had urinary thallium levels below 50 Jig/litre, seven workers had lev-
els between 50 and 1  00 Jig/litre, while three had values up to 236 Jig/litre with a median 
value of 28.0 Jig/litre (Marcus,  1985). Urinary thallium estimation was carried out using 
the colorimetric method of Jacobs but no details were given. Following the introduction 
of a code of practice and  of atomic absorption spectroscopy (Wall,  1977) for thallium 
estimation, urinary thallium levels fell to a median value of 0.5 Jig/litre, with a highest 
outlying value of 5.2 Jig/litre.  Random environmental samples using Casella personal 
monitors showed a maximum level of airborne thallium of 0.022 mg/m
3
. All the workers 
were without evidence of thallium poisoning, as ascertained through a review of their 
existing medical records. 
It has been proposed (Giomme,  1983) that a urine thallium level of 300 Jig/litre should 
be considered the threshold for thallium poisoning until an agreed figure is established. 
The ACGIH (1977) stated that despite extensive studies on thallium poisoning, no sat-
isfactory data exist from which to derive an  airborne threshold limit value for thallium. 
The current value of 0.1  mg/m
3  had  been based largely on  analogy with other highly 
toxic heavy metals.  Marcus (1985),  using accepted physiological parameters, consid-
ered that 40 hours per week exposure to thallium at an  airborne concentration of 0.1 
mg/m3  would correspond to a concentration of thallium in  urine of about 100 Jig/litre. 
He considered a level of 300 Jig/litre for thallium in urine to be too high and suggested 
the alerting level requiring action should  be  no more than 50 Jig/litre.  It should,  how-
ever, be pointed out that the purpose of the 300 Jig/litre limit proposed by Glom me was 
considered to be the threshold for thallium poisoning, and not the level at which effec-
tive preventive action should be taken. 
Indicators of effect 
Following long-term,  low-level exposure, as has occurred in  particular in  the occupa-
tional environment, a pattern of symptoms and clinical signs compatible with a diagno-
sis of early or subacute thallium poisoning requires evaluation with  regard to a differ-
ential diagnosis.  In  particular paraesthesia requires careful evaluation as an  indicator 
of neurotoxicity. Thallium poisoning should be considered in all cases with unexplained 
neurological symptoms or signs, in  particular where accompanied by  painful extremi-
ties, and the urine screened for thallium without waiting for hair loss to occur. 
Experimental in vivo studies have demonstrated inhibition of delta-aminolaevulinic acid 
dehydratase and ferrochelatase following thallium exposure. Alterations in haemo- and 
haemo-dependent enzyme activity has been shown to be closely related to disruption 
of the  hepatic  endoplasmic  reticulum  (Woods  and  Fowler,  1986).  It  has  been  sug-
gested that estimation of porphyrins in  blood  and  in  urine may prove to be  a useful 
early indicator for evidence of thallium cellular toxicity (Fowler,  1988). Abnormal liver 
function,  in  particular  raised  transaminase  levels  and  abnormal  renal  function  evi-
denced by proteinuria may also be regarded as indicators of effect. 
89 Conclusions 
There are  numerous reports  of acute thallium  poisoning,  and the clinical  and  patho-
logical features of this condition have been extensively described. The adverse health 
effects of lower level, long-term exposure to thallium require further investigation. It has 
not as yet been possible to relate subjective symptoms in thallium exposed workers to 
indicators of internal dose, and no dose-response relationship has been identified. Fur-
thermore,  from  the  nature  of the  effects  produced,  in  particular  on  the  central  and 
peripheral nervous system, thallium is likely to be a metal with a continuum of toxicity 
in  which  clinically  apparent effects  have  their  asymptomatic,  subclinical  precursors. 
Such biological markers for thallium have yet to be identified. 
Estimation of the concentration of thallium  in  urine is of value  in  monitoring subjects 
with occupational exposure. 
Data are inadequate for the evaluation of the relationship between occupational expo-
sure levels and thallium concentrations in blood. However, because of rapid disappear-
ance of thallium from  blood,  it is  unlikely that blood levels would be of value for bio-
logical monitoring. 
Hair and nail clippings, and tissue samples, are of value in the diagnosis of acute thal-
lium poisoning. However, with regard to occupational exposure external contamination 
of hair may invalidate this approach. 
Research needs 
The use of urine samples for biological monitoring,  in  particular with  regard to expo-
sure levels in the working environment, requires further evaluation. 
The estimation of thallium levels in  hair and  in  nail requires further investigation with 
regard  to their  usefulness in  monitoring for past exposure,  in  particular in  situations 
where long-term,  low-level exposure may occur. 
The estimation of porphyrin levels in blood and in urine requires further study to evalu-
ate the usefulness of this approach in detecting specific early evidence of thallium tox-
icity. 
Because of the occurrence of paraesthesia as an early symptom of thallium poisoning, 
detailed electrophysiological studies, including both sensory and motor nerve conduc-
tion velocity should be performed on thallium exposed workers. 
Analytical methods 
Simple colorimetric methods are available for the determination of thallium in urine. In 
the 'rhodamine B method' (Bank et al., 1972), thallous ions are oxidized by adding bro-
mide reagent and complexed with  rhodamine B which is extracted with  benzene, giv-
ing a fluorescent red colour at 254 nm under ultraviolet light. The detection limit for this 
screening test,  which  can  be  applied to one drop  of urine,  has  been  given  as  0.03 
J.Lg/ml. 
The routine estimation of thallium in urine and other biological samples is by means of 
flame or graphite furnace atomic absorption spectroscopy. The methods in current use 
are sensitive,  specific and  accurate and  these have been  reviewed  by  Leloux et al. 
(1987a).  However,  wet  digestion  and  extraction  methods  have  to  be  used  as  pre-
treatment to  reach  detection limits of 6 x  1  o-s  g/kg.  Using  graphite furnace  methods 
detection limits of 5 x 1  o-s g/litre can  be achieved without additional preconcentration 
steps.  Stabilized temperature platform furnace technology enables isothermal atomi-
zation,  which  can  result in  higher sensitivity and  which  is  less time consuming than 
extraction method.  (Leloux et al.  1987 b). 
Thallium in hair and nail clippings has been estimated by means of neutron activation 
analysis (Henke and  Fitzek,  1971 ).  The detection limit of the method has been given 
as 0. 1 J,Lg/kg.  More recently thallium levels in hair have been estimated by I  CAP emis-
sion spectroscopy (Paschal et al.,  1989). 
Radiochemical  neutron activation  analysis has  been  developed for the estimation of 
thallium at the cellular level in  metabolic studies (Sabbioni et al.,  1988). 
The need for a rigorous, standardized protocol to minimize contamination of biological 
samples during collection, handling and storage has been addressed by Minoia et al. 
(1990). 
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92 II-Tin 
Summary 
Inorganic tin, predominantly in tetravalent form, is widely but unevenly distributed in the 
earth's crust and present in many foodstuffs.  Mono-, di-,  .:ri- and tetra-organic tin com-
pounds have been synthesized for use in the chemical ir1dustry, for use as stabilizers 
and as biocides. A number of these are  environmental pollutants and  have produced 
gross disturbance of ecosystems. 
Inorganic tin compounds are of a low order of toxicity. Ingestion of high concentrations 
of soluble tin  salts  in  canned foods and  fruit juices may cause  gastroenteritis,  while 
inhalation of tin oxide dust has given rise to a benign pneumoconiosis, without pulmo-
nary fibrosis.  In contrast, certain organic tin compounds, in  particular trimethyl and tri-
ethyl tin,  are  highly toxic giving  rise  respectively to  cell  damage and  oedema in  the 
central  nervous  system.  Dibutyl  and  triphenyl  tin  cause  bile  duct damage  and  liver 
damage,  respectively,  and  many  of  these  compounds  are  skin  and  eye  irritants. 
Immune system  suppression  has  been  demonstrated  in  experimental  animals,  with 
thymic atrophy and lymphopenia. 
Inorganic tin  is  poorly absorbed, the  highest concentration  being  found  in  bone  with 
lower  levels  in  kidney  and  liver.  High  concentrations  have  been  found  in  the  lungs 
which can be considered to be the critical organ in those occupationally exposed to tin 
oxide.  The average concentration of tin  in  whole blood  is  of the order of less than 2 
ng/ml to 5ng/ml.  Excretion occurs via urine and  bile. Average urine levels have been 
variously reported  between one and 20 pg/litre, with an  increased excretion following 
an  increased daily intake. The biological half-life in  human bone has been  estimated 
of the order of 400 days. 
With regard to the organic tin compounds, absorption, distribution and metabolism are 
highly influenced  by  both  number and  type  of  covalently  bound  radicals.  Thus  gas-
trointestinal  absorption  increases with  increasing  number of radicals  and  decreases 
with size. Absorption also occurs through the skin.  Excretion occurs mainly into urine 
and, to a lesser extent, in faeces via bile. While the central nervous system is the criti-
cal organ for organic tin compounds, data on availability and on critical organ concen-
tration are lacking. 
Blood and  urine are likely to  be the most appropriate indicators of internal dose and 
most useful for biological  monitoring for  both  inorganic and  organic tin  compounds, 
although data are inadequate for such monitoring at present in  part due to analytical 
difficulties at low levels. Data are also lacking on  indicators of effect. 
Both  inorganic tin  and  lead  are  deposited  in  bone and  inhibit b-aminolaevulinic acid 
dehydratase.  Both  triethyl  tin  and  triethyl  lead  influence  mitochondrial function,  the 
activity of glutathione transferase  and  the  utilization  of ATP  for sodium  and  calcium 
transport. 
Research is required in particular to ascertain whether significant interference with the 
haemo-synthetic pathway occurs in  humans and whether this may be  of value as an 
early indicator of effect. Further work is required on analytical procedures to establish 
the  relationship  between  exposure,  concentration  in  blood  and  urine  and  possible 
health effects. It is necessary to investigate the possible effects on the immune system 
93 of low-level exposure to organic tin  compounds in  those occupationally exposed,  in 
view of the suppressive effects observed in experimental animals. 
Introduction 
Chemical and physical properties 
Tin  (chemical symbol Sn) is a soft, lustrous white metal of tetragonal crystalline form, 
which converts slowly to grey tin, of cubic form, and which converts further, on heating 
to over 200 oc to a brittle, white rhombic form. Tin  is of atomic number 50,  melting at 
231 .9 oc  and  boiling at between 2 26Q-2 270 oc.  Tin  has oxidation states at +2  and 
+4,  giving rise to a series of stannous and stannic compounds, the latter being more 
covalently bound. The principal salts of industrial significance are tin oxides, in particu-
lar stannic oxide,  stannic  and  stannous  chloride,  fluorides  and  halogenated  sodium 
stannates. Tin forms one to four covalent bonds with carbon, giving rise to mono-, di-, 
tri- and  tetraorganic  tin  compounds,  those  more  commonly  encountered  being  the 
methyl, ethyl, butyl and octyl organic tins in mono- to tetra-forms, and triphenyl and tri-
cyclohexyl tin. The complex chemistry of tin is considered in detail by Harrison (1989). 
Production and industrial uses 
Tin  is  extracted  most  commonly from  stannic  oxide;  occurring  as  cassiterite  in  the 
earth's crust. A small proportion of tin is recovered from secondary smelting operations. 
The metal is most used for tin  plating, acting as a protective coating for other metals, 
and because of its pliability and ready combination with other metals, it forms a large 
number of useful alloys, in particular alloyed with copper to produce bronze. Inorganic 
tin  compounds  are  used  in  ceramics  and  in  the  textiles  industry.  A wide  range  of 
organic tin compounds have increasing uses as catalysts and  in  organic synthesis in 
the chemical industry. The dialkyl tins are used as stabilizers for PVC plastics, the tri-
substituted organic tins are widely used as biocides, with in  particular tributyl tin used 
in anti-fouling paints for the protection of ships' hulls from molluscs, and triphenyl tin in 
agricultural pesticides. Tin  is a component of dental amalgam, and tin  porphyrins are 
being developed for their potential use as chemotherapeutic agents. 
Environmental and occupational exposure 
Tin  is  widely  but  unevenly  distributed  in  the  earth's  crust  with  soil  concentrations 
between about 2 and 200 J1g/kg. Anthropogenic sources greatly exceed natural emis-
sions into the atmosphere, the principal sources being industrial emissions and organic 
tin biocides. The latter by leaching from  paint films on  ships' hulls have been respon-
sible for high  pollution levels in  harbours,  marinas and  lakes producing gross distur-
bance of ecosystems  (UNEP,  1981). Toxic  effects in  the aqueous environment have 
been observed at levels of tributyl tin at or below 1 ppb (We is and Kim,  1988). Biom-
ethylation of inorganic tin  (Sn+ 
4
)  has been shown to occur in the marine environment 
(Brinckman  and  Olson,  1988). Atmospheric  concentrations of tin  are  of the  order of 
0.01 J1g/m3  as a background level, rising to 0.3 J1g/m
3  in some urban areas and to over 
4 J1g/m3  in the vicinity of industrial emissions (WHO,  1980). Much higher levels, of the 
order of several  mg/m
3
,  have  been  encountered  in  smelters and  workplaces where 
concentrates of tin ores are handled. 
Tin  is  present in  trace amounts in  most foods.  It has  been  used  extensively for the 
coating of cans, for household utensils and  as tin foil for the wrapping of some foods 
and  pharmaceuticals. Average  daily intake  has  been  variously quoted  ranging  from 
187 J1g/day (Hamilton and Minski,  1972/73) in the UK to between 1.5 and 8.8 mg/day 
in the USA (Tipton et al.,  1969). In tinned foods, the tin content increases with low pH, 
high storage temperature and delay in consumption after opening (WHO 1980). Widely 
varying levels of tin intake in different populations are likely to reflect differences in con-
sumption of tinned foods and  in their packaging, lacquered can surfaces reducing the 
tin content. In one total diet study performed in five Italian towns daily tin intake ranged 
from 335 Jlg to 1 41 0 Jlg/day (Byrne and Kosta,  1979). 
94 Table 1: Tin content of Italian freeze-dried total diet samples. {From Byrne and Kosta, 1979). 
Town diet sample  Dry weight  lln concentration  Daily tin intake 
(g)  (j.Jg/g,  mean ±SD)  (j.Jg) 
Aosta  310  4.2±0.4  1 300 
L'Aquila  173  8.15±0.5  1 410 
Montfalcone  278  1.2±0.2  335 
Mount Amiata  377  3.5±0.02  1 320 
Rome  285  1.2  340 
Effects in humans 
While tin is  a non-essential element,  because of its lack of toxicity it has  been used 
extensively in the food industry.  However the ingestion of more than 50-1 00 mg of tin 
from acid fruit juices stored in unlacquered tin cans has given rise to outbreaks of diar-
rhoea and vomiting. Similarly the inhalation of tin oxide dust or fumes is relatively non-
toxic,  although deposition of inhaled particles in the lung gives rise to minute, dense 
nodular opacities without significant fibrosis or loss of pulmonary function. The radio-
logical appearance of this benign pneumoconiosis is termed stannosis. 
The organic tin compounds contrast sharply with regard to their adverse health effects, 
certain compounds, in  particular trimethyl and triethyl tin being highly toxic.  In general 
the toxicity of the trialkyl  organic tin  compounds  is  related  to the  length  of the alkyl 
radical, the short chain compounds being more toxic than the long chain ones, the lat-
ter being  less readily absorbed  (Barnes and  Stoner,  1958). The mono-alkyl tin com-
pounds are less toxic, and the toxicity of the tetra-alkyltin compounds is due to the tri-
alkyl  compound  resulting  from  enzymic dealkylation.  Extensive animal  experimental 
studies have been performed with a variety of organic tin  compounds and these have 
been reviewed by Magos (1986), by Aldridge and Brown (1988), and by Selwyn (1989). 
In  humans  both  local  and  systemic effects  have  been  observed.  Workers  handling 
dibutyl and tributyl tin have developed eye and skin irritation with conjunctivitis and dif-
fuse erythematoid dermatitis. Brief contact has resulted in acute burns with early recov-
ery following rapid removal from exposure, but with a lethal effect following prolonged 
contact. 
The target organ following absorption of trialkyl tin is the central nervous system,  but 
speciation of the compound determines the nature of the damage produced. Thus tri-
methyl tin causes  cell  loss due to  neuronal  necrosis in  the  central  nervous system, 
while triethyl tin  gives rise to  oedema of the  brain and spinal cord  with  intramyelinic 
vacuolation.  In  France,  more than  100 people died and several hundreds were pois-
oned  following  the  ingestion  of Stalinon,  a  proprietary  pharmaceutical  used  for the 
treatment of acne,  which  had  been  contaminated  with  up  to  1  0%  triethyl  tin  iodide. 
Symptoms and signs were those of increased intracranial pressure. The principal find-
ings were oedema of the brain and spinal cord (Aiajouanine et al.,  1958). 
Following  occupational  exposure,  a chemist working  with  trimethyl tin  developed  in-
somnia, absent-mindedness and hyperactivity followed by recovery after removal from 
exposure (Brown et al., 1979). Two other chemists developed similar symptoms which 
were ignored and which proceeded to mental confusion with generalized epileptiform 
convulsions.  Again,  recovery  was  complete  following  removal  from  exposure,  (For-
temps et al.,  1978). Two  farmers  handling triphenyl tin acetate used  as  a fungicidal 
spray developed asthenia, vertigo, severe headaches, vomiting and  photophobia fol-
lowed by recovery (Manzo et al.,  1987). Tremor,  hallucinations and  psychotic behav-
iour have also been reported.  Of a group of six workers exposed to trimethyl tin,  one 
died after 12 days with neuronal necrosis involving cerebellar Purkinje cells. Two other 
workers survived with severe memory and cerebellar deficits (Besser et al.,  1987). 
Bile duct proliferation and  liver damage have  been  observed  in  animal  experimental 
studies in particular with dibutyl and triphenyl tin compounds. Reports of liver damage 
following human exposure have been uncommon (Mijatovic,  1972). Dose-related kid-
ney damage has been  reported  in  rats  and  monkeys with trimethyl tin,  ranging from 
slight vacuolation to extensive degeneration of proximal tubular cells after three days 
(Opacka and Sparrow,  1985). 
Extensive studies have also been performed on  animals on  the immunosuppressive 
effects of organic tin compounds. A series of di- and tri-substituted organic tin  com-
pounds induce thymus atrophy associated with a reduction in spleen and lymph node 
95 weights and  reduction  in  circulating  lymphocytes.  Function  studies  have shown  evi-
dence of diminished T-cell  mediated immunity and  depression  of non-specific resis-
tance (Penninks et al.,  1990). Observations on  immunomodulatory effects in  humans 
are lacking. However inhibition of proliferation of human thymocytes has been demon-
strated in vitro with dibutyl tin  (Penninks and  Seinen,  1980). 
The high toxicity of the organotin compounds is reflected in the ACGIH threshold limit 
value (TLV)  of 0.1  mg  Sn/m
3  compared with 2.0 mg Sn/m
3  for tin, tin oxide and other 
inorganic compounds with the exception of tin tetrahydride. 
Metabolism 
Absorption 
Following ingestion, inorganic tin is poorly absorbed from the gastrointestinal tract. Two 
male  and  two female  volunteer  subjects  with  undetectable tin  levels  in  blood  (<  2 
ng/ml) each consumed 60 mg tin in fruit juice from an unlacquered can. Blood samples 
taken  after two,  five and  24  hours showed,  in  the females,  detectable tin  at 3 ng/ml 
only in the five-hour samples. One male showed a peak of 4. 7 ng/ml after two hours, 
the  other  of 3.9  ng/ml  after  24  hours,  the  remaining  samples  having  undetectable 
amounts (Byrne and  Kosta,  1979). Another study in  humans in  which 50  mg  tin  was 
added to the diet estimated absorption to be of the order of 3%  (Johnson and Gregor, 
1982).  However,  when  intake  was  reduced to  about  0.1  mg/day,  the  proportion  ab-
sorbed  increased  to  about  50%  of the  total.  Following  inhalation,  tin  oxide  dust  is 
deposited in the lungs but there are no reliable data on absorption from this site. 
The organic tin compounds are more readily absorbed from the gastrointestinal tract. 
In  general,  gastrointestinal absorption increases with the  number of organic radicals 
and decreases with their size.  In studies in the rat,  trimethyl tin has been shown to be 
almost totally absorbed (Brown et al.,  1979) while the absorption of monoethyl tin has 
been estimated to be of the order of 8%. (Bridges et al., 1967) Similar large differences 
in  absorption have been shown  with  other organic tin  compounds. Absorption  of the 
short chain alkyl tin compounds and of triphenyl tin also occurs through the skin. 
Distribution 
All  human tissues contain tin,  in  variable amounts.  Following absorption inorganic tin 
accumulates and  is  stored  mainly in  bone with  lower concentrations in  liver and  kid-
neys. The inhalation of tin oxide leads to a progressive accumulation in  the lung  with 
age.  Following occupational exposure,  high levels of tin  oxide are found in the lungs. 
Following absorption, certain organic tin compounds are followed by enzymic dealky-
lation.  Thus,  tetramethyl tin  is  rapidly dealkylated to  trimethyl tin  and tetraethyl tin  is 
metabolized to triethyl  tin,  mainly by the  mixed  function  oxidase  system  in  the  liver 
(Cremer,  1959). 
While  there  are  extensive  data on  the  distribution  of a number of organic tin  com-
pounds in experimental animals, data in  humans are lacking.  In  general, tissue distri-
bution differs both  with  speciation of the organic tin compound and  with  animal spe-
cies. Examples are given to illustrate these points: in the rat,  retention of injected tin in 
the  brain  was found  to  increase in  the following  order:  tricyclohexyl tin,  triphenyl tin, 
tributyl tin,  tripropyl tin,  trimethyl tin  and  triethyl tin  (Mushak et al.,  1982).  Thus,  the 
neurotoxic  effects  of  trimethyl  and  triethyl  tin  could  in  part  be  attributed  to  their 
increased availability to the central nervous system.  In the blood of the rat,  both trim-
ethyl and triethyl tin are located mainly in the red blood cells, but this is not so in other 
experimental animals. As a result of this high affinity of rat haemoglobin for these two 
alkyl tin compounds, four hours following the intravenous injection of 1  0 pg/kg triethyl 
tin chloride the blood concentration of tin was found to be 26.6 pg/ml in  rats and just 
below 1.0 pg/ml in  hamsters and  guinea-pigs  (Rose  and Aldridge,  1968)  The tissue 
concentrations 24 hours following injection were,  in decreasing order,  blood, liver, kid-
ney and brain.  In the rat,  following oral administration, dimethyl tin has been shown to 
cross the placental barrier and to accumulate in foetal brain (Noland et al.,  1983). Fur-
ther data on tissue distribution of organic tin  compounds in  animal species are given 
by Magos (1986). 
96 Excretion 
Inorganic tin is excreted mainly into urine and to a lesser extent in faeces via the bile. 
In  humans,  an  increased dietary intake of inorganic tin  is  reflected  by an  increased 
excretion in  the urine  (Johnson  and  Gregor,  1982). Mono- di- and trimethyl tin  have 
been identified in  human urine samples (Braman and Tompkins,  1979). 
Organic tin compounds are also excreted mainly into urine and to a lesser extent into 
faeces via the bile, but with certain exceptions. Thus, due to high biliary excretion, the 
faecal  excretion of diethyl tin  in  the rat was found to be twice as high  as the urinary 
excretion (Bridges et al.,  1967). 
After occupational exposure to triphenyl tin, the urinary excretion of tin has been shown 
to be increased (Manzo et al.,  1981). 
Biological indicators 
Indicators of internal dose 
Widely varying values have been reported by different investigators for levels of tin in 
blood and in  urine in the general population,  in  part due to analytical problems at low 
levels and to the  lack of inter-laboratory comparison.  Normal values for tin  in  blood 
have  ranged  from  non-detectable to  290 Jlg/litre  and  in  urine  between  1.0  and  65 
Jlg/litre in different studies. More recent studies have shown lower values, probably to 
be  related to improved analytical procedures. Thus, the mean concentration  of tin  in 
blood  has been  given as  5 Jlg/litre  (Hamilton  et al.,  1972/73),  and  in  a series of 14 
unexposed subjects, below a detection unit of 2 ng/ml (Byrne and Kosta,  1979). Total 
tin concentration in plasma was found to be 3.3±2.92 Jlg/1 00 g in a group of eight work-
ers engaged in soldering processes, compared with  1. 76±0.35 Jlg/1 00 g in a group of 
controls.  (Ogihara et al.,  1981) 
In urine, in a series of 11  unexposed male subjects the average tin concentration was 
1.0 Jlg/litre, of which  18% of the total excreted was present in methylated forms (Bra-
man  and  Tompkins,  1979).  The  individual  values  are  shown  in  Table  2.  Possible 
mechanisms for the biomethylation of tin on the basis of oxidation-reduction chemistry 
and the environmental conditions under which this may occur are considered by Rid-
ley et al.  (1977). 
Table 2: Analysis of human urine samples for total and methylated forms of tin. (From Bra-
man and Tompkins, 1979). 
Subject  Tin  (IV)<  Methyltin  Dimethyltin  Trimethyltin  Total tin 
(Age)  Jig/litre  (%)  Jig/litre  (%)  Jig/litre  (%)  Jig/litre  (%)  Jig/litre 
26  0.36  64  ND  - 0.067  12  0.13  23  0.56 
47  1.0  83  0.041  3.4  0.11  9.2  0.017  1.4  1.2 
28  0.72  87  0.028  3.4  0.074  8.9  0.007  0.82  0.83 
28  0.92  77  0.089  7.4  0.11  9.2  0.041  3.4  1.2 
28  0.27  40  0.32  48  0.003  9.4  0.016  2.4  0.67 
26  0.93  90  ND  - 0.074  7.2  0.029  2.3  1.0 
30  1.1  85  0.15  12  0.049  3.8  ND  - 1.3 
25  1.1  69  0.27  17  0.17  11  0.074  4.6  1.6 
26  0.88  95  ND  - 0.035  3.8  0.012  1.3  0.93 
25  0.06  85  0.043  5.5  0.054  6.9  0.0023  2.9  0.78 
30  1.1  92  0.054  4.5  ND  - 0.055  4.6  1.2 
Average  0.82  82  0.09  9.0  0.073  7.3  0.042  4.2  1.0 
{ND  < 0.02 Jig/litre) 
Data on  blood  and  urine  levels following  occupational  exposure to  organotin  com-
pounds are lacking. Because of analytical difficulties regarding speciation, total tin con-
centration in  blood and urine are likely to be the better indicators of exposure.  In  one 
case of clinical poisoning by triphenyl tin acetate followed by recovery, samples taken 
on the day of exposure, showed by neutron activation analysis mean values of 48±29 
ng tin/ml for blood and  113±20.6 ng tin/ml urine on  six determinations (Manzo et al., 
1981). 
97 Indicators of effect 
There are no validated, specific indicators of effect for tin  or its compounds.  lnhala-
tional  exposure to  inorganic tin,  as  occurs  in  the occupational  environment,  is  best 
monitored  by  means  of routine  chest X-ray,  early  evidence  of stannosis,  a  benign 
pneumoconiosis, being an increase in  bronchovascular markings and hilar thickening. 
(Schuler et al.,  1958) 
As with  inorganic lead,  inorganic tin  has been shown experimentally to inhibit delta-
aminolaevulinic acid  dehydratase with  increased  coproporphyrin  levels in  blood  and 
urine (Chiba et al.,  1980).  In this study rabbits injected with tin chloride at 5 pmol/kg 
body weight sustained  a decrease  in  erythrocyte delta ALAD to  almost zero  levels, 
which remained low for two days before increasing to normal. Tin  has been shown to 
increase haemo-oxygenase activity in liver and kidney and to decrease the mitochon-
drial concentration of respiratory cytochromes (Kappas and Maines,  1976). 
Triethyl tin  accumulates in  brain  mitochondria,  inhibits oxidative phosphorylation and 
glucose oxidation and the incorporation of phosphate into brain phospholipids (Rose 
and Aldridge, 1968; Aldridge and Street,  1971; and Cremer,  1970). A number of other 
enzymes  are  inhibited  by  triethyl  and  trimethyl tin  (See Aldridge  and  Brown,  1988). 
These include adenosine triphosphatases, cytochrome oxidase,  NADP transhydroge-
nase,  hexokinase, pyruvate kinase, glutatione-s-transferase and cytochrome P-450 in 
liver and adenylate cyclase in brain. 
There is at present no evidence that any of the above possible mechanisms of action 
could provide indicators of early effect following human exposure. Similarly, there are 
no studies in  humans exposed to the di- and tri-substituted organic tin compounds to 
show whether the immunosuppressive effects demonstrated  in  experimental animals 
produce effects in  humans which could  be of value as early indicators of effect. 
Conclusions 
Inorganic tin and  its more commonly encountered compounds in the general and the 
occupational environment are of a low order of toxicity. Numerous animal experimental 
studies with  a range  of mono-,  di-,  tri- and  tetra-substituted  organic tin  compounds 
have shown a wide range of toxic effects involving, in  particular, the nervous system, 
the  liver  and  biliary system,  the  kidney,  the  immune  system,  the  skin  and  mucous 
membranes. Complex interactions with cellular proteins and enzymes have been dem-
onstrated.  The  speciation  of the  organic tin  compound  is  critical  with  regard  to  the 
effect produced, there is also evidence for species specificity. Of the large number of 
organic tin  compounds synthesized,  triethyl  tin  has  exhibited the  greatest hazard to 
humans followed by trimethyltin and tripropyltin. Tributyl tin,  because of its use as an 
anti-fouling agent,  has been  responsible for gross disturbance of marine ecosystems 
but has been less toxic to mammals. 
While, following exposure, tin  both  in inorganic and organic forms is present in  blood 
and  is excreted in urine, analytical methods have been insufficiently precise and spe-
ciation of organic tin compounds has been inadequate to enable blood and urine lev-
els to be used for biological monitoring as indicators of absorption. There are no quan-
titative  data  on  the  relationship  between  occupational  exposure  to  organic  tins  at 
different levels, the corresponding concentrations in blood and urine and their relation-
ship to adverse health effects. 
There are currently no early indicators of effect applicable to either inorganic or organic 
tin compounds. 
Biological monitoring of workers exposed to inorganic or organic tin compounds is not 
currently feasible  because  of inadequate data on  indicators of internal  dose  and  of 
early effect. 
Research needs 
(i)  The validation of reference values for inorganic tin in blood and urine and the spe-
ciation of organic tin compounds in biological samples. 
(ii)  Studies on  the  relationship between concentrations of tin  in  blood  and  urine and 
exposure levels, both in the occupational and the general environment. 
98 (iii)  To  ascertain  whether  the  effects  of  tin  on  haemosynthesis  and  on  porphyrin 
metabolism  observed  in  experimental  animals  also  occur  in  humans  and  if  so  to 
assess whether these might be used as early indicators of effect (Alessio and Deii'Orto, 
1988). 
(iv)  To ascertain whether abnormalities of liver function or of renal function,  in particu-
lar renal  tubular dysfunction,  may  occur following  low-level  exposure to  organic tin 
compounds. 
(v)  To  ascertain whether the immunosuppressive effects of the organic tins demon-
strated  in  experimental animals also  occur in  humans and to ascertain whether sur-
veillance of the immune response in workers exposed to organic tin compounds may 
provide an early indicator of an adverse effect. 
Analytical methods 
A variety of analytical techniques have been  used for estimating tin  in  biological and 
environmental samples. These include spark source spectrometry, emission spectros-
copy,  neutron  activation  analysis,  total  reflecting  X-ray fluorescence,  isotope dilution 
mass  spectrometry  and  atomic  absorption  spectrometry  with  flame,  furnace  and 
hydride/cold vapour techniques.  Platform furnace techniques with correction systems 
based on the Zeeman effect have increased detection power and reliability for estima-
tion of tin in  biological samples at low levels (Stoeppler,  1988). The wide range of nor-
mal values for blood and  urine quoted,  with  lower levels in  more recent publications 
could  in  part be  due to lower levels of tin  intake in  food  in  more  recent years but  in 
larger part to  improved analytical  methodology.  The  lack of inter-laboratory compari-
son  procedures  makes  it  difficult  to  evaluate  their  precision  and  accuracy.  Weber 
(1985)  considered  that tin  concentrations  in  blood,  plasma  and  urine cannot at the 
present time be regarded as reliable. 
With regard to the organic tin compounds, because of the analytical problems involved 
in their speciation in blood and urine, total tin concentration is perhaps the most useful 
indicator. The gas chromatographic speciation of hydrated tin compounds followed by 
atomic  absorption  spectrophotometric  estimation  is  one  promising  approach  to  the 
problem (Jackson et al.,  1982). 
With regard to the environment, the analysis of organic tin compounds in water and  in 
marine and  other sediments is one of the most actively researched areas in  environ-
mental organometallic chemistry. A summary of 27  reported  methods over the period 
1978 to 1988 of quantitative analysis of alkyl tin compounds from environmental matri-
ces is given by Ashby et al.,  (1988). 
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